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Mitochondria are a key organelle within human cells, with functions ranging from ATP 
synthesis to apoptosis. Changes in mitochondrial function are associated with many diseases, 
as well as ‘natural’ processes like ageing. Mitochondria have a unique evolutionary origin, as 
the result of an endosymbiotic relationship between a bacterium and an archaeal cell. 
Therefore, the phylogenetic history of the mitochondrial proteome is also unique within the 
total human proteome. A new description of the genes encoding the human mitochondrial 
proteome – IMPI (Integrated Mitochondrial Protein Index) 2017 – provided an opportunity 
for exploration of mitochondrial proteome history and the application of this knowledge to the 
understanding of gene function, disease and ageing. 
To facilitate the exploration of the mitochondrial proteome, I created a manually curated 
dataset of 190,097 predicted orthologues of the 1,550 IMPI 2017 human genes across 359 
species, using reciprocal best hit analysis as the basis for orthologue prediction. I used this to 
explore gene history and the potential for phylogenetic profiling to predict the function of 
uncharacterised genes. This inspired the use of phylogenetic profiling within two phyla of 
animals, to link presence and absence of metabolic genes to the function of mitochondrial 
transporters. Potential transport substrates were predicted for two groups of uncharacterised 
mitochondrial carriers. 
I also used the dataset to identify features of genes associated with monogenetic disease, as 
well as differences between recessive and dominant disease genes. A similar orthologue 
identification method was used to explore the total sequenced viral proteome for potential 
orthologues of mitochondrial proteins. This showed that a range of mitochondrial proteins are 
shared with viruses, potentially facilitating the co-opting of mitochondrial function during 
viral infection of eukaryotic cells. I then used orthology to explore the conservation of 
residues linked to protein acetylation and identify a link with lifespan in warm-blooded 
vertebrates.  
 iv 
In conclusion, I have used orthology to further the understanding of human mitochondrial 
proteome history and developed applications of this information. For example, phylogenetic 
features of disease genes are being used as part of a wider pipeline to predict mitochondrial 
disease genes. Furthermore, predicted substrates of the SLC25A14/30 mitochondrial carriers 
are being tested. My dataset provides further opportunities to explore the evolution and 
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What are mitochondria? 
Mitochondria are double-membrane bound organelles found in nearly all eukaryotic cells. 
Figure 1.1 shows a traditional diagram of a single mitochondrion, with the two membranes 
and the folds of the inner membrane known as cristae. Electron tomography work has shown 
that the cristae are only connected to the boundary inner mitochondrial membrane by small 
structures known as crista junctions, which allows tight regulation of protein and metabolite 
distribution within the cristae (Zick et al. 2009).   
 
Figure 1.1 Cut-through structure of a single mitochondrion, showing the inner and outer mitochondrial 
membranes, cristae and crista junctions (yellow dots). 
In vivo mitochondrial structure is more complex. Mitochondria are dynamic organelles in a 
constant state of flux, with fusion and fission facilitating the creation of an interconnected 
network (Chan 2006). Control of this network is important for maintaining mitochondrial and 
cellular health, and dysfunction of the network has been implicated in both monogenetic 
disease and neurodegenerative disorders (Westermann 2010). Mitochondria also form 
connections with other parts of the cell, including the endoplasmic reticulum (Giacomello & 
Pellegrini 2016), making them a highly connected and dynamic part of eukaryotic cells.  
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Powerhouse of the cell 
Mitochondria are often described as the ‘powerhouse of the cell’ and, indeed, they are the 
main site of aerobic production of adenosine triphosphate (ATP) – the energetic currency – in 
most eukaryotic cells. In mammals, including humans, the majority of ATP is produced by 
ATP synthase, located in the inner mitochondrial membranes which form cristae (Fernandez-
Moran 1962). ATP synthase activity is dependent on the proton gradient across the membrane 
(ΔpH), as well as the charge gradient across the membrane (Δψ), which combined are known 
as the proton motive force.  
In humans, the proton differential is produced by the action of the four protein complexes 
(complexes I – IV) which form the electron transport chain (Figure 1.2), plus the electron 
transfer flavoprotein (ETF). In general, these complexes couple energy-releasing redox 
reactions, involving electron transport between electron donors of increasing redox potential, 
to the transport of protons across the inner mitochondrial membrane into the intermembrane 
space formed by the cristae. Electrons can enter the electron transport chain from two electron 
carriers: NADH (nicotinamide adenine dinucleotide) and FADH2 (flavin adenine 
dinucleotide). 
 
Figure 1.2 Summary of the complexes of the electron transport chain and ATP synthase. The red line 
shows the flow of electrons. Q pool = pool of ubiquinol/ubiquinone; Cyt c = cytochrome c. 
Electrons from NADH enter the electron transport chain at complex I (NADH 
dehydrogenase), transferring to the flavin mononucleotide prosthetic group (Zhu et al. 2016). 
Electrons then move down a series of iron-sulphur clusters of increasing redox potential, 
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which is coupled to the movement of four protons across the inner mitochondrial membrane. 
Finally, the electrons, plus additional protons, are transferred to the hydrophobic electron 
carrier ubiquinone, forming ubiquinol which is free to move in the inner mitochondrial 
membrane.  
Electrons from FADH2 enter the electron transport chain at either complex II (succinate 
dehydrogenase) (Sun et al. 2005) or the ETF (Roberts et al. 1996). The reactions catalysed by 
these complexes are not directly coupled to proton transport. FAD+ is covalently bound to 
these complexes. Complex II is also part of the tricarboxylic acid cycle. Electrons and protons 
are released from the oxidation of succinate to fumarate and transferred onto a covalently 
attached FAD+ cofactor on complex II, forming FADH2. These electrons, along with two 
protons, are eventually transferred onto ubiquinone forming ubiquinol – the same endpoint as 
with complex I. Electrons from ETF also enter the ubiquinol pool, via the action of ETF 
dehydrogenase. 
Electrons from complex I, complex II and ETF, therefore, converge in the ubiquinol pool, and 
move through the remaining complexes in the same way. Reduced ubiquinol delivers 
electrons to complex III (coenzyme Q : cytochrome c oxidoreductase), with four protons 
pumped to the intermembrane space per ubiquinol (Rieske 1976). The reactions of complex 
III result in the production of two reduced molecules of cytochrome c, which move to 
complex IV (cytochrome c oxidase) (Capaldi 1990). Electrons moving through complex IV 
are used to reduce oxygen to water, with four protons pumped to the intermembrane space per 
oxygen molecule reduced, as well as using four matrix protons to form the water molecules. 
ATP is produced by the controlled re-entry of protons to the mitochondrial matrix through 
ATP synthase, driving the rotation of the c-ring. This is coupled to the production of ATP 
from ADP and inorganic phosphate (Pi) (Yoshida et al. 2001). As animals have eight 
c-subunits in their c-ring rotor and three ATPase subunits in the hydrophilic F1 domain, the 
movement of approximately 2.7 protons through ATP synthase into the mitochondrial matrix 
produces one molecule of ATP (Watt et al. 2010). ATP can then either be used within the 
mitochondria or transported out to the cytosol through the ATP/ADP transporter (Kunji 
2004), to act as a source of energy in a variety of biological processes. 
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More than the powerhouse of the cell 
The electron transport chain and ATP synthesis are only a small part of mammalian 
mitochondrial function. Mitochondria are also the site of a variety of metabolic pathways, as 
well as being linked to a range of other cellular processes (McBride et al. 2006). Central 
mitochondrial metabolism includes pathways with obvious links to energy metabolism, such 
as the tricarboxylic acid cycle, fatty acid -oxidation and the synthesis/consumption of ketone 
bodies; but also steps of nucleotide metabolism, amino acid metabolism (Nunnari & 
Suomalainen 2012) and steroid synthesis (Miller 2013).  
Mitochondria are important in the synthesis and processing of several cofactors. They are the 
location of the iron-sulphur cluster (ISC) assembly pathway (Stehling & Lill 2013) and a part 
of the haem synthesis pathway (Ryter & Tyrrell 2000) – both cofactors which coordinate iron. 
Mitochondria are also the site of the formation of adenosylcobalamin (an active derivative of 
vitamin B12) (Quadros 2010) and one of the early steps in the synthesis of molybdenum 
cofactor, which coordinates the transition metal molybdenum (Schwarz et al. 2009). These 
cofactors can be utilised by proteins within the mitochondria and/or other sub-compartments 
of the cell.  
Beyond metabolism and biosynthesis, mitochondria are involved in the process of apoptosis – 
the programmed death of a cell (Wang & Youle 2009). In particular, they participate in the 
intrinsic pathway of apoptosis (a.k.a. the mitochondrial pathway) which initiates cell death 
when the cell suffers certain stresses (e.g. DNA damage). These stresses trigger the 
permeabilisation of the mitochondrial membranes, causing the release of mitochondrial 
proteins into the cytoplasm. Several of these proteins have defined roles in apoptosis. For 
example, release of cytochrome c into the cytoplasm triggers the formation of the apoptosome 
(Zou et al. 1999), which drives the process of cell death.  
The mitochondrial apoptotic pathway is also connected to their involvement in calcium ion 
(Ca2+) homeostasis and signalling (Contreras et al. 2010). The mitochondrial Ca2+ 
concentration is very responsive to the cellular Ca2+ concentration, despite the low affinity of 
the mitochondrial calcium uniporter for Ca2+ (Rizzuto et al. 1993). This is due to contact sites 
between the endoplasmic reticulum (a Ca2+ storage site) and mitochondrial membranes, 
exposing mitochondria to localised high concentrations of Ca2+ (Csordás et al. 2006). 
Mitochondria act as overflow Ca2+ storage sites. Large and sustained increases in 
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mitochondrial Ca2+ concentration have been linked to the permeabilisation of mitochondrial 
membranes and, thus, apoptosis (Contreras et al. 2010). 
More complex cell-wide processes, such as movement through the cell cycle and signals 
controlling gene expression, have also been linked to the mitochondria (McBride et al. 2006), 
giving the mitochondria roles in both large- and small-scale cellular functions.  
 
The mitochondrial proteome 
The mitochondrial proteome consists of the proteins which localise to the mitochondria. 
These proteins then function in the many parts of metabolism and cellular activity in which 
mitochondria have been implicated. The size of the mammalian mitochondrial proteome has 
been predicted to be around 1,500 proteins (Meisinger et al. 2008). Human mitochondria 
contain their own circular genome (mtDNA). However, human mtDNA only encodes thirteen 
proteins (membrane subunits of the electron transfer chain complexes), twenty-two transfer 
RNAs and two ribosomal RNAs (Anderson et al. 1981). It is clear that the majority of the 
human mitochondrial proteome must be encoded on the nuclear genome and imported into the 
mitochondria, but which of the proteins encoded by the nuclear genome are part of the 
mitochondrial proteome? 
There have been several attempts to predict the human mitochondrial proteome, but there is 
not a definitive description. MitoP2 (Elstner et al., 2008) and MitoProteome (Guda et al. 
2007) are two older efforts, but these are no longer available online. MitoCarta (Pagliarini et 
al. 2008) and the more recent update MitoCarta 2.0 (Calvo et al. 2015) are two well-used 
predictions of the human mitochondrial proteome. MitoCarta integrates data from seven 
different experimental methodologies using a Bayesian classifier, producing a dataset of 
1,158 predicted human genes encoding the mitochondrial proteome.  
IMPI (Integrated Mitochondrial Protein Index) 2017 is a new attempt to predict the 
mitochondrial proteome (http://www.mrc-mbu.cam.ac.uk/impi). IMPI was created by training 
a machine learning classifier to separate training sets of mitochondrial and non-mitochondrial 
proteins based on a wide range of evidence types, some of which have not been previously 
used in attempts to define the mitochondrial proteome. These include: a large range of mass 
spectrometry studies, GFP (green fluorescent protein) tagging studies, mitochondrial targeting 
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sequence predictions from four programs and several species, antibody data and more. This 
classifier was then used to score all human genes based on their evidential properties, with 
genes above a score threshold of 0.8 assigned to the human mitochondrial proteome. The 
human mitochondrial proteome defined by IMPI 2017 consists of proteins encoded by 1,550 
genes: 1,130 from the mitochondrial positive training set and 420 predictions. This more 
extensive proteome prediction provides an excellent source for investigating the history of the 
human mitochondrial proteome. 
 
Mitochondrial evolution 
Current evidence supports the ‘endosymbiotic theory’ of the origin of mitochondria, made 
famous by Lynn Margulis in 1967 (Sagan 1967), although the idea had been discussed much 
earlier in the century by Ivan Wallin (Wallin 1927). This theory proposes that mitochondria 
are the result of an ancient, mutually beneficial relationship between free-living bacteria and a 
host cell which somehow took up these bacteria. Evidence for this theory includes the double 
cellular membrane around the mitochondria (one from the original bacterium and one derived 
from the host on take-up of the bacterium); the presence and structure of the mitochondrial 
genome, which is circular as in bacteria (Anderson et al. 1981); and the independent 
reproduction of mitochondria by binary fission, as seen in bacteria (Margolin 2005). 
Phylogenetic analysis has suggested that the bacteria which eventually became the 
mitochondria were members of the α-proteobacteria, related to the order Rickettsiales 
(Andersson et al. 1998) whereas the host cell was potentially archaeal, though this is still 
under discussion (Gribaldo et al. 2010).  
There are two general groups of hypotheses about how this uptake may have occurred (Gray 
2015). The first group suggest that uptake happened by phagocytosis of the bacteria by a host 
cell which already had some eukaryotic features, where the bacteria then somehow survived 
and became functionally useful to the host. The second suggests that the bacteria and host 
developed some form of metabolic dependence as free-living organisms. The bacteria were 
then eventually taken up by the host, which sparked the development of cellular complexity 
observed in eukaryotic cells. This second hypothesis is supported by theoretical work which 
suggests the genome complexity required by eukaryotes was supported by the huge increase 
in bioenergetic membrane surface area that mitochondria provide (Lane & Martin 2010).  
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While mitochondria are only found in eukaryotic species, not all eukaryotic species have 
mitochondria. One early explanation for this was the Archezoa theory (Cavalier-Smith 1989). 
This theory suggested that there were primitive eukaryotic organisms, known as Archezoa, 
which had developed much of the complexity of eukaryotic cells (nucleus, endoplasmic 
reticulum etc.) but not mitochondria. However, later work showed that these species thought 
to lack mitochondria instead have degenerate forms of mitochondria, which vary in size and 
function. Examples include mitosomes in the Microsporidia, which retain iron-sulphur cluster 
assembly machinery (Goldberg et al. 2008); mitosomes in Entamoeba species, which retain a 
sulphate activation pathway (Mi-Ichi et al. 2009); and hydrogenosomes in Trichomonas 
vaginalis, the site of an anaerobic form of carbon metabolism (Müller 1993) and iron-sulphur 
cluster assembly (Sutak et al. 2004; Dolezal et al. 2007). Recently, an oxymonad 
(Monocercomonoides sp.) has been sequenced with no recognisable mitochondrial marker 
proteins, suggesting possible loss of the entire mitochondrial organelle (Karnkowska et al. 
2016). 
The remarkable history of mitochondria and the wide variation in function across species 
make the genes encoding the mitochondrial proteome a particularly interesting group for 
phylogenetic-based analysis. 
 
The mitochondrial carrier family 
One potentially interesting group of proteins is the mitochondrial carrier family. In general, 
mitochondrial carrier proteins are localised to the mitochondrial inner membrane, and act to 
move compounds or ions in either direction across this membrane (Gutiérrez-Aguilar & 
Baines 2013). Transporter family proteins are necessary as, unlike the outer mitochondrial 
membrane, the inner mitochondrial membrane is relatively impermeable. This allows strict 
control of the molecules which can enter and leave the mitochondrial matrix, creating a 
compartmentalised environment within the cell. 
There are fifty-three known members of the mitochondrial carrier family in humans 
(Gutiérrez-Aguilar & Baines 2013). Several of these have characterised transport substrates. 
For example, the four carriers encoded by the genes SLC25A4, SLC25A5, SLC25A6 and 
SLC25A31 are known to exchange mitochondrial ATP for cytosolic ADP (Dolce et al. 2005). 
Mitochondrial carrier proteins are also known to transport a variety of metabolites and ions. 
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Other mitochondrial carriers have been associated with particular pathways, even where the 
exact transport substrate remains unknown. For example, the mitochondrial carrier encoded 
by SLC25A38 has been associated with haem biosynthesis (Guernsey et al. 2009). It has been 
suggested that this is due to its function as a glycine transporter, as glycine is an early 
substrate for haem biosynthesis (Guernsey et al. 2009). This has not been biochemically 
confirmed using transport assays.  
However, there are several mitochondrial carriers with no associated transport substrate, 
pathway or function (Gutiérrez-Aguilar & Baines 2013). Understanding the function of these 




Mitochondrial dysfunction has been implicated in many types of disease, ranging from late-
onset, complex diseases, such as neurological disorders (Onyango et al. 2017), to paediatric-
onset, monogenetic diseases, such as those involving the respiratory chain (DiMauro & Schon 
2003). Currently, exome sequencing produces genetic diagnoses for approximately half of the 
studied patients assumed to be suffering from mitochondrial disease caused by mutations in 
single genes (Calvo et al. 2012; Taylor et al. 2014). One bottleneck for identifying new genes 
associated with mitochondrial disease is prioritising the results from sequencing (which 
identifies variants in a number of different genes) for biological study. 
Learning more about the features of known mitochondrial disease genes may help in the 
prioritisation of candidates for new disease genes in future mitochondrial disease patients. 
Understanding differences between disease genes associated with different types of disease 
inheritance (recessive versus dominant) could also be informative. This is important to 
consider as evidence is beginning to support a larger contribution of dominant de novo 
mutations to disease burden than may have been expected. For example, around 40% of a 
sequenced developmental disease cohort encoded de novo variants that were predicted to be 
pathogenic (McRae et al. 2017). Understanding the phylogenetic properties of these disease-
associated genes may, therefore, be of interest. 
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Viruses and the mitochondria 
Mitochondria, and the various functions they are involved in, have been implicated in the 
lifecycle of a variety of viruses (Ohta & Nishiyama 2011). This may include viral hijacking or 
processes such as metabolism, apoptosis, DNA replication, transcription and translation. 
Viruses encode a range of proteins to aid in the manipulation and control of host cell 
mitochondria. These proteins can be novel to viruses, or proteins which appear orthologous to 
eukaryotic proteins known to localise to the mitochondria and/or affect mitochondrial 
function (Ohta & Nishiyama 2011). For example, a variety of Bcl-2 family proteins 
(associated with the mitochondrial pathway of apoptosis in humans (Gross et al. 1999)) have 
been identified in viruses (Cuconati & White 2002). While there are many individual studies 
studying orthologues of mitochondrial proteins in viruses, a wider scale study looking at the 
total known viral proteome has not been carried out, leaving an opening for research into this 
area. 
 
Non-enzymatic lysine acetylation 
Proteins throughout the cell, including those localised to mitochondria, can be modified by 
the addition of a range of chemical groups. Modifications include the addition of an acetyl 
group to the -amino group of exposed lysine residues on a protein surface, which is known 
as lysine N-acetylation. Though acetylation is often thought of as a controlled process which 
is important for protein regulation, non-enzymatic protein acetylation occurs in conditions 
replicating those seen in the mitochondrial matrix (Wagner & Payne 2013). More recent work 
has shown that acetyl groups can be transferred non-enzymatically from acetyl-CoA to a 
protein lysine residue, via a nearby cysteine residue (James et al. 2017).  
It has been hypothesised that this non-enzymatic acetylation is non-functional and potentially 
damaging to the cell – a ‘carbon stress’ (Wagner & Hirschey 2014). The idea that general 
non-enzymatic acetylation may be damaging is of particular interest as changes in acetylation 
have been linked to changes in lifespan in several model organisms, including yeast and mice, 
particularly in relation in caloric restriction (Lin et al. 2000; Schwer et al. 2009). Though 
these experiments have thought about the link between non-enzymatic acetylation and 
Chapter 1  Introduction 
 12 
lifespan within species, it may be of interest to consider acetylation as a modifier of lifespan 
between species. 
 
The bioinformatic approach 
The work in this thesis uses bioinformatic techniques in a variety of ways to investigate the 
mitochondrial proteome, including looking at protein function, features of disease genes and 
conservation of acetylation motifs. Bioinformatics involves the development and use of 
computational techniques to organise and analyse data (Rhee 2005). Bioinformatic 
approaches, in general, are at their best as a set of methods used to make predictions and 
prioritise hypotheses, guiding the development of wet laboratory experiments. For example, 
bioinformatic methods can be used to predict the association of a protein with a complex or 
pathway. This could then guide biological experiments which focus around function of the 
complex or pathway of interest, rather than looking more generally at the function of the cell 
or organism.  
Bioinformatic techniques are also useful to study topics which are currently experimentally 
intractable. This could include experiments which would need to occur over long periods of 
time, those that would be prohibitively expensive, or those that require a degree of 
experimental specificity not currently available to scientists. In these cases, bioinformatic 
methods can provide information to support a hypothesis, though experimental confirmation 
is preferable where this becomes possible. 
In summary, the bioinformatic approaches inform the biological approaches but are usually 
not an endpoint in themselves. 
 
Thesis outline 
This thesis describes the use of a newly predicted human mitochondrial proteome, defined by 
IMPI 2017, as the basis to explore the history of the mitochondrial proteome from a human 
perspective; as well as several applications of this exploration in aspects of disease, 
metabolism and function of the mitochondria.  
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In Chapter 2, I describe the creation of an orthology dataset of the genes encoding the human 
mitochondrial proteome, over a large range of species (both eukaryotic and prokaryotic). I use 
reciprocal best hit analysis as a basis for predicting orthology. From the resulting dataset, I 
explore the potential development of the human mitochondrial proteome over time.  
In Chapter 3, I present the use of this orthology dataset to predict genes associated with the 
function of the respiratory complexes, particularly complex I, using the predicted presence 
and absence of genes across the investigated species (the phylogenetic profile). 
In Chapter 4, I use a dataset of mitochondrial proteome orthologues in two metazoan phyla 
(Nematoda and Platyhelmintha) to predict the transport substrates of uncharacterised 
members of the mitochondrial carrier family, using phylogenetic profiling and extensive 
manual assessment of the resulting patterns.  
In Chapter 5, I use the orthology dataset to explore the genes of the mitochondrial proteome 
in terms of their association with monogenetic diseases, including a comparison of recessive 
and dominant disease genes. I also assess the utility of model organisms in the prediction of 
disease genes.  
In Chapter 6, I describe the prediction of potential viral orthologues of human IMPI 2017 
genes. I explore some general features of the genes and viruses with predicted orthologues 
and look further into some groups of predicted orthologues. 
In Chapter 7, I describe an analysis of the conservation of sites of non-enzymatic acetylation 
in cytoplasmic and mitochondrial proteins across vertebrates; and a potential link to the 
lifespan of these species.  
In Chapter 8, I present a brief summary of the findings from each chapter, as well as a 
discussion of further work which may be prompted by this thesis.











Building an orthology dataset of genes 










Homologues, orthologues and paralogues 
There are three key classifications for related genes (Fitch 2000). Genes which are 
orthologous to each other (orthologues) are genes which have been separated by a speciation 
event – in Figure 2.1, Gene 1 from Species 1 and Gene 1 from Species 2 are orthologues. 
Genes which are paralogous to each other (paralogues) are genes which have been separated 
by a duplication event. Genes can be in-paralogues – two genes in the same species separated 
by a duplication event – as with Gene 1 and Gene 2 from Species 1 in Figure 2.1. Genes can 
also be out-paralogues – two genes in different species, separated by both a speciation event 
and a duplication event – as with Gene 2 from Species 1 and Gene 1 from Species 2 in 
Figure 2.1. Genes which are homologous to each other (homologues) may have been 
separated by speciation, duplication or a combination of both events – all genes in Figure 2.1 
are homologues.  
 
Figure 2.1 Examples of orthologues and paralogues of a single ancestral gene, after speciation and 
duplication events. 
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One assumption that is often made is that orthologues will encode proteins with more similar 
functions than paralogues (Tatusov et al. 1997; Koonin 2005a). The theory behind this is that 
a duplication event produces a paralogous gene which is not under the same evolutionary 
pressure to conserve function as the original gene, as the function is maintained by the 
original gene. Therefore, the paralogous gene can diverge in both sequence and function 
(Conant & Wolfe, 2008).  
Testing this assumption is complicated as, in many cases, gene function has not been 
experimentally confirmed across a range of species, and functional annotation may have been 
propagated over predicted orthologous sequences automatically. Different aspects of gene 
function may also have been studied in different species, biasing the annotation. One study, 
comparing the functional annotation of genes in humans and mice, seemed to refute the 
traditional view of homologous function, finding that paralogues were more functionally 
similar than orthologues (Nehrt et al. 2011). However, the methodology used in this study has 
been challenged (Thomas et al. 2012) and a later study, looking at a larger number of species 
and correcting for more potential biases, found that orthologues were significantly more 
similar in function than paralogues, though the difference was smaller than may have been 
expected (Altenhoff et al. 2012). This supports the idea of trying to separate orthologous and 
paralogues when investigating homologous sequences, where conservation of function is 
often assumed. 
Whilst conserved function is often assumed when predicting orthologues, computational 
orthology prediction methods do not usually take function into account, instead looking at 
sequence similarity and/or positions in phylogenetic trees. This is important to keep in mind 
when using predicted orthologues in analyses in which conservation of function is an 
important assumption – for example, when trying to predict the function of an uncharacterised 
gene using phylogenetic profiling, as is discussed later in this thesis (Chapter 3 & Chapter 4). 
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Orthologue prediction 
Understanding the history of the human mitochondrial proteome requires two things. The first 
is a good definition of the genes which encode the mitochondrial proteome, which is now 
provided by IMPI 2017. The second is a set of orthologous sequences of these genes from 
species spread throughout the tree of life.  
Many methods have been developed that attempt to predict orthologous sequences. Hulsen et 
al. (2006) suggest that the method of choice should depend on the question being asked – 
what are the performance measures that are most important to you? This was supported by a 
more wide-scale comparison of the sensitivity (a measure of the proportion of false negatives) 
and specificity (a measure of the proportion of false positives) of different orthology detection 
methods which suggested improvement in one performance measure was often a trade-off 
with lower performance in the other (Altenhoff & Dessimoz 2009). This study also suggested 
one of the simpler methods of orthology detection (best bidirectional hit or reciprocal best hit) 
performed well when compared to more complex methodologies (Altenhoff & Dessimoz 
2009). A more recent comparison of fifteen common orthologue detection methodologies, 
using a suite of standardised benchmarking tests, confirmed that reciprocal best hit was one of 
the most specific of the tested methodologies, with an average level of sensitivity (Altenhoff 
et al. 2016). This is consistent with the results of other smaller-scale analyses comparing 
different methods of orthology detection (Chen et al. 2007; Dalquen & Dessimoz 2013). 
The reciprocal best hit method uses two separate searches – in this case BLASTp (Basic 
Local Alignment Search Tool) searches (Altschul et al. 1990, 1997) –  to predict orthologues 
and reduce the identification of paralogues (Rivera et al. 1998). To be deemed orthologous, 
sequences from two different species must be the best hit of each other, when searching 
across the opposite species’ genome (Figure 2.2).  
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Figure 2.2 Principle of reciprocal best hit orthologue identification. (a) Examples of failures to identify 
an orthologue. A BLASTp search using the species 1 sequence returns a sequence in species 2 as the 
top hit. However, the search back using the species 2 sequence does not return the original species 1 
sequence, or vice versa. The sequences from each species are not the top hit of the other. (b) Example 
which would return a pair of predicted orthologues, as the sequences from each species are the top hit 
of the other, using BLASTp searches. 
The aim of this work was to create a history of orthologous sequences in relation to human 
genes, not to identify all homologues within the studied species that form a gene family. 
Reciprocal best hit can be centred around the genes of a particular species. So, in this case, 
genes can be specifically identified as orthologues of human genes, rather than as groups of 
homologous genes from a gene family. This should facilitate good separation of paralogues in 
species closely related to humans. Reciprocal best hit is also relatively easy to set up and run 
for a range of species, which can be defined by the user. This was important for some of the 
potential uses for the dataset (e.g. to investigate the presence and absence of specific genes in 
certain species of interest). Therefore, I based the creation of a dataset of orthologues of genes 
encoding the human mitochondrial proteome on reciprocal best hit analysis.  
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Chapter summary 
In this chapter, I describe the automated creation and manually curated improvement of a set 
of predicted orthologues of genes encoding the human mitochondrial proteome, as defined by 
IMPI 2017, across a variety of eukaryotic and prokaryotic species. A summary of the 
properties of this dataset is provided, including an analysis of the potential origins of the 
genes encoding the human mitochondrial proteome.  
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 Methods 
Definition of the human mitochondrial proteome 
The genes encoding the human proteome were defined as the genes included in the 2017 
release of IMPI (Integrated Mitochondrial Proteome Index) developed by the Bioinformatics 
group of the Medical Research Council Mitochondrial Biology Unit (available from 
www.mrc-mbu.cam.ac.uk/impi). IMPI was built from a number of both publicly available and 
custom evidence sources looking at the mitochondrial localisation of proteins, including 
network analysis scores, mitochondrial targeting prediction programs, mass spectrometry 
analyses and more. This evidence was provided as input to a supervised machine learning 
classifier, along with manually curated lists of positive training genes (for proteins known to 
localise to mitochondria) and negative training genes (for proteins believed not to localise to 
mitochondria), and the classifier used these data to identify the most important evidential 
properties of these training sets. The classifier was then used to assign each human gene a 
score from between 0 and 1, that predicted its likelihood of being mitochondrial. Genes from 
the positive training set and other genes with a score of 0.8 or above were included in IMPI 
2017, producing a list of 1,550 human genes predicted to encode the mitochondrial proteome. 
 
Choosing species and downloading proteomes 
A selection of species was chosen from those with fully sequenced genomes and predicted 
proteomes in the NCBI Protein database (www.ncbi.nlm.nih.gov/protein). Species were 
selected to cover a representative range from the eukaryotes, archaea and bacteria, as well as 
to cover species with known variations in the function of their mitochondria. The internet and 
literature were also searched for sites and papers describing sequenced species whose taxa are 
not covered in the NCBI database, and which had publicly available predicted proteomes 
(Table 2.1). This resulted in the choice of 359 species for orthology analysis (see Appendix I – 
Table 1). 
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Table 2.1 Additional sources of species’ proteomes, for those not retrieved from the NCBI Protein 
database. 
Species Download source Reference 
Schmidtea mediterranea http://parasite.wormbase.org/ 1 
Mnemiopsis leidyi http://research.nhgri.nih.gov/mnemiopsis/ 2 
Symbiodinium minutum Clade B1 http://marinegenomics.oist.jp/gallery/ 3 
Cyanophora paradoxa http://cyanophora.rutgers.edu/cyanophora/ 4 
Monocercomonoides sp. PA203 Supplementary information of reference 5 
1 – (Robb et al. 2015); 2 – (Ryan et al. 2013); 3 – (Shoguchi et al. 2013); 4 – (Price et al. 2012); 
5 – (Karnkowska et al. 2016) 
For each species’ proteome, each sequence was checked for an individual identifier – paying 
particular attention to the sequences from outside the NCBI Protein database. Sequences 
which were completely identical (i.e. redundant) within each species’ proteome were 
removed.   
 
Reciprocal best hit analysis to predict orthologues 
First, a custom BLAST database was created, combining the non-redundant proteomes of 
each of the 359 species included in the analysis. The canonical human protein sequence for 
each of the 1,550 IMPI 2017 genes was identified and downloaded from the NCBI Protein 
database. The sequence with ‘RecName’ (a UniProt assignment) in the title was chosen as the 
canonical sequence where possible. Else, the longest protein sequence associated with the 
gene was chosen. 
For each of these human protein sequences, a local BLASTp search (Altschul et al. 1990, 
1997) was carried out against the custom BLAST database, with default settings, and an 
Expect-value (E-value) threshold of 10. For each of the 359 species, the top protein hit with 
the smallest E-value was identified. If two or more proteins in one species returned the same 
E-value, the sequence with the highest bit score was chosen. If two or more sequences also 
returned the same bit score, both sequences were taken forward (Moreno-Hagelsieb & 
Latimer 2008). 
A second custom BLAST database was then created. This database contained all human 
protein sequences (NCBI: txid9606) that could be associated via their annotated gene name 
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with a list of all human gene names downloaded from the HGNC (HUGO Gene 
Nomenclature Committee) (Gray et al. 2014). 
A BLASTp search (Altschul et al. 1990, 1997) was then carried out against this human 
protein database, for each of the top protein hits, for each species, for each IMPI 2017 gene. 
The results of these reciprocal BLAST searches were analysed to predict orthologues. The top 
hits from the reciprocal search were identified as in the original search – the sequence with 
the lowest E-value; then the sequence with the highest bit score. All sequences that fitted 
these criteria were considered. 
A sequence was declared a potential orthologue if the top result was a protein sequence 
encoded by the same human gene that the analysis started with. If the top result was a human 
protein sequence encoded by any other human gene, the sequence was not declared an 
orthologue. 
This reciprocal best hit process is summarised in Figure 2.3. 
 
 
Figure 2.3 Summary of the reciprocal best hit process for the prediction of potential orthologues of 
IMPI 2017 human proteins. 
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Identifying and utilising protein domain structure 
Protein domains were identified using the NCBI Conserved Domain Database (CDD) 
(Marchler-Bauer et al. 2017). The CDD was used to assign predicted domains to the human 
protein sequence for each gene and then for all predicted orthologous sequences for each 
gene, with an E-value threshold of 0.01. Predicted orthologous sequences with domains 
matching the human sequence were retained as orthologues for further analysis.  
Sequences with non-matching domain structures were investigated further. For these 
sequences, I manually assessed the domain predictions. Sequences without identical matches 
to the domains from the human protein were kept if they fit at least one of the following 
criteria: 
• The human protein was a known fusion protein and the predicted orthologous 
sequence matched the domain structure for one half of the fusion protein, or vice 
versa, 
• The human protein and predicted orthologous protein were assigned domains from 
differing databases included in the total CDD database which are functionally 
equivalent, 
• At least one from the human protein and the predicted orthologous protein were 
assigned a domain that is specific to its phylogenetic group, but the domains of the 
two proteins are functionally equivalent, 
• The human domain prediction was weak (E-value  1  10-5) and there was no domain 
prediction for the predicted orthologous sequence, 
• The orthologous sequence domain predictions were weak (E-value  1  10-5) and 
there was no domain prediction for the human protein sequence. 
 
Improving consistency of paralogue assignment 
Genes were grouped together based on the results of the reciprocal best hit analysis. For a 
gene (Gene 1), if the reciprocal BLAST search for any species predicted a non-orthologous 
sequence, the human gene returned as the top hit (Gene 2) was noted. Gene 1 and Gene 2 
were grouped together if the human proteins encoded by these genes contained the same 
predicted protein domains.  If genes from outside IMPI 2017 were identified in these groups, 
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a reciprocal best hit analysis was carried out for these genes, using the methodology described 
above.  
The phylogenetic patterns of the genes within each of these groups were then manually 
assessed. Predicted orthologous sequences were assigned to different members of the gene 
groups as supported by manual assessment, using the support of the literature where available. 
Where no strong literature evidence was available, orthologues from more distant species 
were moved to the gene member of the group with the highest number of assigned 
orthologues, to improve the consistency of assignment for paralogous groups. 
 
Phylogenetic tree 
The peroxiredoxin phylogenetic tree was calculated using a variety of sequences from across 
the tree of life which were predicted orthologues for any of PRDX1-4. These sequences were 
aligned using MUSCLE with default settings (Edgar 2004a, 2004b) and alignments were 
manually inspected and improved in Jalview 2.0 (Waterhouse et al. 2009). A phylogenetic 
tree was calculated using PhyML 3.0, using the SPR (Subtree Pruning and Regrafting) 
method and 100 bootstrap replicates (Guindon et al. 2010). The tree was visualised in 
Interactive Tree Of Life (Letunic & Bork 2016). 
 
Gene enrichment 
KEGG (Kyoto Encyclopaedia of Genes and Genomes) pathway annotation and enrichment 
was carried out using the DAVID functional annotation tool (Huang et al. 2009b), with IMPI 
2017 genes as the background. Benjamini corrected p-values from the DAVID analysis were 
returned, with a p-value threshold of 0.05 set for significance. 
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Assignment of potential gene ancestry 
Each gene was assigned to one of six groups, depending on the identification of orthologues 
in different sets of species. The criteria for each group were implemented in order, as follows: 
• -proteobacteria – any gene with at least one orthologue identified in the three 
studied -proteobacteria (Agrobacterium tumefaciens str. C58, Rhizobium etli 
CFN 42, Rickettsia prowazekii str. Madrid E), 
• Other bacteria and archaea – any gene with at least one orthologue in the bacterial 
species and at least one orthologue in the archaeal species, 
• Other bacteria (not archaea) – any gene with at least one orthologue in any species of 
bacteria but not in the -proteobacteria or archaea, 
• Archaea – any gene with at least one orthologue in the archaeal species, but not in any 
of the bacterial species, 
• Holozoa – any gene with orthologues only in the studied Holozoa (animals and the 
closely related, single-celled ichthyosporea and choanoflagellates), 
• Eukaryota – the remaining genes, which have no orthologues in any studied 
prokaryotic species, but have orthologues in eukaryotes outside of the Holozoa. 
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 Results & Discussion 
Building an orthology dataset 
The aim of the work described in this chapter was to produce a dataset of orthologues of the 
human mitochondrial proteome, across a range of eukaryotes and prokaryotes. This dataset 
could then be utilised to investigate the history and function of the human mitochondrial 
proteome. Therefore, I used reciprocal best hit analysis with BLASTp searches to identify 
orthologous sequences of the human mitochondrial proteome, across 359 species, including 
97 holozoans (animals and their closest single-celled relatives), 134 other eukaryotic species 
from a variety of taxa, 37 archaea and 91 bacteria (species listed in Appendix I – Table 1). The 
mitochondrial proteome was defined as the canonical proteins encoded by the genes in the 
human version of IMPI 2017 (www.mrc-mbu.cam.ac.uk/impi), which includes 1,550 
individual genes.  
The accurate identification of orthologues using BLASTp is dependent on several factors. 
One of the most varied across the literature is the E-value (Expect value) threshold set for 
positive results. The E-value is a probabilistic measure of the number of similarly scored hits 
which would be expected by chance, which is dependent on the size of the database being 
searched. A lower E-value suggests that a similarly scored result would be less likely to be 
observed by chance. Increasing the E-value threshold, therefore, increases the number of 
positive hits from a search, particularly for those sequences which are more distantly related 
(i.e. increases the sensitivity of the analysis), but also runs the risk of increasing the number 
of false positives (i.e. decreases the specificity of the analysis).  
Therefore, I looked at the effect of changing the E-value of the two different BLASTp 
searches used in the reciprocal best hit process on the number of predicted orthologues, using 
E-values ranging between a strict threshold of 1  10-30 and a more liberal threshold of 10 
(Table 2.2). The most liberal tested criteria (E-value of 10 for both BLASTp searches) 
predicted 36.1% more orthologues than the strictest tested criteria (E-value of 1  10-30 for 
both BLASTp searches). Change in either E-value produced large changes in the number of 
predicted orthologues.  
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Table 2.2 Number of predicted orthologues of human proteins encoded by IMPI 2017 genes across 359 
species, varying the E-value of the first and reciprocal BLASTp searches. 
First BLASTp 
E-value 
Reciprocal BLASTp E-value 
1  10-30 1  10-20 1  10-10 1  10-5 1 10 
1  10-30 149,741 150,131 150,134 150,134 150,136 150,136 
1  10-20 152,454 164,421 164,845 164,846 164,849 164,849 
1  10-10 152,529 167,140 180,878 181,190 181,213 181,213 
1  10-5 152,547 167,180 183,791 180,432 190,688 190,691 
1 152,598 167,254 184,035 194,027 201,360 201,415 
10 152,604 167,262 184,051 194,101 203,642 203,779 
 
When both E-value thresholds are raised to 10, the increase in the number of predicted 
orthologues levels off, with only hundreds of additional predictions made compared to the 
previous tested E-value (1). This suggests that the reciprocal best hit method, using the human 
sequence only as bait, is reaching its limits in identifying potential additional orthologues. 
Raising the E-value higher than this is, therefore, not likely to contribute a significant amount 
– orthologues being missed by the method at this threshold are likely to be missed due to the 
limitations of the method. 
The effect of the E-value threshold was particularly important to consider when attempting to 
identify orthologous sequences from species which share a more distant common ancestor 
with humans, such as the prokaryotes, as sequences could be assumed to have diverged more 
over time. If increasing the E-value threshold increased the number of potential prokaryotic 
predicted orthologues in particular, then this would justify the use of a higher E-value 
threshold. To explore how changing the E-values might affect the identification of 
orthologues in different phylogenetic groups of species, I visualised the number of predicted 
orthologues in three different phylogenetic groups: the Holozoa (animals and the single-celled 
ichthyosporea and choanoflagellates), other eukaryotes and prokaryotes (Figure 2.4), as the 
E-value thresholds were varied.  
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Figure 2.4 Number of predicted orthologues by phylogenetic group, varying the E-value of the BLASTp 
searches. As the E-value threshold is increased for either BLASTp search, the number of predicted 
orthologues increases. This is particularly true of the prokaryotic predicted orthologues. 
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The number of predicted orthologues in eukaryotes increased when increasing the E-value 
thresholds of both of the first BLASTp search and the reciprocal BLASTp search, but only by 
a small proportion. The largest proportional change was in the number of predicted 
prokaryotic orthologues, with an increase in predicted orthologues of 110% when the most 
liberal E-values were tested (10), compared to the most stringent E-values (1  10-30). 
From previous knowledge of orthologue identification, I knew that some orthologous 
prokaryotic sequences were identified only using high E-value thresholds when searching 
using the human sequence as bait. For example, the MT-ATP6 orthologue in Bacillus subtilis 
(P37813.1) has been confirmed experimentally (Santana et al. 1994), but is only identified 
with an E-value of 9.9 for the first BLAST search and 0.015 for the reciprocal BLAST search. 
From this knowledge and the analysis of E-value thresholds which showed a large increase in 
prokaryotic predicted orthologues at the most liberal E-values, I decided to use an E-value 
threshold of 10 (the highest tested threshold) for both the BLASTp searches in the reciprocal 
best hit process. This is likely to produce a larger number of false positives (orthologues 
predicted where there is no true orthologous sequence) compared to a more stringent E-value, 
but minimise the number of false negatives (orthologues not predicted where there is a true 
orthologous sequence). This is important as the reciprocal best hit process only has average 
sensitivity amongst orthology detection processes (Chen et al. 2007; Dalquen & Dessimoz 
2013; Altenhoff et al. 2016).  
 
Using protein domains to improve orthologue predictions 
As I used liberal E-values for the BLASTp searches to improve the potential sensitivity of the 
reciprocal best hit analysis, it was possible that the specificity of orthologue prediction may 
suffer (i.e. that there would be an increased number of false positive orthologue predictions). 
To attempt to counteract this, I used the idea that proteins with similar domain structures 
should be stronger candidate orthologues (Li et al. 2003). For each gene, predicted 
orthologous sequences with domain predictions matching that of the human protein sequence 
for that gene were kept as potential orthologous sequences, using the NCBI’s CDD resource 
to assign protein domains (Marchler-Bauer et al. 2017).   
Before discarding the remaining sequences, which did not exactly match the domain structure 
of the human protein, I manually assessed the results for each gene. I used five additional 
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criteria to assess the potential domain orthology of each sequence – if a predicted sequence 
fulfilled any one of these criteria, they were kept as potential orthologues and taken forward 
to the next step. An explanation of each of the criteria with examples is provided below.  
The first criterion considered was if the human protein was a bifunctional predicted fusion 
protein and the predicted orthologue matched the domain structure of one half of the human 
protein, or vice versa. Fusion proteins usually include two proteins with functions involved in 
the same pathway (Enright et al. 1999), and so I made the assumption that detection of one 
part of a fusion protein was enough to assume the presence of both parts, as reciprocal best hit 
analysis would only ever allow the identification of one protein as the top hit.  For example, 
PAPSS1 encodes a bifunctional protein involved in sulphate activation. The human protein 
contains two domains corresponding to the two functions of this protein – an ATP-sulfurylase 
domain (cd00517) and an adenylylsulphate kinase domain (pfam01583). However, the top 
protein hit for Saccharomyces cerevisiae S288c (O43252.2) only encoded an adenylylsulphate 
kinase domain. Therefore, O43252.2 was assigned as an orthologue of PAPSS1, despite 
encoding only half the domains of the human protein, as it encoded one half of a known 
fusion protein. The presence of a second protein encoding the ATP-sulfurylase domain was 
assumed and, indeed, the second hit in a BLASTp search using the human PAPSS1 sequence 
is a S. cerevisiae protein with an ATP-sulfurylase domain (NP_012543.3).  
The second two criteria were similar and considered the differences between domains 
identified from the different protein domain sources included in CDD. There are some 
domains in the CDD which are equivalent in function but have different names – either due to 
coming from different data sources included in the CDD, or there being phylogenetically 
specific domains within the CDD which share similar function. Proteins assigned functionally 
equivalent domains were taken forward as predicted orthologues. One example is the 
identification of an orthologue of the human gene ATIC (involved in purine biosynthesis) in 
Escherichia coli. Using CDD search, the human protein contains two domains corresponding 
to the two functions of this protein – a 5-aminoimidazole-4-carboxamide ribonucleotide 
transformylase domain (PRK07106) and an inosine monophosphate cyclohydrolase domain 
(cd01421). However, the E. coli protein was predicted with only a single domain (PRK00881: 
bifunctional phosphoribosylaminoimidazolecarboxamide formyltransferase/inosine 
monophosphate cyclohydrolase), which is the functional equivalent of the two domains of the 
human protein. Therefore, while these two proteins do not produce exactly matching protein 
domain structures using CDD, they should be, and were, considered orthologous. 
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The last two criteria were also similar – where one of the protein sequences had a weak 
domain prediction (E-value  1  10-5) and the potential orthologue had no predicted domain, 
these proteins were still considered orthologous. This assumed that small variation in 
sequence may have influenced these domain predictions to cross the E-value threshold either 
way. For example, the human protein sequence for the gene C15orf62 has no identified 
domains using a CDD search at the E-value threshold of 0.001. However, the predicted 
orthologous sequence in mouse (AAI50993.1) has a single predicted domain (pfam14957), 
but with an E-value of only 2.6  10-4. Therefore, this protein was assigned as an orthologue 
of C15orf62, despite the predicted protein domains not matching. 
In summary, protein domain structure was used to attempt to improve the rate of false 
positives in the orthology dataset, under the assumption that proteins with similar domain 
structures are stronger candidate orthologues (Li et al. 2003). A set of additional common-
sense criteria based on the domain structure were also implemented to reduce the number of 
true positives excluded from further analysis. 
 
Manually improving paralogue assignment consistency 
Despite the use of reciprocal best hit to improve the separation of orthologues and paralogues, 
it was clear from the presence and absence patterns of predicted orthologues of closely related 
genes that the method struggled with the consistent assignment of orthology within some 
closely related human gene groups. This was particularly obvious for sequences from species 
who shared a common ancestor less recently with humans, whilst the method did reasonably 
well at separating predicted paralogues in more closely related species (Dalquen & Dessimoz 
2013). Therefore, to improve the consistency of assignment of orthologues within these gene 
groups, I used a manual curation process. This is particularly important for the potential use 
of this dataset in phylogenetic profiling, which relies on the patterns of presence and absence 
of orthologues across different species – random scattering patterns of orthologues within 
gene families will reduce the accuracy of this process. 
To address this issue, I considered groups of related genes. These groups were based on 
human genes which returned reciprocal best hits to each other – i.e. genes were grouped 
together if the reciprocal best hit for an original BLASTp search for Gene 1 instead returned 
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Gene 2 – and had identical predicted protein domain structures. This included genes not 
present in IMPI 2017 that were identified as a best hit. I then manually considered the 
phylogenetic patterns of presence and absence of each of the genes in each group, across all 
species. Orthologue assignment within these groups was altered where deemed appropriate to 
improve the consistency of orthologue identification both within and between phylogenetic 
groups. These changes were made so that, where the phylogenetic pattern of presence and 
absence of different genes within the gene group was inconsistent across species, a single 
human gene in the group was chosen, and orthologues from more distantly related species 
were assigned to this gene. This change worked under the assumption that the gene group 
developed from a single ancestral gene, which should, therefore, be represented by a single 
member of the gene group. Where possible, these decisions were made based on information 
about gene family development from the literature.  
One example of deconvoluting the orthologues in a gene family is provided by the three 
paralogous human genes encoding subunit c of the ATP synthase (ATP5G1, ATP5G2, and 
ATP5G3), which were formed by gene duplication (Abbasi 2010). Figure 2.5(a) shows the 
original gene assignments of the orthologous sequences from all tested species with at least 
one predicted orthologue. Despite the erratic phylogenetic patterns of presence and absence of 
orthologues across these three genes, the highest number of orthologues are assigned to 
ATP5G2. This is consistent with the literature evidence from Abbasi (2010) of ATP5G2 
branching earliest from the ancestral gene sequence, before the duplication and separation of 
the ATP5G1/3 ancestral sequence into the two genes now observed in humans (Abbasi 2010). 
Therefore, orthologues in species where only one ATP5G orthologue was predicted were 
assigned to ATP5G2, creating a consistent phylogenetic pattern across species. The 
improvement in consistency of gene assignment is visible in Figure 2.5(b), which shows the 
manually curated assignment of predicted orthologues of the ATP5G genes across species.  
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Figure 2.5 Phylogenetic assignment of ATP5G predicted orthologues across all species with at least 
one predicted orthologue. Each block represents a predicted orthologue of the labelled gene for one 
investigated species. (a) Original assignments after reciprocal best hit analysis and protein domain 
checks. (b) Corrected assignments after manual improvement, showing the greater consistency across 
species. 
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Another, more complex, example is provided by the 2-Cys class of peroxiredoxins, which 
includes the human genes PRDX1, PRDX2, PRDX3 and PRDX4 – all included in the IMPI 
2017 mitochondrial gene inventory. Figure 2.6 shows a bootstrapped phylogenetic tree of 
some of the most diverse predicted orthologous sequences of proteins encoded by these four 
genes, coloured by their original gene assignment from the reciprocal best hit analysis. It is 
clear from the tree that the reciprocal best hit method found it difficult to consistently assign 
sequences as orthologues of genes, particularly for species which are more distantly related to 
humans. Potential PRDX4 orthologues from holozoans grouped reasonably well and so were 
separated from the other sequences, as did PRDX3 potential orthologues from the Holozoa 
(Figure 2.6). The tree also suggests that PRDX1 separated off from PRDX2, with sequences 
representing orthologues of these two genes clustered together.  
In this case, there was little literature evidence investigating the history of this group of genes, 
particularly in relation to the human genes which are most of interest in this analysis. Without 
this knowledge and with no strong evidence from the tree, the more distant sequences were 
assigned to PRDX2 to maintain consistency across species, as more sequences had hit back to 
PRDX2 than any of the other genes. This assignment was made, as before, under the 
assumption that the more distantly related sequences (from species beyond the Holozoa) 
developed from one ancestral sequence. Predicted orthologous sequences from holozoan 
species were kept at their original assigned gene. 
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This example shows the difficulty with assigning orthologous sequences predicted from 
distantly related species within groups of related genes using the reciprocal best hit 
methodology. Literature knowledge, manual assessment and simple phylogenetic trees can 
inform the assignment in some cases. but the history of most of these gene groups, in relation 
to humans, remains obscure, and would justify a full and further analysis to understand the 
homology relationships of these genes across the tree of life.  
This protocol assumes a low rate of horizontal gene transfer. This assumption is more likely 
accurate within the eukaryotes than within prokaryotes due to lower rates of horizontal gene 
transfer, although horizontal gene transfer is known within the eukaryotes (Keeling & Palmer 
2008). It also does not consider paralogous sequences in species apart from those in humans, 
grouping all these together under the representation of one sequence from each species. This 
itself is a general limitation of reciprocal best hit analysis, contributing to the method’s lower 
sensitivity levels (Dalquen & Dessimoz 2013).  However, this weakness is not relevant to the 
success of this particular analysis, which is concerned with how the human mitochondrial 
proteome developed over time – not in how families of genes developed over time in different 
species.  
In this analysis, consistency across species was prioritised, with a single human gene within 
each gene group chosen to assign orthologous sequences from more distantly related species, 
where there was less knowledge of the gene history. This assumption should be considered 
when using this dataset for further analysis. 
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Final orthology dataset 
The final orthology dataset contains 190,097 predicted orthologues of the 1,550 IMPI 2017 
genes, across 359 species of eukaryota, archaea and bacteria. This is a net loss of 13,682 
predicted orthologous sequences from the original reciprocal best hit analysis, after protein 
domain analysis and manual curation of orthologue assignment within gene groups. Over half 
(56.1%) of the total number of predicted orthologues are from the 97 studied holozoans, with 
32.7% of the predicted orthologues from the 132 other eukaryotic species. Only 1.7% of all 
the predicted orthologues are from the 37 archaea and 9.5% of all the predicted orthologues 
are from the 92 bacteria.  
The species with the highest number of predicted orthologous sequences were other primates 
(see Appendix I – Table 1). Orthologues of 98.8% of human IMPI 2017 genes were predicted 
in Pan troglodytes – the most closely related species to humans studied in this analysis. The 
studied species with fewest predicted orthologues were archaea (Figure 2.7), with only 2.6% 
of IMPI 2017 genes identified in the archaeal species Nanoarchaeum equitans Kin4-M. The 
prokaryotic species with the highest number of predicted orthologues was Rhizobium etli – 
one of the three studied -proteobacteria. This is consistent with the proposed origin of the 
mitochondria as an -proteobacterium in endosymbiosis with a host cell (Fitzpatrick et al. 
2006). 
Twenty-four of the studied eukaryotic species had fewer identified orthologues than 
Rhizobium etli (labelled on Figure 2.7). Twenty-three of these species are known to contain 
derivative remnants of full mitochondria. The eukaryote with the fewest predicted IMPI 2017 
orthologues is Enterocytozoon bieneusi H348, a member of the Microsporidia – a division of 
parasitic fungi. These species contain highly derived forms of mitochondria called mitosomes 
(Vávra 2005). E. bieneusi is known to have a highly reduced genome even among the 
Microsporidia (Akiyoshi et al. 2009), which is reflected in the number of predicted IMPI 
2017 orthologues.  
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The one exception, which is not known to have derivative mitochondria, is a holozoan species 
– Thelohanellus kitauei – which has only 228 predicted orthologues of the 1,550 studied IMPI 
2017 genes (14.7%). T. kitauei is a member of the Myxozoa (Yang et al. 2014) – a poorly 
studied taxon consisting of obligate parasites. The Myxozoa have recently been assigned to 
the taxon Cnidaria, which includes jellyfish, sea anemones, corals and box jellies (Chang et 
al. 2015). Considering the paucity of mitochondrial proteome orthologues identified in T. 
kitauei, it could be interesting to investigate the structure and function of mitochondria in this 
species and/or in other Myxozoa.  
 
Evolutionary history of the human mitochondrial proteome 
Mitochondria have a unique evolutionary history in eukaryotes, as they are thought to be the 
result of an endosymbiotic relationship of an a-proteobacterium with another cell (Sagan 
1967). The subsequent development of mitochondria has led to a proteome with a wide-
ranging evolutionary history, ranging from genes predicted to have been inherited from the 
original a-proteobacterial endosymbiont, to genes which are novel to eukaryotes (Szklarczyk 
& Huynen 2010). Most previous work analysing the origins of the mitochondrial proteome 
has been based on the yeast Saccharomyces cerevisiae (Kurland & Andersson 2000; Karlberg 
et al. 2000; Gray 2015). However, only 30.8% of IMPI 2017 genes have predicted 
orthologues in S. cerevisiae. One simple analysis of the potential origins of the human 
mitochondrial proteome has been carried out (Pagliarini et al. 2008). This analysis was 
performed using only single BLASTp searches, as well as examining only a few eukaryotic 
genomes. It is, therefore, interesting to consider the possible origins of genes encoding the 
human mitochondrial proteome, using the newly derived set of orthologues from a wide range 
of species. 
There is a wide variety in the number of predicted orthologues for each of the IMPI 2017 
genes (Figure 2.8). The 10% of IMPI 2017 genes with the highest numbers of predicted 
orthologues are significantly enriched for two KEGG pathways at the 0.05 significance level: 
‘Ribosome’ (p = 1.1  10-6) and ‘Aminoacyl-tRNA biosynthesis’ (p = 8.3  10-3). The bottom 
10% of genes from IMPI 2017 with the lowest numbers of predicted orthologues are not 
enriched for any KEGG pathway. 
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Figure 2.8 Histogram of the number of predicted orthologues identified for each of the 1,550 human 
IMPI 2017 genes, in 359 species. 
There are several peaks of gene innovation (Figure 2.8): 
• the first peak of genes with orthologues predicted in approximately 40 species 
• the second peak at around 80 species 
• the third, smaller and less distinct peak at around 180 species 
• and a fourth and final peak at around 260 species, which tails off to the right. 
 By looking at the breakdown of the number of orthologues identified in different 
phylogenetic groups for each gene, it is possible to estimate what these numbers mean in 
terms of the types of species with predicted orthologues of these genes (Figure 2.9).  








































































































































































































































































Chapter 2  Building an Orthology Dataset 
 44 
The first peak (~40 species) is equivalent to genes which are new innovations in the 
vertebrates. The second peak (~80 species) is equivalent to genes which are novel to the 
Holozoa – animals and closely related single-celled organisms. The third peak (~180 species) 
is equivalent to genes which are eukaryotic innovations. The fourth peak (~260 species) 
contains only genes that have predicted orthologues in at least some of the prokaryotic species 
studied. Overall, this suggests that there have been several important points in evolutionary 
time for the evolution of the human mitochondrial proteome, two of which potentially 
occurred post the split of Holozoa from fungi (and, therefore, post the split with S. cerevisiae, 
which has been the mitochondrial proteome studied most often). 
I decided to breakdown the potential origins of IMPI 2017 genes further by using a simple 
assignment process, based on the prediction of orthologues in defined groups in a linear 
assignment process (Figure 2.10), starting from assignment to the -proteobacterial group.  
 
Figure 2.10 Potential ancestry of IMPI 2017 genes. Genes are assigned to a group based on the 
prediction of orthologues within certain taxa. Any gene with a predicted orthologue in the 
-proteobacteria are assigned to the group ‘-proteobacteria’. Genes with other prokaryotic predicted 
orthologues are assigned to the corresponding prokaryotic group. Genes with predicted orthologues 
only in holozoan species are assigned to the group ‘Holozoa’, with all remaining genes assigned to the 
group ‘Eukaryota’. 
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Genes with at least one orthologue identified in one of the three -proteobacteria investigated 
were assigned to the -proteobacterial group, assuming that these genes originated from this 
group as the probable origin of the mitochondria (Müller & Martin 1999). This is probably a 
simplification of the true contribution of -proteobacteria to the mitochondrial proteome for 
several reasons. Genes may have been transferred to -proteobacteria after the mitochondrial 
endosymbiotic event. Genes may, also, have been present in other -proteobacteria at the 
time, but not the specific and unknown endosymbiotic ancestor. Lastly, genes may have been 
lost from the endosymbiont and regained from another source later in evolutionary history. 
Despite these issues and the inclusion of only three -proteobacteria in the dataset, 312 IMPI 
2017 proteins (20.1%) have at least one identified α-proteobacterial orthologue, with 280 
(18.1%) identified in at least two α-proteobacteria. This is consistent with previous analyses 
using different methods and descriptions of the mitochondrial proteome, which have 
suggested between 10 and 20% of the eukaryotic mitochondrial proteome is derived from α-
proteobacteria (Karlberg et al. 2000; Gabaldón & Huynen 2007; Wang & Wu 2014). 
Genes with predicted orthologues in other prokaryotes but not α-proteobacteria were then 
assigned to one of three groups. 29 human genes had predicted orthologues in bacteria and 
archaea. 43 human genes had predicted orthologues in other bacteria but not archaea. 22 
human genes had predicted orthologues in archaea but not in bacteria. In total, 198 genes had 
predicted orthologues in at least one bacteria but not in archaea. This is probably reflective of 
the presumed origin of the mitochondria as a bacterial endosymbiont. 
Genes with at least one predicted prokaryotic orthologue were enriched for several pathways 
(Table 2.3). These results suggest the key parts of the mitochondrial proteome inherited from 
prokaryotic species were the mitochondrial ribosome (known to be at least partially inherited 
from bacteria (O'Brien 2002)) and the basic metabolic pathways that are localised to the 
mitochondria in humans, such as the tricarboxylic acid cycle, and amino acid biosynthesis.  
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Table 2.3 Enriched KEGG pathways for IMPI 2017 genes with predicted prokaryotic orthologues 
(corrected p-value threshold of 0.05). 




Ribosome 54 3.2  10-16 4.8  10-14 
Metabolic pathways 156 3.7  10-4 0.03 
Biosynthesis of antibiotics 20 8.4  10-4 0.04 
Carbon metabolism 34 1.2  10-3 0.04 
Biosynthesis of amino acids 21 1.5  10-3 0.04 
 
In total, 1,143 (73.8%) IMPI proteins were only identified in eukaryotes. This is a larger 
proportion than in previous analyses of mitochondrial proteins of eukaryotic organisms, 
where between 20 – 54% of identified proteins had a predicted eukaryotic origin (Marcotte et 
al. 2000; Smith et al. 2007; Pagliarini et al. 2008; Szklarczyk & Huynen 2010). These genes 
were then divided into those with orthologues only in holozoan species (45.5%), and those 
with predicted orthologues in at least one of the other studied eukaryotes (28.3%). It is 
surprising that nearly half of the genes encoding the human mitochondrial proteome are novel 
to the Holozoa. KEGG pathway enrichment analysis shows that these genes are enriched for a 
wide range of processes (Table 2.4), but these processes, in general, tend to be involved in 
signalling, complex diseases and the immune system. An increase in the complexity and 
number of signalling pathways has previously been noted in animals compared to other 
related species (Suga et al. 2013). 
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Table 2.4 Enriched KEGG pathways for IMPI 2017 genes with only holozoan orthologues (corrected 
p-value threshold of 0.05). 




Hepatitis B 16 1.4  10-5 3.3  10-3 
MicroRNAs in cancer 16 4.7  10-5 5.6  10-3 
PI3K-Akt signalling pathway 17 1.4  10-4 0.01 
Ras signalling pathway 13 2.4  10-4 0.01 
Progesterone-mediated oocyte maturation 11 4.8  10-4 0.02 
Gap junction 11 4.8  10-4 0.02 
Oestrogen signalling pathway 12 6.0  10-4 0.02 
Focal adhesion 14 7.1  10-4 0.02 
Proteoglycans in cancer 14 7.1  10-4 0.02 
Insulin signalling pathway 14 7.1  10-4 0.02 
Prolactin signalling pathway 10 1.2  10-3 0.04 
Viral carcinogenesis 16 1.4  10-3 0.04 
MAPK signalling pathway 12 1.6  10-3 0.04 
 
In summary, this analysis suggests that the human mitochondrial proteome has been formed 
over time from a mosaic of different sources, as has been suggested for the yeast 
mitochondrial proteome (Gray 2015). The mitochondrial proteome has continued developing 
even within the Holozoa, likely expanding and complicating the functions of mitochondria 
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 Conclusions 
In this chapter, I have described the process of creating a dataset of orthologues of the IMPI 
2017 genes predicted to encode the human mitochondrial proteome, across 359 eukaryotes, 
archaea and bacteria. Reciprocal best hit analysis was used to identify the initial orthologous 
sequences. This was then improved by utilising the protein domain structure of the sequences. 
Finally, manual analysis of closely related groups of genes was used to improve the 
consistency of assignments among these groups. This provides a resource for furthering our 
understanding of the history of the human mitochondrial proteome, as well for other 
phylogeny-based analyses to understand the function of particular genes in the mitochondria.  
I then used this dataset to study the potential origins of the genes encoding the human 
mitochondrial proteome. A surprising number of these genes were recent innovations, unique 
to the Holozoa, suggesting a large increase in complexity of the mitochondria even within 
animals. This is interesting for an organelle which has traditionally been viewed mainly in 









Investigating the mitochondrial respiratory 










Assembly of the mitochondrial respiratory chain complexes  
The four complexes of the mitochondrial respiratory chain and ATP synthase are each formed 
from a combination of different protein subunits and cofactors. These protein complexes may 
assemble to form supercomplexes – groups of these functionally related complexes in the 
inner mitochondrial membrane (Schägger & Pfeiffer 2000). A group of proteins known as 
assembly factors help to coordinate the formation of these complex structures (Mckenzie & 
Ryan 2010; Smith et al. 2012).  
Complex I (NADH dehydrogenase) is the largest of the four respiratory complexes, consisting 
of forty-five subunits in humans – fourteen highly evolutionarily conserved core subunits and 
thirty-one supernumerary subunits (Zhu et al. 2016). These subunits form an L-shaped 
assembly, with a hydrophobic arm sitting in the inner mitochondrial membrane, and a 
hydrophilic arm pointing into the mitochondrial matrix (Zhu et al. 2016). The complex I 
structure also includes cofactors – a flavin mononucleotide as well as several iron-sulphur 
clusters (Zhu et al. 2016). There are currently at least fourteen assembly factors known to 
support the assembly and stability of mammalian complex I (Guerrero-Castillo et al. 2017). 
The size and complexity of the complex I structure and the existence of complex I deficient 
patients without a current genetic diagnosis even after exome sequencing (Calvo et al. 2012) 
suggests that there may be additional assembly factors still to be identified (Andrews et al. 
2013). Even the electron transfer flavoprotein, which also moves electrons into the electron 
transport chain, but is formed from only two subunits (Roberts et al. 1996), has two known 
assembly factors (Małecki et al. 2015; Floyd et al. 2016).  
One potential method to identify genes with functions associated with complex I and the other 
respiratory complexes is phylogenetic profiling. 
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Phylogenetic profiling 
There are many different ways to predict the function of a protein. Phylogenetic profiling is a 
technique which uses the presence and absence of genes across species to predict the possible 
function of an uncharacterised protein. Proteins with related functions tend to have similar 
patterns of presence and absence within species (Pellegrini et al. 1999; Loganantharaj & Atwi 
2007). While this technique has been widely and successfully applied in prokaryotic species, 
usage in eukaryotic species is limited by the decreased variation in the phylogenetic profiles 
of genes and the larger number of paralogous gene families (Snitkin et al. 2006). Successful 
use of this technique with eukaryotic species therefore relies on good orthology prediction, 
and variation in the presence and absence of the complex or pathway of interest between 
related species.  
A paper from the Mootha group used phylogenetic profiling to identify potential complex I 
assembly factors, with two of the highest rated predictions being functionally confirmed 
(Pagliarini et al. 2008). Whilst the orthology detection technique used in this study was 
simple (a single BLASTp search), there was a strong phylogenetic pattern for the subunits of 
complex I. This includes several related yeast species with a loss of this complex, which was 
also noted in additional parasitic eukaryotes. The expansive orthology dataset described in 
Chapter 2 provided an opportunity to repeat this type of analysis on a wider range of 
mitochondrial proteins and species, and to look beyond complex I at other respiratory 
complexes, the electron transfer flavoprotein and ATP synthase. 
 
Chapter summary 
In this chapter, I describe the use of the mitochondrial proteome orthology dataset and the 
technique of phylogenetic profiling to investigate the mitochondrial proteome for potential 
assembly factors of the respiratory complexes, particularly complex I and the electron transfer 
flavoprotein.  
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 Methods 
Phylogenetic profiling of complex I  
A binary matrix of presence and absence of predicted orthologues of the 1,550 IMPI 2017 
genes across 359 species was created from the orthology dataset described in Chapter 2. This 
was used to facilitate the identification of genes fitting different phylogenetic profiles for the 
respiratory chain complexes, electron transfer flavoprotein and ATP synthase. 
For complex I, COPP Tier 1 (Complex I Phylogenetic Profile Tier 1) genes were identified 
using a slightly modified version of the phylogenetic pattern defined in Pagliarini et al. 2008. 
The pattern for the identification of COPP1 genes was as follows: 
• Absent in: Schizosaccharomyces pombe 972h-, Candida glabrata CBS 138, 
Saccharomyces cerevisiae S288c, Cryptosporidium hominis TU502, Cryptosporidium 
parvum Iowa II, Plasmodium falciparum 3D7, Theileria annulata strain Ankara, 
Theileria parva, Giardia lamblia ATCC 50803 and Encephalitozoon cuniculi GB-M1. 
(Does not include Ashbya gossypii which was in the original paper, as this species was 
not included in the orthology dataset). 
• Present in a bacterial genome. 
• Present in at least one of the plant-like species: Arabidopsis thaliana, Oryza sativa 
Japonica group, Dictyostelium discoideum AX4 and Cyanidioschyzon merolae strain 
10D. 
• Present in at least two of the following yeast species: Yarrowia lipolytica CLIB122, 
Candida albicans SC5314, Scheffersomyces stipitis CBS 6054 and Debaryomyces 
hansenii CBS767.  
The newly designated COPP Tier 1B genes were identified using the same criteria, except 
removing the requirement for identification of at least one bacterial orthologue.  
Further complex I deficient species were identified by looking at the presence and absence of 
the core complex I subunits (MT-ND1, MT-ND2, MT-ND3, MT-ND4, MT-ND4L, MT-ND5, 
MT-ND6, NDUFS1, NDUFS2, NDUFS3, NDUFS7, NDUFS8, NDUFV1 and NDUFV2) for 
each species in the orthology dataset. Species missing all or most of the core subunits were 
designated as complex I deficient, confirmed by the literature where possible.  
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The full complex I phylogenetic profile, therefore, also included the additional criteria of 
absence from the following complex I deficient species: Nematocida parisii ERTm3, 
Edhazardia aedis USNM 41457, Vavraia culicis, Trachipleistophora hominis, Spraguea 
lophii 42_110, Encephalitozoon intestinalis ATCC 50506, Enterocytozoon bieneusi H348, 
Rozella allomycis CSF55, Entamoeba dispar SAW760, Entamoeba histolytica HM-1:IMSS, 
Vitrella brassicaformis CCMP3155, Symbiodinium minutum Clade B1, Babesia bovis T2Bo, 
Eimeria tenella, Eimeria maxima, Eimeria acervulina, Cryptosporidium muris RN66, 
Theileria orientalis strain Shintoku, Toxoplasma gondii GT1, Neospora caninum Liverpool, 
Plasmodium chabaudi chabaudi, Trichomonas vaginalis G3, Tritrichomonas foetus and 
Monocercomonoides. 
 
Electron transfer flavoprotein phylogenetic profiling 
Eukaryotic species predicted to be missing electron transfer flavoprotein were identified as 
those without predicted orthologues of the two genes encoding the subunits of the electron 
transfer flavoprotein (ETFA and ETFB) and the essential associated dehydrogenase (ETFDH).  
These species were: Schistosoma mansoni, Schistosoma haematobium, Hymenolepis 
microstoma, Echinococcus granulosus, Echinococcus multilocularis, Thelohanellus kitauei, 
Pneumocystis jirovecii RU7, Nematocida parisii ERTm3, Edhazardia aedis USNM 41457, 
Vavraia culicis, Trachipleistophora hominis, Spraguea lophii 42_110, Encephalitozoon 
intestinalis ATCC 50506, Encephalitozoon cuniculi GB-M1, Enterocytozoon bieneusi H348, 
Entamoeba dispar SAW760, Entamoeba histolytica HM-1:IMSS, Ostreococcus tauri, 
Ostreococcus lucimarinus CCE9901, Micromonas pusilla CCMP1545, Babesia bovis T2Bo, 
Eimeria tenella, Eimeria maxima, Eimeria acervulina, Cryptosporidium hominis TU502, 
Cryptosporidium muris RN66, Cryptosporidium parvum Iowa II, Theileria annulata strain 
Ankara, Theileria parva, Theileria orientalis strain Shintoku, Plasmodium chabaudi 
chabaudi, Plasmodium falciparum 3D7, Trichomonas vaginalis G3, Tritrichomonas foetus, 
Giardia lamblia ATCC 50803 and Monocercomonoides. 
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The phylogenetic profile for identification of potential electron transfer flavoprotein 
associated genes was then defined as follows: 
• Absent in all eukaryotic species predicted to lack electron transfer flavoprotein. 
• Present in at least two of the free-living cnidarians: Nematostella vectensis, Acropora 
digitifera and Hydra vulgaris. This criterion was included to exclude genes that were 
not identified in any cnidarians, rather than specifically lost in Thelohanellus kitauei.  
• Present in at least two of the following platyhelminthes: Schmidtea mediterranea, 
Clonorchis sinensis and Opisthorchis viverrini. This criterion was included to exclude 
genes that were not identified in any platyhelminthes, rather than specifically lost in 
blood flukes and tapeworms. 
 
Complexes II-IV and ATP synthase phylogenetic profiling 
Eukaryotic species missing each of the complexes II-IV and ATP synthase were identified as 
those missing all subunits of each of the considered complexes. The subunits of the 
complexes considered were identified from the HGNC (HUGO Gene Nomenclature 
Committee) gene families (Gray et al. 2016) as listed in Table 3.1. Known assembly factors 
were also included and were identified from the literature. 
Table 3.1 HGNC gene families for the respiratory complexes II-IV and ATP synthase. Loss of the genes 
within these families was used to inform the phylogenetic profiles for these complexes. 
Complex HGNC gene family No. of subunits 
Complex II Mitochondrial complex II: succinate 
dehydrogenase subunits 
4 
Complex III Mitochondrial complex III: ubiquinol-
cytochrome c reductase complex subunits 
10 
Complex IV Mitochondrial complex IV: cytochrome c 
oxidase subunits 
19 




Chapter 3  Profiling of Respiratory Complexes 
 56 
 Results & Discussion 
Phylogenetic profiling of complex I (NADH dehydrogenase) 
Phylogenetic profiling uses the phylogenetic pattern of genes in a presence and absence 
matrix to associate genes with certain pathways or functions (Loganantharaj & Atwi 2007). 
Previous studies had used this technique to identify assembly factors of complex I (Ogilvie et 
al. 2005; Pagliarini et al. 2008). Given the large spread of species investigated and the 
increased accuracy of orthologue prediction expected from the orthology dataset described in 
Chapter 2, I decided to explore the use of phylogenetic profiling in identifying additional 
respiratory chain complex assembly factors. 
Initially, I applied this technique to complex I – the largest of the four respiratory chain 
complexes and the first complex of the electron transport chain (Vinothkumar et al. 2014). I 
first repeated the analysis from the Mootha group paper which had identified two complex I 
assembly factors (Pagliarini et al. 2008), to compare any changes brought about by using the 
IMPI 2017 dataset and a different orthology prediction method. This paper identified potential 
complex I associated genes known as ‘COPP Tier 1’ (Complex I Phylogenetic Profile Tier 1) 
genes. These genes followed a specific pattern of presence and absence across species, 
including loss in several species known to lack complex I, presence in at least one bacteria 
and one plant-like species, and presence in at least two yeast species which are known to 
contain complex I (Pagliarini et al. 2008). 
Twenty-one IMPI 2017 genes fit the COPP Tier 1 phylogenetic pattern: thirteen known 
complex I subunits, three known complex I assembly factors and five other genes (highlighted 
in green and yellow in Figure 3.1). This included one known complex I assembly factor – 
NUBPL (Bych et al. 2008; Sheftel et al. 2009) – which was not identified in the original 
paper. However, it missed one complex I associated gene (FOXRED1) which was identified 
in the original paper, and which has since been confirmed as a complex I assembly factor 
(Formosa et al. 2015). FOXRED1 did not fulfil the phylogenetic profiling criteria in this 
analysis, as orthologues were not predicted in some of the designated yeast species known to 
encode complex I (Figure 3.1). This may be the result of the more specific orthology 
prediction methodology I used incorrectly removing some true orthologues of FOXRED1. 
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Figure 3.1 (overleaf) Phylogenetic profile of known complex I subunits, associated genes and predicted 
genes. Each box represents presence or absence of a single gene in a species or taxon. A filled box 
represents the prediction of an orthologue of the labelled gene in at least one species of the labelled 
taxon. Numbers in brackets indicate the number of species represented by the label. Species or taxa 
labelled in red are known to be missing complex I. Gene labels are coloured if they match at least one 
of the investigated complex I phylogenetic profiles: (i) the COPP1 profile from the MitoCarta paper, 
(ii) the COPP1B profile, which removes the requirement for a bacterial orthologue, and (iii) the full 
complex I phylogenetic profile, which requires gene loss from several additional species lacking 
complex I not studied in the MitoCarta paper. Approximately half of the known complex I associated 
genes are not predicted by any tested phylogenetic profile. Predicted genes are IMPI genes not currently 
associated with complex I, which fit at least one of the studied phylogenetic profiles. No predicted genes 
fit the full complex I phylogenetic profile. (Green = match the COPP1 profile and the full complex I 
phylogenetic profile; yellow = match the COPP1 profile but not the full complex I phylogenetic profile; 
blue = match the COPP1B profile and the full complex I phylogenetic profile; orange = match the 
COPP1B profile but not the full complex I phylogenetic profile; pink = gene identified in the MitoCarta 
paper, but not this analysis).  
I then extended the analysis by removing the criteria for a bacterial orthologue, due to the 
high proportion of genes with no bacterial orthologues in my dataset (75%) compared to the 
original paper dataset (25%). The seventeen additional genes that fit these criteria were 
designated ‘COPP Tier 1B’ (COPP1B) genes and consisted of nine known complex I 
subunits, four known complex I assembly factors and four other genes (highlighted in blue 
and orange in Figure 3.1). These genes were all identified as fitting the COPP1 profile in the 
original paper (Pagliarini et al. 2008).  
The wide range of species included in my orthology dataset provided an opportunity to make 
a more specific analysis, by including criteria for twenty-four additional species known to be 
missing complex I which had not been included in the original analysis. These included 
members of entirely different phyla (the Parabasalia, Chromerida and Dinoflagellata). I refer 
to this as the ‘full complex I phylogenetic profile’. While these additional criteria did not 
identify any new genes potentially associated with complex I activity, it did rule out all the 
genes previously predicted as COPP1 or COPP1B genes which have not already been 
characterised as complex I associated (genes ruled out by the full complex I phylogenetic 
profile are highlighted in yellow and orange in Figure 3.1). Thus, whilst the expansion of the 
criteria did not identify any potential new associated genes, it did seemingly correctly rule out 
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several false predictions, showing the power of the increased scope of the phylogenetic 
analysis. 
One of these specific changes in gene identification compared to the original analysis was the 
exclusion of LYRM5 as a gene with a function potentially associated with complex I. This 
occurred due to better separation of the LYRM family using the reciprocal best hit technique, 
rather than the simple one-way BLAST. LYRM5 has recently been identified as a regulatory 
protein of the electron transfer flavoprotein, rather than a complex I associated protein (Floyd 
et al. 2016), validating this change.  
 
Electron transfer flavoprotein (ETF) 
While LYRM5 no longer fit the pattern for a complex I associated protein, it did fit the 
observed pattern of loss for the core subunits of the electron transfer flavoprotein (ETF) 
(Figure 3.2). As I now had the pattern of loss of the ETF across the species in the orthology 
dataset, I used this to identify additional genes with possible electron transfer flavoprotein 
associated functions. I combined the pattern of loss across the studied species with criteria 
specifying identification in at least two free-living cnidarians and two of the remaining 
platyhelminthes – this identified thirty potentially associated genes. Removing genes with 
already well-defined functions left six genes (Figure 3.2).  
Of these six genes, C8orf82 is of particular interest. C8orf82 is one of only five genes with 
more than one experimental association with ETFA in the BioGRID database (Islamaj Doğan 
et al. 2017). (Two of the others are LYRM5 and ETFB, which are characterised parts of the 
electron transfer flavoprotein or known to affect its function.) Both of these interactions are 
from high throughput affinity-capture mass spectrometry experiments (Huttlin et al. 2015, 
2017). C8orf82 was included in the IMPI positive training set due to strong evidence from an 
ascorbate peroxidase (APEX) tagging experiment (Hung et al. 2014) and contains a domain 
of unknown function (DUF4504) – the only protein in the human genome to contain this 
domain. C8orf82 is well expressed in most human tissues, as are ETFA and ETFB (Uhlén et 
al. 2015). Therefore, phylogenetic profiling suggests that C8orf82 would be a candidate for 
functional studies related to electron transfer flavoprotein, especially given how little else is 
known about its function. 



































































































































































































Chapter 3  Profiling of Respiratory Complexes 
 61 
Other complexes and the limitations of phylogenetic profiling 
Attempting this phylogenetic profiling analysis helped identify restrictions which limit the 
utility of this technique – particularly for its application in the understanding of human genes. 
One of the limitations of phylogenetic profiling in this context is that it is restricted by the 
identification of species which show variation in the pathway or complex of interest. So, in 
the case of the complex I analysis, the closest studied species to humans with a loss of 
complex I were members of the fungi, such as S. cerevisiae.  Whilst there was variation in the 
actual identified complex I subunits within the studied holozoan species, there was no 
holozoan species studied with a complete loss of complex I. This means that the possible 
function of any genes which originate more recently than the fungi would not be addressed by 
this methodology. Seeing as nearly 45.5% of the IMPI 2017 genes were only identified in 
holozoan species (see Chapter 2), this is a considerable limitation. Therefore, phylogenetic 
profiling for the purpose of identifying the potential functions of human genes will potentially 
be most useful for complexes or pathways with patterns of loss in species which share a more 
recent common ancestor with humans. 
Another limitation is that, for well-conserved pathways or complexes, species (often 
parasites) which have lost one complex or pathway have lost many others, which makes it 
much harder to predict the potential function of genes fitting the same phylogenetic profile. A 
good example of this is seen in the phylogenetic profiles of the respiratory complexes II-IV 
and ATP synthase (Figures 3.3-3.6). Species that have lost one of these complexes have 
nearly always lost all of them. Not only that, but these species are all known to contain 
degenerate forms of mitochondria (mitosomes or hydrogenosomes), so also do not encode 
many genes necessary for other parts of mitochondrial function or metabolism, with only 
between 4.7% and 13.2% of IMPI 2017 genes identified in these species. This makes it 
difficult to predict the potential function of the genes which have been lost in this species, as 
they could function in any number of pathways or complexes. Complexes or pathways 
considered for phylogenetic profiling should therefore preferably show good variation of 
presence and absence across a variety of species, and not just those which have highly 
divergent or minimal genomes.  
Despite the limitations of the technique, this analysis confirms that phylogenetic profiling is a 
potentially useful tool in predicting the function of human genes. The limitations of the 
technique should be considered before use, to identify good potential targets for study. 
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Parasitic species within the Holozoa, such as the myxozoans and some nematodes and 
platyhelminthes, may be good species to consider for phylogenetic profiling. They share a 
more recent common ancestor with humans (in comparison to Saccharomyces cerevisiae) and 
their genomes contain up to 48% of IMPI 2017 genes, increasing the potential number of 
genes which can be analysed. 
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 Conclusions 
In this chapter, I have described a phylogenetic profiling analysis based around the orthology 
dataset created in Chapter 2. This analysis attempts to predict potential assembly factors of 
the mitochondrial respiratory complexes, particularly complex I and electron transfer 
flavoprotein. The analysis did not identify any new potential complex I assembly factors, 
though the increased phylogenetic spread and different orthology detection method improved 
the accuracy of the identification of the known complex I subunits and assembly factors, by 
removing several false positives. Complex I assembly factors discovered in the future are 
more likely to be novel to the Holozoa. The analysis predicted the association of the 
uncharacterised gene C8orf82 with the electron transport flavoprotein, which is supported by 
some literature evidence. Further work is necessary to confirm this prediction. More 
generally, I have derived guidelines for features of species, complexes and pathways which 
will be most amenable to future phylogenetic profiling attempts.   
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 Introduction 
Lessons from Chapter 3 
Whilst phylogenetic profiling is a powerful technique for predicting gene function, the 
analyses I carried out in Chapter 3 using this technique to explore the mitochondrial 
respiratory complexes gave indications of some limitations of the methodology. The success 
of this technique is dependent on finding genes with strong phylogenetic profiles, preferably 
in species which share a relatively recent common ancestor with the original species of 
interest (in this case humans). In general, parasitic species are a good source of variation in 
phylogenetic profiles, as their dependence on hosts for a variety of metabolic processes often 
leads to comparative gene loss (Keeling & Slamovits 2005). However, parasites which have 
lost too much metabolism become less useful. 
The orthology dataset from Chapter 2 was useful as a source of information on which 
families of genes may be tractable to phylogenetic profiling, within certain taxa. These could 
then be taken forward for a further targeted analysis. It was noticeable that there was variation 
in the presence and absence of different members of the mitochondrial carrier gene family 
across eukaryotic species, with the differences present even within the Metazoa.  
 
Mitochondrial carriers 
Mitochondria form distinct compartments within the cell, bounded by a double membrane. 
The outer mitochondrial membrane is relatively porous, due to the presence of porin 
structures (VDAC1, VDAC2 and VDAC3 in humans). These β-barrel proteins form channels in 
the outer mitochondrial membrane, allowing movement of molecules less than approximately 
5,000 Da between the cytoplasm and the intermembrane space (Sorgato et al. 1993). Passage 
of molecules across the inner mitochondrial membrane is more tightly controlled. This means 
the cell can control the localisation and concentrations of a variety of molecules and 
metabolites, allowing mitochondrial compartmentalisation of certain processes and the 
formation of concentration gradients within the cell (e.g. the H+ gradient across the inner 
mitochondrial membrane). 
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The mitochondrial carrier family of proteins form a large group of transporters, mostly 
localised to the inner mitochondrial membrane. There are fifty-three members of this family 
in humans (Palmieri 2013). The basic structure of proteins within the carrier family is three 
homologous repeats of approximately 100 aa each (Walker & Runswick 1993). Each repeat 
consists of two transmembrane helices (for a total of six in the protein) (Figure 4.1), and they 
are linked by shorter α-helices on the matrix side (Pebay-Peyroula et al. 2003). 
 
Figure 4.1 General structure of proteins in the mitochondrial carrier family. Six transmembrane helices 
(blue) are ordered in a three-fold homologous structure. Short alpha helices (pink) connect the helices 
on the matrix side. 
Evidence suggests that transport of substrates by members of this family occurs through 
movement of the protein between two conformational states – one which is open to the 
intermembrane space, and one which is open to the matrix (Kunji et al. 2016). Each of the 
three repeats in the carrier contains two signature motifs: PX[DE]XX[RK] on the matrix side 
(Nelson et al. 1998) and [FY][DE]XX[RK] on the intermembrane space side (Robinson et al. 
2008). The charged residues can form salt bridges, which allows the transporter to be held 
open to either the matrix side or the intermembrane space side, whilst the opposite side is 
closed off, facilitating the transport process (King et al. 2016). 
Transport function for several mitochondrial carriers has been characterised. Members of this 
family transport a wide range of substrates, including nucleotides, amino/keto acids and 
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inorganic ions, such as iron and phosphate (Gutiérrez-Aguilar & Baines 2013). Other 
members function in processes beyond transport activity. For example, UCP1 is linked to the 
production of heat in brown adipose tissue, which is important in keeping new-born babies 
warm, through the uncoupling of proton movement across the inner mitochondrial membrane 
from ATP synthesis (Nedergaard et al. 2001). MTCH1 and MTCH2 are localised to the outer 
mitochondrial membrane and are associated with apoptosis (Mao et al. 2008; Robinson et al. 
2012). However, many members of the mitochondrial carrier family await functional 
characterisation, providing an opportunity for bioinformatic input.  
 
Chapter summary 
In this chapter, I identify phyla with variation in mitochondrial carrier presence and absence 
which support further study through phylogenetic profiling. I build a dataset of orthologues of 
genes encoding the mitochondrial proteome within two phyla – the Nematoda and the 
Platyhelmintha. I use this dataset to attempt to match phylogenetic profiles of characterised 
mitochondrial carriers to missing metabolic genes, to assess the likelihood of success of this 
methodology and identify features which may be indicative of a link to function. I then use 
what I have learnt to explore the possible transport activities of uncharacterised members of 
the mitochondrial carrier family in humans.  
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 Methods 
Human carrier phylogenetic tree 
To create the tree of human mitochondrial carrier family proteins, I retrieved the canonical 
human protein sequences for each carrier from the NCBI (National Center for Biotechnology 
Information) protein database (https://www.ncbi.nlm.nih.gov/protein). These sequences were 
aligned using MUSCLE with default settings (Edgar 2004a, 2004b) and alignments were 
manually assessed in Jalview (Waterhouse et al. 2009). A phylogenetic tree was calculated 
using PhyML 3.0 using the best method (highest maximum likelihood) from the two topology 
search methods (SPR – Subtree Pruning and Regrafting; and NNI – Nearest Neighbour 
Interchange) and 100 bootstrap replicates. The tree was visualised in Interactive Tree Of Life 
(Letunic & Bork 2016). 
 
Identifying carriers by using sequence clustering and hidden Markov models 
Identification and classification of orthologues of the mitochondrial carriers in 
platyhelminthes and nematodes was carried out by Dr Alan Robinson of the Bioinformatics 
group, Medical Research Council Mitochondrial Biology Unit, University of Cambridge, CB2 
0XY, UK.  
Proteomes of representative multicellular metazoan species having a fully sequenced and 
annotated genome were downloaded, including chordates (Homo sapiens, Pan troglodytes, 
Macaca mulatta, Mus musculus, Rattus norvegicus, Canis familiaris, Monodelphis domestica, 
Gallus gallus, Taeniopygia guttata, Xenopus tropicalis, Danio rerio, Fugu rubripes, 
Tetraodon nigroviridis, Branchiostoma floridae, Ciona intestinalis, Oikopleura dioica, 
Halocynthia roretzi), arthropods (Drosophila melanogaster, Drosophila pseudoobscura, 
Pediculus humanus corporis, Ixodes scapularis), nematodes (Loa loa, Caenorhabditis 
briggsae, Caenorhabditis elegans), platyhelminthes (Clonorchis sinensis, Echinococcus 
multilocularis, Echinococcus granulosus, Hymenolepis microstoma, Opisthorchis viverrini, 
Schistocephalus solidus, Schistosoma japonicum, Schistosoma haematobium, Schistosoma 
mansoni), cnidaria (Hydra magnipapillata, Nematostella vectensis), and porifera 
(Amphimedon queenslandica). 
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Sequences of mitochondrial carriers in each species’ proteome were identified by using the 
Pfam model for the mitochondrial carrier family (Pfam: MitoCarr) and by BLASTp searches 
(Altschul et al. 1990, 1997) with human mitochondrial carriers. First, the chordate carriers 
were grouped and aligned into subfamilies using clustering with ClustalW (Thompson et al. 
2002). Then, sequences from phyla progressively more distant from chordates were assigned 
to subfamilies by using BLASTp searches together with ClustalW alignments and clustering. 
A sequence was assigned to a new subfamily if it was not a reciprocal best hit of an existing 
subfamily. Finally, sequences were aligned by using MUSCLE (Edgar 2004a, 2004b) and 
Jalview (Waterhouse et al. 2009), and inspected manually. Each subfamily contained one 
sequence per species, except in the case of indistinguishable paralogs (e.g. UCP1, UCP2 and 
UCP3). 
The multiple sequence alignment of each subfamily was used as a seed alignment to calculate 
a hidden Markov model (HMM) by using HMMER (Eddy 1998).  
Protein sequences from nematodes and platyhelminthes having more than 1,000 protein 
sequences in the NCBI ‘nr’ database were downloaded, as summarised in Table 4.1. 
Sequences for the free-living platyhelminth Schmidtea mediterranea were also retrieved from 
WormBase ParaSite (Howe et al. 2017). These protein sequences were searched for 
mitochondrial carriers using HMMER (Eddy 1998) and the HMM of the mitochondrial carrier 
sub-families generated previously (E-value threshold of 1.0). Each protein sequence was 
initially assigned to the subfamily with which it had the most significant HMM match. 
Sequences were aligned to the original seed subfamily by using MUSCLE (Edgar 2004a, 
2004b) and Jalview (Waterhouse et al. 2009). Each subfamily’s alignment was inspected 
manually to check for contaminants and for sequences of new subfamilies. 
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Building nematode and platyhelminth orthologue datasets 
Reciprocal best hit was used to identify orthologues of proteins encoded by the human IMPI 
positive training set genes in ten platyhelminthes and twenty-five nematodes (Table 4.1).  
Table 4.1 Species of platyhelminthes and nematodes included in the phylogenetic profiling analysis. 
Phyla Species 
Platyhelmintha Tricladida Schmidtea mediterranea 
Plagiorchiida Clonorchis sinensis 
Plagiorchiida Opisthorchis viverrini 
Schistosoma Schistosoma mansoni 
Schistosoma Schistosoma japonicum 
Schistosoma Schistosoma haematobium 
Cestoda Echinococcus granulosus 
Cestoda Echinococcus multilocularis 
Cestoda Hymenolepis microstoma 
 Cestoda Taenia solium 
Nematoda Diplogasterida Pristionchus pacificus 
 Rhabditida Caenorhabditis briggsae 
 Rhabditida Caenorhabditis elegans 
 Rhabditida Caenorhabditis remanei 
 Rhabditida Caenorhabditis brenneri 
 Rhabditida Haemonchus contortus 
 Rhabditida Necator americanus 
 Rhabditida Ancylostoma ceylanicum 
 Rhabditida Ancylostoma duodenale 
 Rhabditida Oesophagostomum dentatum 
 Ascaridida Ascaris suum 
 Ascaridida Toxocara canis 
 Filarioidea Brugia malayi 
 Filarioidea Wuchereria bancrofti 
 Filarioidea Loa loa 
 Dorylaimia Trichinella britovi 
 Dorylaimia Trichinella murrelli 
 Dorylaimia Trichinella native 
 Dorylaimia Trichinella nelson 
 Dorylaimia Trichinella papuae 
 Dorylaimia Trichinella patagonensis 
 Dorylaimia Trichinella pseudospiralis 
 Dorylaimia Trichinella spiralis 
 Dorylaimia Trichinella zimbabwensis 
 Dorylaimia Trichuris suis 
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Two BLASTp protein sequence databases were built – one containing sequences from the 
platyhelminth species and one containing sequences from the nematode species. Any identical 
protein sequences within each species were removed. For each IMPI positive training set 
gene, a BLASTp search was performed against each database, using the canonical human 
protein sequence as a bait sequence (E-value cut-off 1  10-5). For each species, the top hit(s) 
for each gene was chosen for a reciprocal BLASTp search against a dataset of human proteins 
(E-value cut-off 1  10-5). Each sequence which returned a human protein equivalent to the 
original human gene as the top hit in the reciprocal BLASTp search was called an orthologue 
(summarised in Figure 4.2).  
 
Figure 4.2 Summary of the reciprocal best hit method for identifying orthologues of IMPI 2017 
positive training set proteins in the targeted nematodes and platyhelminthes. 
Manual analysis was then used to attempt to fill any gaps in orthologue identification and to 
clarify assignments of orthologues to different members of paralogous groups. Additional 
BLASTp searches were used to identify fragments of proteins missed by the original searches, 
using the WormBase ParaSite database (Howe et al. 2017).  
Where there was confusion between the assignment of orthologues between human genes 
with closely related sequences, phylogenetic trees were used to provide clarification where 
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possible. Sequences from a variety of model organisms and predicted orthologous sequences 
from platyhelminthes or nematodes were aligned using MUSCLE with default settings (Edgar 
2004a, 2004b). PhyML 3.0 was used to calculate a predicted phylogenetic tree for these 
sequences using the best method (highest maximum likelihood) from the two available 
topology search methods and 100 bootstrap replicates (Guindon et al. 2010). Manual 
assessment of the trees was used to clarify assignments of nematode and platyhelminth 
sequences to an appropriate human gene. Efforts were made to maintain consistency for 
assignment decisions made within the studied phyla and between the platyhelminth and 
nematode analyses.  
 
Clustering 
R was used to cluster genes by their phylogenetic patterns. Distance matrices were calculated 
from the phylogenetic pattern matrix using the function dist(), with the method ‘manhattan’. 
Clustering was achieved using the function hclust(), with the method ‘ward.D2’. 
 
Pathway analysis 
Pathway enrichment analysis was carried out in Reactome (Fabregat et al. 2018), using the 
‘Analyze Pathway’ tool. This tool looks for Reactome pathways which are significantly 
overrepresented in the given list of genes and is based on known human genes and pathways.
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Mitochondrial targeting sequence prediction 
Four programmes were used to produce mitochondrial targeting sequence predictions: 
• iPSORT (Bannai et al. 2002) – which returns a binary prediction (0 or 1),  
• MitoProt (Claros & Vincens 1996)– which returns a score between 0 and 1, 
• TargetP (Emanuelsson et al. 2000) – which returns a score between 0 and 1, 
• MitoFates (Fukasawa et al. 2015) – which returns a score between 0 and 1. 
For the continuous prediction scores, predictions were considered of interest if the score was 
above 0.75. 
  
Chapter 4  Mitochondrial Carriers 
 80 
 Results 
Human mitochondrial carrier family 
The human genome encodes fifty-three members of the mitochondrial carrier protein family, 
many of which are still functionally uncharacterised (Gutiérrez-Aguilar & Baines 2013). 
Some of these genes encode proteins that are very similar in both sequence and transport 
function. I, therefore, first calculated a phylogenetic tree of the human proteins from the 
mitochondrial carrier family, to identify members of the family so closely related that they are 
likely to have highly similar or identical functions (Figure 4.3).  
 
Figure 4.3 Unrooted phylogenetic tree of the human mitochondrial carriers. Comprises all the human 
mitochondrial carrier family proteins, with characterised functions where known/predicted. Bootstrap 
values (from 100 replicates) are provided for each branch. Groups of proteins with known or predicted 
similar function are marked in grey. Branch length scale indicates number of substitutions per site. 
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This tree shows a distinct pattern of some highly supported groups of genes (marked in grey), 
joined at a poorly supportive centre. All characterised genes group together with others of the 
same function. For example, the four adenine nucleotide transporters (SLC25A4/5/6/31) group 
together with a completely supportive bootstrap value (100/100). I therefore used this tree to 
identify three groups of the genes without characterised functions, whose patterns of presence 
and absence should be combined when looking at phylogenetic profiling: SLC25A45/47/48, 
SLC25A14/30, and SLC25A51/52. These groups were taken forward to the next stage of the 
analysis. 
 
Identifying useful species for phylogenetic profiling  
One potential way to characterise the function of the carrier proteins is to match patterns of 
missing metabolism and missing carriers across different species. Previous work looking at 
the respiratory complexes (Chapter 2) indicated that the best groups of species to study 
should fulfil several criteria. First, the date of the most recent common ancestor of the 
investigated taxon and the original species of interest (human) should be as recent as possible, 
as the more recently the two taxa share a common ancestor, the more likely the metabolic 
pathways are similar. Additionally, using metazoan species means they are more likely to 
contain pathways which are unique to the Metazoa, which is important as a large proportion 
of human mitochondrial proteins only had predicted orthologues within the Metazoa (Chapter 
2). Secondly, species within the taxon should have varied patterns of gene loss, which may be 
exemplified by species with different types of parasitic lifestyles. Thirdly, any taxon with 
studied parasitic species should contain at least one less-degenerate (e.g. free-living) species 
to compare to. 
Two different phyla fit these criteria: the Nematoda (nematodes or roundworms) and the 
Platyhelmintha (platyhelminthes or flatworms). Both phyla contain multicellular animals, 
some of which are parasitic with varying types of parasitic lifestyles and some of which are 
free-living. Reasonable numbers of each phyla have had their genome sequenced to allow 
comparative analysis.  
Hidden Markov models (HMMs) were used to identify the presence of mitochondrial carriers 
in ten species of platyhelminth and twenty-five species of nematode worm with fully 
sequenced genomes. This included multiple species with similar characteristics where 
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possible, to reduce the mistakes introduced by less complete sequencing/annotation within 
individual species. Carriers branching closely together in the tree of human mitochondrial 
carriers (Figure 4.3) were grouped together.  
The platyhelminthes included in this analysis have four different lifestyles: free-living, liver 
flukes, blood flukes and tapeworms. Nineteen of the mitochondrial carrier groupings were 
identified in all or nearly all the studied platyhelminthes with four groups identified in none 
(Figure 4.4).  
 
Figure 4.4 Phylogenetic profile of human mitochondrial carrier family proteins in ten platyhelminthes. 
Boxes filled in blue represent a carrier identified in labelled. Species are colour-coded by lifestyle: 
green = free-living; purple = liver flukes; red = blood flukes; yellow = tapeworms. Carrier groups 
which are not currently characterised are highlighted in grey. 
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Eight mitochondrial carrier groups show consistent differences in the phylogenetic pattern 
within the studied platyhelminthes, including four carrier groups with a full or partially 
characterised function and four with no characterised function. The characterised carriers with 
differences in phylogenetic patterns provide a good basis for assessing the usefulness of 
phylogenetic profiling within the platyhelminthes to identify carrier function.  
The nematodes included in the analysis are sampled from a wider range of taxonomic groups 
but, importantly, some are parasitic and some are free-living. Identification of the carriers 
within the nematodes is patchier than in the platyhelminthes (Figure 4.5). Nineteen groups of 
mitochondrial carriers are identified relatively consistently across the species, with four 
groups not identified in any studied nematode species. Eight mitochondrial carrier groups 
show consistent differences between different groups of nematodes, including six with full or 
partially characterised functions (Figure 4.5). The patterns of loss or non-identification of 
carriers differs between the nematodes and the platyhelminthes, providing two separate data 
sources to investigate with phylogenetic profiling. 
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Building an orthologue dataset 
To investigate phylogenetic patterns, I needed a dataset of orthologues of genes within the 
studied platyhelminthes and nematodes. As the carriers are mainly mitochondrial, I looked 
only at genes encoding proteins with a mitochondrial function. I decided to use the IMPI 
positive training set genes for this analysis, which consists of a curated set of 1,130 genes 
with strong evidence for mitochondrial localisation. The positive training set genes are more 
certain to have a characterised function within the mitochondria than the predicted genes from 
the IMPI algorithm. Genes with unknown functions within the mitochondria would not be 
useful in this analysis, as there would be no metabolic functions to link to transport activity. 
Reciprocal best hit analysis identified 4,924 predicted orthologues of 752 IMPI genes in the 
ten studied platyhelminthes and 10,624 predicted orthologues of 777 IMPI genes in the 
twenty-five studied nematodes. The more accurate the phylogenetic pattern, the more likely 
that phylogenetic profiling may be useful in identifying function. I, therefore, carried out two 
manual steps to improve the completeness and accuracy of orthologue identification. To 
improve the completeness of the dataset, I carried out manual BLASTp searches using the 
ParaSite WormBase database (Howe et al. 2017) to look for any fragments of orthologous 
proteins that were potentially missed, for all studied genes with at least one identified 
orthologue.  
To improve the consistency of the orthologue assignment, I looked for groups of human genes 
with similar sequences and checked for consistent assignment of platyhelminth and nematode 
orthologues within these groups, using phylogenetic trees where necessary to attempt to 
identify the closest human orthologue. For example, in the nematode species studied, proteins 
with FUN14 domains were assigned as orthologues to both FUNDC1 and FUNDC2. 
Predicted nematode orthologous sequences cluster together in a phylogenetic tree (Figure 
4.6), and FUNDC2 orthologues seem to be slightly less distant from the common ancestral 
sequence than FUNDC1 orthologues, so all nematode proteins were assigned as FUNDC2 
orthologues. 
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Figure 4.6 Phylogenetic tree of known FUNDC1 and FUNDC2 orthologues from humans and the model 
organisms Mus musculus (mice) and Danio rerio (zebrafish), and predicted orthologues from nematodes 
with bootstrap values (out of 100). Branch length scale indicates number of substitutions per site. 
After completion of these steps, the orthologue dataset contains 5,584 predicted orthologues 
of IMPI positive training genes in the ten platyhelminthes studied; and 10,768 orthologues in 
the twenty-five nematodes studied. 60.8% (688/1130) of IMPI positive training genes have at 
least one predicted orthologue in the studied platyhelminthes and 61.5% (696/1130) have at 
least one predicted orthologue in the studied nematodes. 617 genes have predicted 
orthologues in both phyla, with 71 genes with orthologues only in the platyhelminthes and 79 
genes with orthologues only in the nematodes. Despite both phyla including multicellular 
members of the Metazoa (animals), 363 of the tested genes (32.1%) do not have any predicted 
orthologues in either the platyhelminthes or the nematodes. Of the 459 IMPI positive training 
genes assigned to the Reactome pathway ‘metabolism’, 306 (66.7%) have at least one 
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identified orthologue in the studied platyhelminthes and 307 (66.9%) have at least one 
identified orthologue in the studied nematodes, with 256 (55.8%) identified in both phyla. 
Whilst most genes have either no predicted orthologues or predicted orthologues for all or 
nearly all the studied species of each phylum, there are distinct phylogenetic patterns of 
predicted orthologues in some genes within the platyhelminthes (Figure 4.7) and the 
nematodes (Figure 4.8). The different phylogenetic patterns for some genes within the two 
studied phyla provide a good source of data for attempting phylogenetic profiling to predict 
the function of the mitochondrial carriers. 
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Figure 4.7 Clustered phylogenetic profile of IMPI 2017 positive training genes in ten platyhelminth 
species. Includes 658 genes with at least one predicted orthologue. Boxes filled in blue represent a 
carrier identified in labelled. Species are colour-coded by lifestyle: green = free-living; purple = liver 
flukes; red = blood flukes; yellow = tapeworms. 
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Figure 4.8 Clustered phylogenetic profile of IMPI 2017 positive training genes in twenty-five nematode 
species. Includes 696 genes with at least one predicted orthologue. Boxes filled in blue represent a 
carrier identified in labelled. Species are colour-coded by lifestyle: pink = free-living Diplogasterida; 
green = free-living Rhabditida; orange = parasitic Rhabditida; purple = Ascaridida; red = Filarioidea; 
yellow = Dorylaimia. 
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Investigating the characterised transporters 
The characterised transporters with distinct phylogenetic patterns provide a source to test 
whether phylogenetic profiling is feasible and/or useful in the studied species and, if so, what 
features to look for. For example, are there matching phylogenetic patterns for whole regions 
of metabolism which link to the function of a transporter; or are single genes at key points in 
pathways a better indication of association of a transporter with the pathway. I, therefore, first 
investigated the characterised transporters which showed a variation in phylogenetic profile 
within the nematodes and/or platyhelminthes using phylogenetic profiling. 
 
Characterised transporters: SLC25A21 
SLC25A21 (the mitochondrial oxodicarboxylate carrier) acts to transport 2-oxoadipate into the 
mitochondrial matrix, in exchange for 2-oxoglutarate movement out of the matrix (Palmieri et 
al. 2001a; Fiermonte et al. 2001). Within the platyhelminthes, an orthologue of SLC25A21 
was predicted in the free-living platyhelminth Schmidtea mediterranea, but not in any of the 
studied liver flukes, blood flukes or tapeworms (Figure 4.4). Clustering of the orthologue 
dataset showed forty-eight additional IMPI positive training set genes with the same 
phylogenetic pattern, including two additional members of the mitochondrial carrier family 
(SLC25A16/SLC25A43) (Appendix II – Table 1). I analysed these genes (excluding the 
mitochondrial carriers) using the Reactome Pathway Knowledgebase (Fabregat et al. 2018) to 
identify overrepresented pathways. The top metabolic pathways are listed in Table 4.2.  
Table 4.2 Top enriched Reactome metabolic pathways for IMPI genes only identified in the free-living 
platyhelminth Schmidtea mediterranea. 




Choline catabolism 4 2.10  10-6 3.40  10-4 
Urea cycle 2 7.35  10-3 0.19 
Lysine catabolism 2 1.35  10-2 0.19 
Fatty acid metabolism 5 2.93  10-2 0.19 
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One of the top enriched pathways was lysine catabolism (Reactome ID: R-HAS-71064). 
There are two routes of lysine catabolism in humans: the saccharopine pathway, located in the 
mitochondria (Higashino et al. 1965, 1967), and the pipecolate pathway, located in the 
peroxisomes and cytoplasm (Wanders et al. 1988, 1989). The pipecolate pathway is utilised 
mainly in the adult brain, whereas the saccharopine pathway dominates in other tissues 
(Chang 1976). The two genes of the lysine catabolic pathway identified by phylogenetic 
profiling were: AADAT and ALDH7A1. The proteins encoded by these genes function in the 
latter part of the saccharopine pathway, leading to the production of 2-oxoadipate – one of the 
main identified substrates of the carrier encoded by SLC25A21 (Figure 4.9). So, it appears in 
this case that phylogenetic profiling provided useful information to predict the function of a 
mitochondrial carrier. 
However, the saccharopine pathway is localised to the mitochondria, and so 2-oxoadipate is 
produced within the mitochondrial matrix. The main function of SLC25A21 is not to transport 
2-oxoadipate out of the matrix, but to bring 2-oxoadipate into the matrix in exchange for 
mitochondrial 2-oxoglutarate. Therefore, I expanded my phylogenetic analysis out into the 
parts of metabolism surrounding SLC25A21, in both the cytoplasm and the mitochondria 
(Figure 4.9), to investigate whether pathways producing 2-oxoadipate outside the 
mitochondria had the same phylogenetic profile.  
Two further mitochondrial genes with the same phylogenetic pattern could be linked into the 
metabolism of 2-oxoadipate: DHTKD1, which catalyses the production of glutaryl-CoA from 
2-oxoadipate, and SUGCT, which also catalyses the production of glutaryl-CoA but this time 
from glutarate. Using the MitoCore model of central metabolism (Smith et al. 2017) and the 
KEGG database of reactions (Kanehisa et al. 2016), I identified tryptophan breakdown in the 
cytoplasm as an additional site of 2-oxoadipate production, and therefore of interest to study 
phylogenetically. Six of the known genes of tryptophan catabolism also show the same 
phylogenetic profile as the carrier SLC25A21. Though the genes encoding the proteins of the 
last two reactions of the pathway, which lead to the production of 2-oxoadipate, are unknown, 
it can be assumed that this route of tryptophan metabolism as a whole has been lost in liver 
flukes, blood flukes, and tapeworms. This has led to the loss of the 2-oxoadipate carrier, as 
import of this metabolite into the mitochondria is no longer necessary. 
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Figure 4.9 Phylogenetic profile of lysine and tryptophan catabolism in platyhelminthes, which matches 
the platyhelminth phylogenetic profile of the 2-oxoadipate carrier. Coloured boxes indicate that the 
gene is present in the following platyhelminth species: green = free-living; purple = liver flukes; red = 
blood flukes; yellow = tapeworms. Grey boxes mark IMPI positive training genes. 
 
 
Chapter 4  Mitochondrial Carriers 
 93 
However, the phylogenetic pattern of lysine and tryptophan catabolism does not appear to be 
linked to that of SLC25A21 in the studied nematodes (Figure 4.10). 
 
Figure 4.10 Phylogenetic profile of lysine and tryptophan catabolism in nematodes. Coloured boxes 
indicate that the gene is present in the following nematode species: pink = free-living Diplogasterida; 
green = free-living Rhabditida; orange = parasitic Rhabditida; purple = Ascaridida; red = Filarioidea; 
yellow = Dorylaimia. Half-filled boxes indicate this protein is missing in some of the species of that 
group.  Grey boxes mark IMPI positive training genes. 
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SLC25A21 is identified in the Dorylaimia, but the genes of tryptophan and lysine catabolism 
are not; whilst the genes of tryptophan and lysine catabolism are identified in Pristionchus 
pacificus, but without identification of the SLC25A21 transporter. The latter could be due to 
variability in the quality of protein annotation and orthologue prediction within this single 
species. However, the former is more problematic for use of phylogenetic profiling within the 
nematodes. 
SLC25A21 provides a good study of what may be necessary to successfully implement 
phylogenetic profiling to identify substrates of carriers. A wider examination of metabolism 
around any possible transport substrate, including reactions located in the cytoplasm, may be 
useful in identifying the transported substrate.  
 
Characterised transporters: SLC25A38 
SLC25A38 has been genetically characterised as a glycine carrier important in haem 
metabolism (Fernández-Murray et al. 2016), though this has not been proven through 
transport assays. There has also been speculation in the literature that this transporter may 
carry 5-aminolevulinate produced from glycine out of the mitochondria (Guernsey et al. 
2009). In my phylogenetic analysis of platyhelminthes, SLC25A38 is identified in the 
free-living S. mediterranea, all liver flukes and tapeworms, but missing in the blood flukes 
(Figure 4.4). I identified thirteen genes showing the same pattern of phylogenetic loss in the 
blood flukes, including SLC25A38 and an isoform of the ATP-Mg2+/Pi carrier SLC25A24. 
This number also includes some genes which are missing in one other studied platyhelminth, 
to allow some leeway for incomplete protein annotation or orthologue prediction.  
The top seven pathways identified through Reactome analysis are all variations on 
mitochondria fatty acid -oxidation (Table 4.3), which involve only the genes ECHS1 (enoyl-
CoA hydratase, short chain 1) and HADH (hydroxyacyl-CoA dehydrogenase). The number of 
counted genes in these identified pathways was three, due to the Reactome analysis 
associating two UniProt protein IDs with HADH. The gene CPT2 (carnitine 
palmitoyltransferase 2) also shows the same phylogenetic pattern and is associated with fatty 
acid -oxidation, producing acyl-CoAs from acyl-carnitines, which go on to enter the -
oxidation spiral (Ramsay et al. 2001). As fatty acid -oxidation is not directly linked to 
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glycine or haem metabolism, the pathway enrichment analysis does not provide an 
appropriate prediction for the function of SLC25A38. 
Table 4.3 Top enriched Reactome metabolic pathways for IMPI positive training genes, which are only 
missing from blood flukes of the studied platyhelminthes. 




-oxidation of hexanoyl-CoA to butanoyl-CoA 3 1.29  10-6 2.33  10-5 
-oxidation of lauroyl-CoA to decanoyl-CoA-CoA 3 1.29  10-6 2.33  10-5 
-oxidation of octanoyl-CoA to hexanoyl-CoA 3 1.29  10-6 2.33  10-5 
- oxidation of decanoyl-CoA to octanoyl-CoA-CoA 3 2.05  10-6 2.87  10-5 
Mitochondrial fatty acid -oxidation of saturated fatty 
acids 
3 3.22  10-5 3.55  10-4 
-oxidation of butanoyl-CoA to acetyl-CoA 2 2.33  10-4 1.93  10-3 
Mitochondrial fatty acid -oxidation 3 2.41  10-4 1.93  10-3 
 
It may be that key individual genes with matching profiles can give clues to the function of a 
mitochondrial carrier. Therefore, I then went on to do a gene-by-gene analysis of the 
remaining eight genes with matching phylogenetic profiles in the platyhelminthes (Appendix 
II – Table 2). Three of these genes have characterised functions related to metabolic 
pathways. One was CLYBL – a malate/-methylmalate synthase, which has been linked to the 
mitochondrial vitamin B12 pathway (Strittmatter et al. 2014). Vitamin B12 metabolism could 
be linked to haem metabolism in some way, as both molecules contain porphyrin rings. 
Vitamin B12 could also be linked to fatty acid -oxidation, as a cofactor derived from vitamin 
B12 is necessary for the oxidation of propionyl-CoA, produced by -oxidation of odd chain 
fatty acids. Whilst this adds further evidence to the idea that fatty acid -oxidation is different 
in blood flukes than other platyhelminthes, no other mitochondrial gene known to be involved 
of Vitamin B12 metabolism shows the same phylogenetic pattern. 
The second was GLYCTK which catalyses the phosphorylation of D-glycerate in serine and 
fructose catabolism. Mutations in GLYCTK had been identified in a patient who also had 
hyperglycinemia (Sass et al. 2010). It was hypothesised that this was caused by a blockage to 
glycine cleavage, through an uncharacterised system. However, more recent work has shown 
that this single patient had an additional mutation in the glycine cleavage enzyme AMT, rather 
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than GLYCTK malfunction influencing glycine levels (Swanson et al. 2017). Therefore, there 
was no clear link to glycine metabolism. 
The third gene was ABCB6 – an outer mitochondrial membrane protein involved in haem 
biosynthesis (Krishnamurthy et al. 2006). Assuming the genetic characterisation is correct 
and SLC25A38 functions as a glycine transporter, I decided to look further at the metabolism 
around ABCB6, as glycine transport is also linked to haem metabolism. Though the two 
transporters both show the same phylogenetic pattern in platyhelminthes, the haem catabolism 
pathway that the transporters are linked to do not (Figure 4.11).  
 
Figure 4.11 Phylogenetic profile of haem metabolism in platyhelminthes. Coloured boxes indicate that 
the gene is present in the following platyhelminth species: green = free-living; purple = liver flukes; 
red = blood flukes; yellow = tapeworms. Grey boxes mark IMPI positive training genes. 
Most of the haem biosynthesis enzymes in humans are conserved across all the studied 
platyhelminthes, confirming haem metabolism as a key pathway. Only the known transporters 
are lost in blood flukes, though not all transport steps have identified genes or are fully 
characterised.  
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Haem synthesis genes have been lost in nematodes (Rao et al. 2005). This is confirmed in my 
analysis of nematode species (Figure 4.12).  
 
Figure 4.12 Phylogenetic profile of haem metabolism in nematodes. Coloured boxes indicate that the 
gene is present in the following nematode species: pink = free-living Diplogasterida; green = free-living 
Rhabditida; orange = parasitic Rhabditida; purple = Ascaridida; red = Filarioidea; yellow = 
Dorylaimia. Half-filled boxes indicate this protein is missing in some of the species of that group. Grey 
boxes mark IMPI positive training genes. 
However, an orthologue of ABCB6 has been identified in C. elegans (hmt-1) and is associated 
with heavy metal (including iron) detoxification (Schwartz et al. 2010). Dependent on the 
localisation of the haem insertion into proteins, haem may still have to enter the mitochondria 
in these species (Kim et al. 2012). Therefore, there may be a haem transporter in these 
nematodes, though it may function mainly to import rather than export haem.   
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The loss of only the transport steps of haem metabolism in blood flukes may suggest alternate 
localisation of some haem metabolic steps in these species – if steps of haem metabolism are 
moved from the mitochondria, there would be no need for the transport steps. Therefore, I 
investigated the predicted mitochondrial targeting scores of the mitochondrial localised parts 
of haem metabolism across the platyhelminthes and several model organisms, using four 
different mitochondrial targeting sequence prediction programs (Table 4.4).  
In this case, the predicted mitochondrial targeting scores are not very consistent either within 
species or between species. Between species differences may be exaggerated by less accurate 
protein annotation, as mitochondrial targeting prediction programs require an accurate 
sequence at the N-terminal of the protein. However, it does not appear that there has been a 
loss of mitochondrial localisation of ALAS, CPOX, and FECH specifically in the blood flukes, 
as these species have some of the highest targeting scores in the studied platyhelminth 
species. Therefore, differences in localisation of parts of haem metabolism does not seem to 
explain the loss of the SLC25A38 carrier in the blood flukes. 
In the studied nematodes, only a single IMPI positive training gene matches the phylogenetic 
profile of SLC25A38 – not identified in the Diplogasterida, most Rhabditida and the 
Filarioidea. That gene (SLC44A1) is a choline transporter, which is partially localised to the 
mitochondrial membrane, allowing transport of choline in and out of the mitochondria 
(Michel & Bakovic 2009). Choline is catabolised to glycine, mainly in the mitochondria, 
providing a possible link to the function of SLC25A38.  
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However, none of the remaining genes of choline catabolism show the same phylogenetic 
profile in nematodes (Figure 4.13), casting doubt on this association. 
  
Figure 4.13 Phylogenetic profile of choline catabolism and the methionine cycle in studied nematodes. 
Coloured boxes indicate that the gene is present in the following nematode species: 
pink = free-living Diplogasterida; green = free-living Rhabditida; orange = parasitic Rhabditida; 
purple = Ascaridida; red = Filarioidea; yellow = Dorylaimia. Half-filled boxes indicate this protein is 
missing in some of the species of that group. Grey boxes mark IMPI positive training genes. 
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In summary, phylogenetic profiling in both nematodes and platyhelminthes does not 
definitively link the SLC25A38 transporter with its genetically characterised substrate 
(glycine), though there are small clues that may point to this being the case. Large parts of the 
haem synthesis pathway in humans are identified in all of the studied platyhelminthes, 
including the blood flukes; although an additional mitochondrial transporter linked to haem 
synthesis (ABCB6) does show the same phylogenetic profile as SLC25A38 in platyhelminthes. 
It does not appear that there is a change in localisation of the mitochondrial parts of haem 
metabolism in blood flukes, which could have been linked to loss of the carrier. 
 
Characterised transporters: SLC25A12/13 
SLC25A12 and SLC25A13 are transporters which exchange mitochondrial aspartate for 
cytoplasmic glutamate (Palmieri et al. 2001b). Together with the oxoglutarate carrier 
(SLC25A11), these carriers facilitate the functioning of the malate-aspartate shuttle, 
supporting the import of reducing equivalents (NADH) into the mitochondrial matrix 
(Amoedo et al. 2016). A predicted orthologue of SLC25A12/13 is identified in the free-living 
platyhelminth S. mediterranea, liver flukes and most blood flukes, but only in T. solium of the 
four studied tapeworms (Figure 4.4).  
No IMPI positive training genes match the phylogenetic pattern of SLC25A12/13 in 
platyhelminthes, and no other genes are only identified in T. solium of the four different 
tapeworm species studied, regardless of the rest of the phylogenetic pattern. The genes 
encoding members of the malate-aspartate shuttle, including the oxoglutarate carrier, are 
completely or almost completely present in all studied platyhelminthes (Figure 4.14). 
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Figure 4.14 Phylogenetic profile of the malate-aspartate shuttle in platyhelminthes. Coloured boxes 
indicate that the gene is present in the following platyhelminth species: green = free-living; purple = 
liver flukes; red = blood flukes; yellow = tapeworms. Half-filled boxes indicate this protein is missing 
in some of the species of that group. Grey boxes mark IMPI positive training genes. 
The malate-aspartate shuttle is linked to the tricarboxylic acid (TCA) cycle, through the 
production of malate from oxaloacetate by MDH2 (malate dehydrogenase 2). In the TCA 
cycle, malate dehydrogenase catalyses the reaction in the opposite direction, producing 
oxaloacetate from malate. Genes encoding all other enzymes of the TCA cycle are identified 
in all the studied platyhelminth species, except fumarase (FH) which is not identified in any 
tapeworm. However, there are two known classes of fumarase – type I and type II. The 
fumarase identified in humans and the rest of the platyhelminth species is a type II fumarase 
(Estévez et al. 2002). All studied tapeworm species instead have a type I fumarase which 
catalyses the same reaction, but which forms iron-dependent dimers (Estévez et al. 2002). 
Therefore, the TCA cycle looks to be complete in all studied platyhelminthes and is not linked 
phylogenetically to the aspartate/glutamate carrier. 
The inconsistency of the phylogenetic pattern in the tapeworms raises the possibility that the 
prediction of an orthologue in T. solium may actually be caused by a contaminant (i.e. this 
transporter group is actually lost from all tapeworms).   
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In the studied nematode species, a predicted orthologue of SLC25A12/13 is missing in the 
Filaroidea and Pristionchus pacificus (Figure 4.5). The loss in all three studied Filariod 
nematodes is particularly interesting for its consistency within that taxon; whilst P. pacificus 
is the only diplogasterid included in the analysis, so the loss is not supported by analysis of 
related species. Five IMPI positive training set genes exactly match the phylogenetic pattern 
of the aspartate/glutamate carriers within the nematodes: PAICS, MTHFS, MMADHC, 
CHCHD4 and MCEE. PAICS (involved in purine synthesis) consumes aspartate, though this 
protein is not solely localised to the mitochondria (French et al. 2016). Two of these genes 
(MMADHC and MCEE) are related to vitamin B12 metabolism. This may be of some interest 
as vitamin B12 dependent enzymes are utilised in some methylation reactions dependent on 
tetrahydrofolate; and tetrahydrofolate itself is synthesised using glutamate. An additional 
fourteen genes are lost in the Filaroidea but identified in P. pacificus, with another nine genes 
with a similar pattern but missing between one and three orthologues from other species. I 
took all these genes forward for further analysis.   
Reactome pathway enrichment analysis of these genes identifies the complete loss of the 
pathway ‘propionyl-CoA catabolism’, which produces succinyl-CoA from propionyl-CoA 
and is dependent on adenosylcobalamin (a derivative of vitamin B12) as a cofactor. Most of 
the remaining identified pathways are related to vitamin and cofactor metabolism, with the 
strongest p-value for the pathway ‘defects in vitamin and cofactor metabolism’ (Benjamini 
corrected p-value = 2.34  10-11). While this is interesting for potential future profiling, this 
does not link the phylogenetic pattern to the function of SLC25A12/13. 
However, one of the genes with a matching or close phylogenetic pattern to SLC25A12/13 in 
the nematodes is GOT2 (mitochondrial aspartate transaminase), which is a key part of the 
malate-aspartate shuttle. I investigated the other genes of the malate-aspartate shuttle in the 
nematodes (Figure 4.15), but there was no loss of any of the cytoplasmic genes of the malate-
aspartate shuttle.  
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Figure 4.15 Phylogenetic profile of the malate-aspartate shuttle in nematodes. Coloured boxes indicate 
that the gene is present in the following nematode species: pink = free-living Diplogasterida; green = 
free-living Rhabditida; orange = parasitic Rhabditida; purple = Ascaridida; red = Filarioidea; yellow 
= Dorylaimia. Grey boxes mark IMPI positive training genes. 
Though this may indicate a small potential link between gene phylogenetic profiles and the 
function of the aspartate/glutamate carrier, it is only one gene from twenty-nine with similar 
patterns. It seems unlikely that this would provide enough evidence to justify wet laboratory 
testing of the carrier if the function was still unknown, even if I had managed to pick out the 
correct gene. Therefore, the phylogenetic pattern analysis of the aspartate/glutamate carrier 
provides some important lessons for the application of this technique. Links to the function of 
the gene may be very small (in this case one gene) and difficult to detect, and it will be 
important to use other corroborating evidence to justify wet laboratory work. 
 
Characterised transporters: SLC25A2/15 
SLC25A2 and SLC25A15 are both characterised ornithine transporters, which transport 
cytoplasmic ornithine into the mitochondrial matrix, in exchange for mitochondrial citrulline 
(Camacho et al. 1999, 2003). A predicted orthologue of the ornithine transporters is identified 
in most studied nematode species with no consistent pattern of loss (Figure 4.5). However, in 
Chapter 4  Mitochondrial Carriers 
 105 
the platyhelminthes, an ornithine transporter is not predicted in either of the two 
Echinococcus species, despite identification in the other two tapeworm species (Figure 4.4).  
The key function of ornithine in human mitochondria is the detoxification of ammonia via the 
urea cycle, where ornithine is combined with carbamoyl-phosphate to form citrulline, via the 
protein encoded by the gene OTC (ornithine carbamoyltransferase). The genes of the urea 
cycle show a very inconsistent phylogenetic pattern within the platyhelminthes (Figure 4.16), 
with different parts lost throughout the studied species. The entire pathway, apart from 
cytoplasmic arginase (ARG1) is lost in Echinococcus species, but also in the other studied 
tapeworms.  
 
Figure 4.16 Phylogenetic profile of the urea cycle in platyhelminthes. Coloured boxes indicate that the 
gene is present in the following platyhelminth species: green = free-living; purple = liver flukes; red = 
blood flukes; yellow = tapeworms. Half-filled boxes indicate this protein is missing in some of the 
species of that group. Grey boxes mark IMPI positive training genes. 
No IMPI positive training genes exactly match the phylogenetic pattern of the ornithine 
carriers in the platyhelminthes. However, five genes are identified in only one of T. solium 
and H. microstoma (the two non-Echinococcus tapeworm species), listed in Table 4.5.  
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Table 4.5 IMPI positive training genes with similar phylogenetic patterns to the ornithine carriers in 
platyhelminthes. 
Ensembl ID Gene Function 
ENSG00000131473 ACLY Synthesis of acetyl-CoA 
ENSG00000159423 ALDH4A1 Proline degradation 
ENSG00000162129 CLPB Peptidase 
ENSG00000100033 PRODH Proline degradation 
ENSG00000115840 SLC25A12 Aspartate/glutamate exchanger 
 
Two of these genes (ALDH4A1 and PRODH) are involved in proline degradation to glutamate 
via 1-pyrroline-5-carboxylate (P5C), but I could find no described link between SLC25A2/15 
and proline transport in the literature. P5C can also be produced from ornithine via the action 
of ornithine aminotransferase (OAT), producing L-glutamate 5-semialdehyde. This can then 
be non-enzymatically converted to P5C (Mezl & Knox 1976). Predicted orthologues of OAT, 
however, are identified in both species of Echinococcus studied – i.e. this step has not been 
lost. In rat liver tissue, OAT can run in reverse, producing ornithine from L-glutamate 
5-semialdehyde, when there are low concentrations of ornithine (Strecker 1965). This may be 
the case in Echinococcus mitochondria, if the loss of the ornithine transporter leads to a lack 
of transport of ornithine into the matrix, explaining the presence of OAT in Echinococcus. 
In summary, small parts of proline metabolism linked to ornithine show a similar 
phylogenetic pattern to the ornithine transporters in the platyhelminthes. However, this link 
would not be obvious if the ornithine transporter was not already functionally characterised. 
 
Characterised transporters: SLC25A10 
The dicarboxylate carrier (SLC25A10) transports dicarboxylates, including malate and 
succinate, out of the mitochondrial matrix in exchange for inorganic phosphate (Pi) (Palmieri 
et al. 1996; Fiermonte et al. 1998). Although orthologues of this carrier are almost 
ubiquitously predicted in the studied platyhelminthes (Figure 4.4), predicted orthologues of 
this gene are not predicted in any of the studied species of Caenorhabditis or in P. pacificus 
(Figure 4.5). Three additional genes have similar phylogenetic patterns to this transporter 
within the nematodes, but none of these have clear metabolic functions (Table 4.6). There are, 
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therefore, no clues in the phylogenetic profiling of mitochondrial genes in the nematodes and 
platyhelminthes as to the function of SLC25A10. 
Table 4.6 IMPI positive training genes with similar phylogenetic patterns to the dicarboxylate carrier 
in nematodes. 
Ensembl ID Gene Function 
ENSG00000114026 OGG1 DNA repair 
ENSG00000164306 PRIMPOL DNA primase-polymerase 
ENSG00000156990 RPUSD3 Mitochondrial rRNA modification 
 
 
Characterised transporters: SLC25A1 and SLC25A29 
SLC25A1 encodes the mitochondrial citrate carrier, which exchanges mitochondrial citrate (or 
other tricarboxylates) for cytoplasmic malate (Bisaccia et al. 1989). This carrier is identified 
in all studied platyhelminthes but is missing from nematode members of the Dorylaimia 
(including both Trichinella and Trichuris species). Thirty IMPI positive training set genes 
have a similar phylogenetic pattern in nematodes (Appendix II – Table 3), but no metabolic 
pathways are significantly overrepresented in these genes in a Reactome pathway analysis – 
the highest ranked pathway is ‘mitochondrial protein import’ (Benjamini corrected 
p-value = 0.045). 
The citrate exported from the mitochondrial matrix by SLC25A1 can be utilised in the 
cytoplasm to feed acetyl-CoA to fatty acid and sterol synthesis, via the action of ATP citrate 
lyase (ACLY). Orthologues of ACLY are identified in all studied nematode species. There is a 
single IMPI positive training gene with a matching phylogenetic pattern linked to fatty acid 
biosynthesis – malonyl-CoA dcarboxylase (MLYCD) – which catalyses the breakdown of 
malonyl-CoA to acetyl-CoA (Sacksteder et al. 1999). However, in general, there is no 
obvious link between the genes matching the phylogenetic pattern of SLC25A1 and its 
function.  
SLC25A29 (the basic amino acid transporter) also shows a similar phylogenetic pattern within 
the nematodes, although an orthologue is identified in a single member of the Dorylaimia (T. 
spiralis). Orthologues are not predicted in any studied platyhelminth species. There are no 
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IMPI 2017 positive training genes that exactly match this phylogenetic pattern. Additionally, 
none of the genes lost in all the Dorylaimia have a clear association with basic amino acid 
metabolism (Appendix II – Table 3). The identification of an orthologue in T. spiralis may 
suggest that orthologues in other very closely related species of Trichinella may have been 
missed due to incomplete protein annotation, or that the orthologous protein in T. spiralis is a 
contaminant. 
In summary, phylogenetic profiling within the nematodes or platyhelminthes does not predict 
the function of either SLC25A1 or SLC25A29. 
 
Lessons from the characterised transporters  
These investigations into the characterised transporters gave good information about the 
potential success rate and limitations of phylogenetic profiling to predict the function of 
mitochondrial carriers. The identified patterns of metabolic loss do not seem to be consistent 
between the platyhelminthes and the nematodes, presumably due to different modifications of 
metabolism in comparison to known human metabolism. The patterns of gene loss within 
certain types of platyhelminthes seem more consistent, and it is only within the 
platyhelminthes that it was possible to link the loss of metabolism to transporter function 
(SLC25A21). In other cases, single genes could be linked to carrier function via their 
phylogenetic pattern, but extensive extra work would have been needed to support a case for 
testing any predicted transport substrate from such a small association. Cases like these would 
be harder to identify for uncharacterised transporters. In other cases, there was no apparent 
link between carrier function and phylogenetic patterns of the metabolism linked to the 
transport substrate, suggesting this approach will not solve all cases. 
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Uncharacterised transporters 
There are four groups of uncharacterised transporters which showed variation in the 
phylogenetic pattern of presence and absence in the platyhelminthes and/or the nematodes: 
SLC25A14/30, SLC25A43, SLC25A44 and SLC25A45/47/48 (Figures 4.4 and 4.5). I applied 
the knowledge gained from investigating the characterised transporters to inform my study of 
these uncharacterised mitochondrial carrier family transporters.  
I also used additional information from the literature to provide more context to any potential 
transport substrate predicted by the phylogenetic analysis. This included looking at a 
symmetry/binding site analysis which predicted the potential type of transport substrate for a 
variety of carriers (Robinson et al. 2008). The binding site analysis looks at the predicted 
substrate binding sites across carrier groups and uses characterised transporters and chemical 
knowledge to predict the likely features of a transported substrate (Robinson et al. 2008).  I 
also carried out a literature search for any other information on the carriers and their potential 
function.  
Table 4.7 summarises the results of this analysis, before a more extensive case-by-case 
discussion of the four studied groups of uncharacterised transporters. 
.
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Uncharacterised transporters: SLC25A14/30 
SLC25A14 and SLC25A30 (also known as UCP5/BMCP1 and KMCP1) are two 
uncharacterised members of the mitochondrial carrier family. They group closely together in 
the human carrier phylogenetic tree (Figure 4.3), so I considered them together in the 
phylogenetic profiling analysis. The studied nematodes have no predicted orthologues of 
these genes (Figure 4.5). In the studied platyhelminthes, orthologues are predicted in the free-
living species S. mediterranea and the liver flukes, but not in the blood flukes or tapeworms 
(Figure 4.4). Therefore, this analysis was concentrated on the platyhelminthes. 
Thirty-five genes (Appendix II – Table 4) from the IMPI positive training set have 
phylogenetic profiles matching SLC25A14/30 within the platyhelminthes. An additional nine 
genes were also included in further analysis, whose phylogenetic profile differed from that of 
SLC25A14/30 by one species, to allow for variation in the quality of the protein annotation 
and orthologue identification processes. Reactome pathway enrichment analysis identified 
several pathways that are significantly enriched within these genes. The top four metabolic 
and non-overlapping pathways are listed in Table 4.8.  
Table 4.8 Enriched Reactome metabolic pathways for genes matching the phylogenetic pattern of 
SLC25A14/30, within the platyhelminth species. 




Branched-chain amino acid catabolism 13 1.11  10-16 9.99  10-15 
Mitochondrial fatty acid -oxidation 8 3.12  10-9 6.86  10-8 
Ketone body metabolism 4 3.03  10-6 3.03  10-5 
Cobalamin (Cbl, vitamin B12) transport and metabolism 3 6.80  10-4 2.72  10-3 
 
One of the significantly enriched pathways is ‘mitochondrial fatty acid -oxidation’, which is 
the process by which fatty acids are broken down to acetyl-CoA (which enters the 
tricarboxylic acid cycle) and the reducing equivalents NADH and FADH2 (Houten et al. 
2016). Large parts of fatty acid -oxidation have been lost in blood flukes and tapeworms, 
including the electron acceptor electron transfer flavoprotein (Figure 4.17). However, the 
transport system feeding fatty acids into the mitochondrial fatty acid -oxidation spiral via 
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carnitine is well characterised (involving carnitine palmitoyltransferases CPT1 and CPT2 and 
the mitochondrial carrier SLC25A20) with no obvious additional transporters left to identify. 
 
Figure 4.17 Phylogenetic profile of mitochondrial fatty acid -oxidation in platyhelminthes. Coloured 
boxes indicate that the gene is present in the following platyhelminth species: green = free-living; purple 
= liver flukes; red = blood flukes; yellow = tapeworms. Grey boxes mark IMPI positive training genes. 
Half-filled boxes = missing in some species of that group. 
The overrepresented metabolic pathway with the highest number of identified genes and the 
lowest corrected p-value is ‘branched-chain amino acid catabolism’ – the breakdown of 
valine, leucine and isoleucine. Most genes encoding parts of this pathway seem to have been 
lost in blood flukes and tapeworms (Figure 4.18), including genes encoding regulatory 
proteins, such as BCKDK (branched chain ketoacid dehydrogenase kinase) and PPM1K 
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(protein phosphatase 1K). The vitamin B12 metabolic pathway, also identified in the 
Reactome analysis, links into this pathway through the vitamin B12 dependent enzyme MUT 
(methylmalonyl-CoA mutase; Figure 4.18). 
 
Figure 4.18 Phylogenetic profile of branched chain amino acid degradation in platyhelminthes. 
Coloured boxes indicate that the gene is present in the following platyhelminth species: green = free-
living; purple = liver flukes; red = blood flukes; yellow = tapeworms. Grey boxes mark IMPI positive 
training genes. AdoCbl = adenosylcobalamin (vitamin B12 derivative). Half-filled boxes indicate this 
protein is missing in some of the species of that group. 
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In humans, this pathway can be localised entirely to the mitochondria. Therefore, any possible 
transport steps should be at the beginning and/or end of this pathway. The beginning of the 
pathway is the three amino acids (valine, leucine and isoleucine). Branched chain amino acid 
transaminase catalyses the first step of this pathway for all three amino acids, producing a 
related branched-chain keto acid. In humans, there are two genes encoding this enzyme: 
BCAT1 (localised to the cytoplasm) and BCAT2 (localised to the mitochondria). If this step is 
carried out in the cytoplasm, there is the potential for import of the keto acid for completion 
of the catabolic process within the mitochondria. Otherwise, the amino acids themselves must 
enter the mitochondria. Therefore, the beginning of the pathway provides two possible groups 
of potential substrates for a transporter – the three branched-chain amino acids and their 
corresponding branched-chain keto acids.  
The end of the branched-chain amino acid catabolic pathway is different for the three amino 
acids involved. Valine and isoleucine can eventually be converted to succinyl-CoA, through 
different but complementary paths, which can enter the tricarboxylic acid cycle. The 
catabolism of leucine, however, leads to the production of acetyl-CoA and acetoacetate. This 
links into the third enriched Reactome pathway – ‘ketone body metabolism’ (Figure 4.19).  
Acetoacetate is one of three ketone bodies in humans, the others being acetone and 
3-hydroxybutanoate. Ketone bodies are produced by the liver in humans, mainly in the 
mitochondrial matrix, and used as an energy source by other tissues, particularly during 
periods of fasting (McGarry et al. 1970). To get to other tissues, or to be used in other 
processes such as sterol synthesis, ketone bodies must be transported out of the mitochondrial 
matrix. Therefore, a third possible group of transport substrates for SLC25A14/30 identified 
from phylogenetic profiling are the ketone bodies.   
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Figure 4.19 Phylogenetic profile of ketone body metabolism in platyhelminthes. Coloured boxes 
indicate that the gene is present in the following platyhelminth species: green = free-living; purple = 
liver flukes; red = blood flukes; yellow = tapeworms. Grey boxes mark IMPI positive training genes. 
As study of the characterised carriers had shown that single genes could also be linked to the 
function of a transporter, I also looked at the four additional metabolic genes from non-
enriched pathways which fit the phylogenetic profile: GSTZ1, NUDT19, AASS, and SHMT2.  
• GSTZ1 (glutathione S-transferase zeta 1) encodes a maleylacetoacetate isomerase, 
important in tyrosine/phenylalanine degradation. Though this was not identified as 
part of the enriched pathways, tyrosine degradation does lead to the production of 
acetoacetate – one of the three ketone bodies – linking this gene into other missing 
parts of metabolism.  
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• NUDT19 is a renal CoA-diphosphohydrolase, involved in the control of coenzyme A 
(CoA) concentrations through its breakdown (Shumar et al. 2018). While there are 
many CoA-based compounds in the enriched pathways there is not an obvious link to 
potential transport substrates.  
• AASS (aminoadipate-semialdehyde synthase) encodes a protein that catalyses the first 
two stages of the lysine degradation pathway, which I have previously explored 
(Figure 4.9). There is no obvious uncharacterised transport step in this pathway.   
• SHMT2 (serine hydroxymethyltransferase 2) encodes a protein which is part of 
mitochondrial glycine and tetrahydrofolate metabolism. It catalyses the conversion of 
glycine to serine via donation of a methyl group from methyltetrahydrofolate. The 
proteins forming the other mitochondrial parts of this pathway are not identified in any 
platyhelminthes, making it hard to speculate on a link to transport activity. 
To further prioritise potential transport substrates, I investigated the literature on the 
mitochondrial carriers themselves, for evidence to support any of the potential transport 
substrates. Robinson et al. (2008) used the three-repeat structure of the mitochondrial carriers 
to investigate substrates of the transporters, by looking for symmetric and asymmetric 
residues between the three repeats. As most transported substrates are asymmetric, residues 
involved in the binding of substrates are also likely to be asymmetric between the three 
repeats; whereas symmetric residues are more likely to be involved in the transport 
mechanism. From this analysis, they predict that the substrate for metazoan UCP5 
(SLC25A14) and related transporters is relatively small, as there are few asymmetric residues 
around the predicted binding site. Arginine residues are located at positions in the binding site 
similar to the oxoglutarate and dicarboxylate transporters. Together, these features predict that 
SLC25A14/30 may transport small keto acids.  
Looking at the structures of the potential transport substrates predicted by the phylogenetic 
profiling (Figure 4.20), this would particularly support the idea of SLC25A14/30 as possible 
transporters of the ketone body acetoacetate or the branched chain α-keto acids produced by 
the first step in the breakdown of the branched chain amino acids. 
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Figure 4.20 Structures of potential transport substrates for SLC25A14/30, grouped by the type of 
substrate.  
mRNA expression analysis shows high levels of expression of SLC25A14 in the brain and 
reproductive tissues (Yu et al. 2000; Thul et al. 2017), whereas SLC25A30 mRNA is highly 
expressed in kidney and muscle tissues (Haguenauer et al. 2005; Thul et al. 2017). These are 
all tissues which are known to oxidise ketone bodies for use, after their production by the 
liver (Laffel 1999). This is particularly true of the brain which does not utilise fatty acids as 
an energy source when glucose concentrations are low, such as during fasting (Owen et al. 
1967).  
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Other evidence in model organisms also suggests a link between this group of mitochondrial 
transporters and ketone bodies. Fruit flies (Drosophila melanogaster) with SLC25A14 
knocked out are more sensitive to the effects of fasting (Sánchez-Blanco et al. 2006). 
SLC25A14 expression is also increased in rats fed on a synthetic ketone-ester diet (Kashiwaya 
et al. 2010) and in mice fed on a ketogenic diet (Ramsden et al. 2012). 
In summary, Table 4.9 shows a prioritised list of candidate transport substrates for the 
mitochondrial transporters SLC25A14/30, from the evidence produced by phylogenetic 
analysis and additional evidence from the literature. 
Table 4.9 Prioritised candidate transport substrates from phylogenetic profiling for SLC25A14/30 with 







1 Acetoacetate X X X 
2 Branched chain α-keto acid X X  
 Acetone, β-hydroxybutyrate X  X 
3 Branched chain amino acids X   
 
 
Uncharacterised transporters: SLC25A43 
SLC25A43 is an uncharacterised member of the mitochondrial carrier family which is not 
closely related to any other family members, at least in humans (Figure 4.3). In the studied 
platyhelminthes, predicted orthologues of SLC25A43 are only identified in the free-living 
S. mediterranea (Figure 4.4), whereas in the studied nematodes, predicted orthologues are 
only identified in the Dorylaimia (Figure 4.5).  
Fifteen IMPI 2017 positive training genes match or almost match the phylogenetic pattern of 
SLC25A43 in the studied nematodes (Appendix II – Table 5). However, Reactome analysis 
does not identify any significant metabolic pathways and only one of the genes (CYP1A1) is 
clearly linked to metabolism. CYP1A1 is a member of the cytochrome P450 family, involved 
in the metabolism of xenobiotic compounds and endogenous steroid metabolism (Lee et al. 
2003). However, its role within the mitochondria is poorly defined. 
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Therefore, I moved on to investigating the genes fitting the phylogenetic pattern in the 
platyhelminthes. This is the same pattern as seen for the oxoadipate transporter SLC25A21, 
where lysine degradation was linked to transport function (Figure 4.9). I could not identify 
any additional uncharacterised transport steps in the lysine degradation pathway and 
associated metabolism, so I then considered the other metabolic genes with matching 
phylogenetic patterns. 
Apart from the genes linked to lysine degradation, there are an additional forty-three genes 
with the same phylogenetic pattern as SLC25A43 in the platyhelminthes, of which nineteen 
encode proteins involved in metabolism. Reactome pathway enrichment analysis identified 
‘choline catabolism’ as an enriched pathway within this set of genes (Table 4.2). Choline 
catabolism occurs partially in the mitochondria and partially in the cytoplasm and is a source 
of methyl units (important in one carbon metabolism) through the methionine cycle. I 
investigated the phylogenetic patterns of choline catabolism and the cytoplasmic metabolism 
it is linked to (Figure 4.21).  
The genes encoding proteins used to process methionine through to cysteine, allowing 
donation of a methyl-group from S-adenosyl methionine (SAM), are maintained across the 
studied platyhelminthes species. However, two routes which allow recycling of methionine 
from homocysteine (one dependent on choline, the other dependent on tetrahydrofolate 
metabolism) are lost. Choline dehydrogenase is the only gene of choline catabolism identified 
in a platyhelminth species beyond the free-living S. mediterranea. According to the known 
sub-cellular localisation of the enzymes involved in choline metabolism in mammals, 
dimethylglycine and either betaine or betaine aldehyde (all parts of choline metabolism) must 
cross the inner mitochondrial membrane, presumably via a carrier (Figure 4.21). Evidence 
suggests that this transporter is different from the choline transporter (SLC44A1), as the 
products of choline metabolism do not inhibit choline transport to a significant level (Porter et 
al. 1992). Therefore, dimethylglycine, betaine and betaine aldehyde are candidate transport 
substrates for SLC25A43.  
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Figure 4.21 Phylogenetic profile of choline catabolism and the methionine cycle in the studied 
platyhelminthes. Coloured boxes indicate that the gene is present in the following platyhelminth species: 
green = free-living; purple = liver flukes; red = blood flukes; yellow = tapeworms. Grey boxes mark 
IMPI positive training genes. Half-filled boxes indicate this protein is missing in some of the species of 
that group.  
Looking at the other metabolic genes with the same phylogenetic pattern as SLC25A43, 
another pathway of possible interest is GABA (γ-aminobutyric acid or 4-aminobutanoate) 
catabolism. GABA is a neurotransmitter which is produced in the cytoplasm or Golgi 
apparatus of the brain (and other tissues) from glutamate (Kanaani et al. 2015). GABA 
metabolism is linked to choline metabolism via betaine, as the plasma membrane transporter 
BGT1 can transport both betaine and GABA into the cell (Yamauchi et al. 1992). GABA is 
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broken down to succinate semialdehyde in the mitochondrial matrix, which can then be 
converted to succinate and enter the TCA cycle. Genes for the two key reactions of GABA 
metabolism – cytoplasmic GAD1/2 (glutamate decarboxylase) for synthesis and 
mitochondrial ABAT (4-aminobutyrate aminotransferase) for catabolism – are only identified 
in the free-living S. mediterranea (Figure 4.22), implying GABA metabolism is unique to this 
species in the studied platyhelminthes. Transport of GABA into the mitochondria is necessary 
for eventual catabolism, suggesting GABA as a candidate compound for transport by 
SLC25A43. An additional neurotransmitter, -hydroxybutyrate, is also metabolised to 
succinate semialdehyde in the mitochondria, by a gene only present in S. mediterranea 
(Figure 4.22). The endogenous production routes of -hydroxybutyrate are unclear, but this 
compound may also be a candidate for SLC25A43 transport. 
 
Figure 4.22 Phylogenetic profile of mitochondrial GABA (4-aminobutanoate) catabolism in studied 
platyhelminthes. Coloured boxes indicate that the gene is present in the following platyhelminth species: 
green = free-living; purple = liver flukes; red = blood flukes; yellow = tapeworms. Grey boxes mark 
IMPI positive training genes. 
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Another pathway of possible interest is the carnitine synthesis pathway (Figure 4.23). 
 
Figure 4.23 Phylogenetic profile of carnitine synthesis in studied platyhelminthes. Coloured boxes 
indicate that the gene is present in the following platyhelminth species: green = free-living; purple = 
liver flukes; red = blood flukes; yellow = tapeworms. Grey boxes mark IMPI positive training genes. 
A single gene in this pathway is thought to encode a mitochondrial enzyme – TMLHE 
(trimethyllysine hydroxylase, epsilon). This enzyme catalyses the first step in the pathway, 
producing 3-hydroxy-trimethyllysine from N6-trimethyllysine. A predicted orthologue of this 
gene was only identified in S. mediterranea. N6-trimethyllysine is predicted to be sourced 
from the breakdown of proteins in the lysosome or proteasome (Strijbis et al. 2010) and so 
would need to enter the mitochondria.  
The remaining steps of the pathway are thought to be cytoplasmic in humans, although the 
enzyme catalysing the second step has not been identified. Of the two remaining enzymes, 
ALDH9A1 is identified in all platyhelminthes except liver flukes and BBOX1 is not identified 
in any platyhelminthes. ALDH9A1 is a promiscuous enzyme, so may be catalysing other 
reactions in the liver flukes and blood flukes. BBOX1 may be truly missing from 
S. mediterranea, but as this analysis only looks at a single free-living species, it may also be 
missing due to poor protein annotation. Knowledge of the enzyme catalysing the second step 
of the pathway and its predicted platyhelminthes orthologues would help clarify this situation. 
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Without that information, both the substrate (N6-trimethyllysine) and product (3-hydroxy-
trimethyllysine) of TMLHE are potential transport substrates for SLC25A43. γ-butyrobetaine 
is a potential substrate depending on subcellular localisation of the later steps and assuming 
carnitine synthesis occurs in S. mediterranea.  
I also investigated each of the additional fourteen genes with links to metabolism showing the 
same phylogenetic pattern as SLC25A43, which were not in any enriched pathway (Table 
4.10). None of these genes seemed to have links to a possible transported mitochondrial 
compound. 
Table 4.10 Additional IMPI positive training set metabolic genes with phylogenetic profiles matching 
SLC25A43 in the studied platyhelminthes. 
Ensembl ID Gene  Function 
ENSG00000167315 ACAA2 Fatty acid -oxidation 
ENSG00000167107 ACSF2 Fatty acid synthesis 
ENSG00000154930 ACSS1 Acetyl-CoA production from acetate 
ENSG00000113492 AGXT2 Multifunctional aminotransferase 
ENSG00000145439 CBR4 Fatty acid synthesis  
ENSG00000132199 ENOSF1 Fuconate dehydratase  
ENSG00000189221 MAOA Outer membrane monoamine oxidase 
ENSG00000103150 MLYCD Control of fatty acid metabolism through controlling 
levels of malonyl-CoA 
ENSG00000161653 NAGS N-acetylglutamate production 
ENSG00000036473 OTC Urea cycle 
ENSG00000128050 PAICS Purine biosynthesis. Mainly cytoplasmic but some 
located in mitochondria  
ENSG00000179598 PLD6 Possibly cardiolipin phosphatase, though located in 
the wrong membrane  
ENSG00000148334 PTGES2 Prostaglandin E2 synthesis 
ENSG00000128311 TST Sulphur metabolism 
 
The salt bridges at the cytoplasmic side of the transporter are predicted to be very weak, 
whereas the matrix side salt bridges look normal, suggesting SLC25A43 may be an importer 
(Robinson et al. 2008). Looking at the symmetry analysis, the residues present in the binding 
pocket predict a possible nucleotide binding pocket, with positive residues to support binding 
the phosphate group. This is supported by the phylogenetic tree of human transporters (Figure 
4.3), where SLC25A43 groups with the nucleotide transporters and the CoA transporters (the 
structure of CoA includes a phosphoadenosine ring).  None of the candidate transport 
substrates have structures which fit these criteria (Figure 4.24). 
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Figure 4.24 Structures of potential transport substrates for SLC25A43, grouped by the type of 
substrate.  
There is very little literature on the carrier SLC25A43. Protein expression analysis by the 
Human Protein Atlas indicates the expression is highest in the lungs, liver, gastrointestinal 
tract and bone marrow (Uhlén et al. 2015); whereas mRNA expression analysis by another 
group shows high expression in the brain, adrenal gland and skeletal muscle (Haitina et al. 
2006). Human Protein Atlas cellular localisation analysis predicts that SLC25A43 is localised 
to the nuclear membrane, though this is only supported by one antibody (Thul et al. 2017). 
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This may be linked to a putative role for SLC25A43 in cell cycle regulation, as seen in a 
breast cancer cell line (Gabrielson et al. 2016). 
In summary, phylogenetic profiling of mitochondrial proteins in the nematodes and 
platyhelminthes does not identify a strong candidate for the transport substrate of SLC25A43. 
Evidence from the literature suggests that this transporter may be localised to the nuclear 
membrane, rather than the mitochondrial inner membrane, possibly transporting a nucleotide 
or related compound. 
 
Uncharacterised transporters: SLC25A44 
SLC25A44 is an uncharacterised member of the mitochondrial carrier family (Figure 4.3). 
While this carrier is present in all studied nematode species (Figure 4.5), it is missing 
specifically from the tapeworms in the studied platyhelminthes (Figure 4.4). Twenty-eight 
additional IMPI positive training set genes exhibit the same phylogenetic pattern, of which 
sixteen are clearly associated with metabolic processes (Appendix II – Table 6). Reactome 
pathway enrichment analysis of these genes identifies several overrepresented metabolic 
pathways in this gene set, of which the top three are listed in Table 4.11. 
Table 4.11 Top three enriched Reactome metabolic pathways for IMPI genes only missing in the 
tapeworms, out of the studied platyhelminth species. 




Glycine degradation 2 5.68  10-5 1.99  10-3 
Molybdenum cofactor 
synthesis 
2 2.26  10-4 3.83  10-3 
Pyruvate metabolism and 
Citric Acid (TCA) cycle 
3 3.25  10-4 4.55  10-3 
 
The glycine degradation pathway refers to the four genes encoding the glycine cleavage 
system: AMT, DLD, GCSH and GLDC. These genes encode proteins which catalyse the 
decarboxylation of glycine linked to the methylation of tetrahydrofolate – an important one 
carbon donor. Predicted orthologues of AMT and GLDC are not identified in the tapeworms, 
whereas predicted orthologues of DLD and GCSH are. DLD encodes a protein which is a 
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component of other dehydrogenase complexes, such as the pyruvate dehydrogenase complex, 
explaining its identification in tapeworms. However, there is no current additional 
characterised function for GCSH, though it has been speculated that GCSH may play 
additional roles in cell survival (Kikuchi et al. 2008). The presence of GCSH in the 
tapeworms supports this hypothesis. However, the phylogenetic loss of the glycine cleavage 
system in tapeworms does not provide any candidate transport substrates for SLC25A44. The 
glycine cleavage system does result in the production of 5,10-methylene tetrahydrofolate, but 
SLC25A32 is already characterised as the mitochondrial tetrahydrofolate transporter (Titus & 
Moran 2000; McCarthy et al. 2004).  
Another metabolic pathway identified from the enrichment analysis is ‘Pyruvate metabolism 
and Citric Acid (TCA) cycle’ (Table 4.11) and includes the genes IDH3B, L2HGDH and FH. 
As previously discussed, FH (fumarate hydratase) is present in tapeworms, though it is a 
different class of fumarate hydratase to that seen in other metazoans. IDH3B is one of the 
three subunits of isocitrate dehydrogenase, which usually functions as a heterotetramer, 
consisting of two IDH3A subunits, one IDH3B subunit and one IDH3G subunit. Both IDH3A 
and IDH3G are identified in tapeworms, and these two subunits can form heterodimers with 
some basal isocitrate dehydrogenase activity (Ehrlich & Colman 1983). This may allow a 
complete TCA cycle in tapeworms to function without IDH3B. L2HGDH is a metabolic 
repair enzyme, catalysing the production of α-ketoglutarate from the neurotoxin L-2-
hydroxyglutrate, which is itself produced by promiscuous activity of malate dehydrogenase 
(Van Schaftingen et al. 2009). These genes do not form a coherent pathway and do not 
suggest any candidate transport substrates. 
The remaining top pathway from the Reactome pathway enrichment analysis is ‘molybdenum 
cofactor synthesis’. Molybdenum cofactor (MoCo) coordinates molybdenum for use in 
enzymes that catalyse redox reaction (Mendel 2013). MoCo is synthesised de novo in 
humans, and the first stage of this synthesis is localised to the mitochondria, while all 
subsequent stages are cytoplasmic. MOCS1 catalyses the synthesis of cyclic pyanopterin 
monophosphate (cPMP) from GTP in mitochondria. This is then exported to the cytoplasm to 
complete the remaining stages of MoCo synthesis. MOCS1 and the genes encoding 
subsequent MoCo synthesis enzymes are lost in the studied tapeworms (Figure 4.25).  
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Figure 4.25 Phylogenetic profile of molybdenum cofactor biosynthesis in platyhelminthes. Coloured 
boxes indicate that the gene is present in the following platyhelminth species: green = free-living; purple 
= liver flukes; red = blood flukes; yellow = tapeworms. Half-filled boxes indicate this protein is missing 
in some of the species of that group. Grey boxes mark IMPI positive training genes. 
This pattern is also reflected in the known MoCo dependent enzymes. Of the five identified in 
humans, only SUOX (sulphite oxidase) is identified at all in any of the studied 
platyhelminthes, and this is lost in the tapeworms (Figure 4.25).  
A transporter (ATM3) identified in the plant species Arabidopsis thaliana has been linked to 
Fe-S and MoCo metabolism through changes noted in these pathways mutant plant studies 
(Teschner et al. 2010). Some have suggested that this gene may encode a cPMP transporter 
(Mendel 2013). However, further work in A. thaliana suggests that this transporter is not 
acting to move cPMP across the mitochondrial membrane, but may control the redox 
environment necessary for cPMP synthesis through the transport of glutathione (Kruse et al. 
2018). The orthologous gene in humans is the mitochondrial ABCB7. Orthologues of this 
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gene are predicted in all the studied platyhelminthes, including tapeworms, supporting a role 
beyond molybdenum metabolism. 
It has also been speculated that cPMP is hydrophobic enough to cross the mitochondrial inner 
membrane without a transporter (Mendel 2013). However, there has been no experimental 
evidence for this. The phylogenetic pattern analysis suggests that cPMP is a candidate 
substrate for the transporter SLC25A44. 
After investigating the overrepresented pathways, I moved onto to looking at the metabolism 
surrounding the remaining metabolic enzymes with the same phylogenetic pattern in 
platyhelminthes as SLC25A44. Another short synthesis pathway that transverses the 
mitochondrial membrane is creatine synthesis, which starts from glycine in the mitochondria 
(Figure 4.26). GATM (glycine amidinotransferase) which catalyses the formation of 
guanidinoacetate from glycine in the matrix fits the phylogenetic profile. However, the 
cytoplasmic enzyme GAMT (guanidinoacetate N-methyltransferase), which transforms 
guanidinoacetate to creatine, after movement across the inner mitochondrial membrane, does 
not. Phylogenetic profiling, therefore, does not support guanidinoacetate a candidate substrate 
for SLC25A44. 
 
Figure 4.26 Phylogenetic profile of creatine biosynthesis in platyhelminthes. Coloured boxes indicate 
that the gene is present in the following platyhelminth species: green = free-living; purple = liver flukes; 
red = blood flukes; yellow = tapeworms. Grey boxes mark IMPI positive training genes. 
The remaining metabolic genes identified from phylogenetic profiling (Table 4.12) did not 
appear to be linked to any potential SLC25A44 transport compounds. 
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Table 4.12 Additional IMPI metabolic genes with phylogenetic profiles matching SLC25A44 in the 
studied platyhelminthes. 
Ensembl ID Gene Function 
ENSG00000059573 ALDH18A1 Proline, ornithine and arginine synthesis 
ENSG00000143149 ALDH9A1 GABA metabolism 
ENSG00000016391 CHDH Choline metabolism 
ENSG00000167113 COQ4 Coenzyme Q synthesis 
ENSG00000102967 DHODH Pyrimidine biosynthesis (outer side of inner 
mitochondrial membrane) 
ENSG00000180185 FAHD1 Oxaloacetate to pyruvate (reverse of PC) 
ENSG00000174099 MSRB3 Sulphur metabolism 
ENSG00000173599 PC Pyruvate to oxaloacetate (reverse of FAHD1) 
 
Symmetry analysis suggests SLC25A44 carries a substrate very different from other 
transporters (Robinson et al. 2008). Residues at substrate contact points include:  
• an arginine, supporting a substrate with a charged group, such as a carboxylate or 
phosphate group (interacting with the positively charged arginine);  
• and a tyrosine, supporting a substrate with a hydrophobic or uncharged polar side 
chain (interacting with the tyrosine ring).  
The structure of cPMP (Figure 4.27) fits this description, as it contains both a charged 
phosphate group, and a complex pyanopterin ring structure. However, symmetry analysis also 
suggests that the carrier will function as both an importer and exchanger, whereas cPMP 
should be exported. cPMP may be exported in exchange for another substrate. 
 
Figure 4.27 Structure of cyclic pyanopterin monophosphate (cPMP) – a potential transport substrate 
for SLC25A44.  
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As with SLC25A43, there is very little literature investigating the SLC25A44 carrier. mRNA 
expression analysis suggests that SLC25A44 is highly expressed in the brain and kidney, 
though there is expression across a range of tissues (Haitina et al. 2006; Uhlén et al. 2015) . 
The MoCo synthesis genes are also widely expressed across tissues.  
In summary, phylogenetic profiling in the platyhelminthes and symmetry analysis supports 
cPMP as a possible candidate transport substrate for the uncharacterised mitochondrial carrier 
SLC25A44. 
 
Uncharacterised transporters: SLC25A45/47/48 
SLC25A45, SLC25A47 and SLC25A48 are all uncharacterised mitochondrial carriers, which 
cluster together in the human phylogenetic tree (Figure 4.3). In the studied platyhelminthes, 
orthologues of this group of carriers are not predicted in the tapeworms or the blood fluke 
Schistosoma japonicum. This type of phylogenetic pattern, with loss in only one of several 
closely related species of schistosomes, provides two possibilities: either this is realistic, and 
this carrier group has been specifically lost in S. japonicum but not in the other studied blood 
flukes, or the lack of identification of an orthologue in S. japonicum is due to incomplete 
sequencing or annotation at the genome level. In the latter case, predicted transport substrates 
would be the same as for SLC25A44. 
I also considered the former case, by identifying IMPI positive training genes with the same 
exact phylogenetic pattern as SLC25A45/47/48. There are four additional genes with a 
matching phylogenetic pattern, of which two have characterised roles in metabolism 
(Table 4.13). Examining the metabolism around these two enzymes did not provide any 
useful information regarding possible carrier function. 
Table 4.13 Additional IMPI genes with phylogenetic profiles matching SLC25A45/47/48 in the studied 
platyhelminthes. 
Ensembl ID Gene Function 
ENSG00000196072 BLOC1S2 Apoptosis 
ENSG00000134463 ECHDC3 Unknown 
ENSG00000115419 GLS Glutamine catabolism 
ENSG00000124370 MCEE Branched chain amino acid catabolism 
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In the studied nematodes, predicted orthologues of SLC25A46/47/48 are missing in the 
species forming the Filarioidea and the Dorylaimia (Figure 4.5). Thirty-two IMPI positive 
training genes match this phylogenetic pattern, with an allowance for lack of identification of 
an orthologue in one additional species. Of these, twenty can be linked to some type of 
metabolic process. Only one specific metabolic pathway is overrepresented in these genes on 
Reactome pathway analysis – ‘lysine catabolism’ (Benjamini corrected p-value = 4.73  10-3). 
I had previously investigated lysine catabolism in the nematodes when exploring the 
oxoadipate carrier (Figure 4.9) and did not identify any additional necessary transport steps. 
I also investigated the other seventeen metabolic genes which were not included in an 
enriched pathway (Table 4.14) but did not identify any good candidates for SLC25A45/47/48 
transported compounds.  
Table 4.14 Additional IMPI metabolic genes with phylogenetic profiles matching SLC25A45/47/48 in 
the studied nematodes. 
Ensembl ID Gene Function 
ENSG00000197150 ABCB8 Iron transport 
ENSG00000111271 ACAD10 Fatty acid -oxidation 
ENSG00000151498 ACAD8 Valine catabolism 
ENSG00000004455 AK2 Adenylate kinase isoform 
ENSG00000136010 ALDH1L2 Tetrahydrofolate metabolism 
ENSG00000164904 ALDH7A1 Choline metabolism 
ENSG00000242110 AMACR Fatty acid -oxidation 
ENSG00000019186 CYP24A1 Vitamin D3 metabolism 
ENSG00000104325 DECR1 Fatty acid -oxidation 
ENSG00000105607 GCDH Lys/Trp degradation 
ENSG00000119927 GPAM Glycerolipid synthesis 
ENSG00000100577 GSTZ1 Phe/Trp degradation 
ENSG00000106049 HIBADH Branched chain amino acid degradation 
ENSG00000189221 MAOA Monoamine oxidation 
ENSG00000213965 NUDT19 CoA diphosphohydrolase 
ENSG00000110435 PDHX Pyruvate dehydrogenase complex 
ENSG00000185973 TMLHE Carnitine biosynthesis 
 
Therefore, phylogenetic profiling in platyhelminthes and nematodes did not identify any good 
potential candidate transport substrates for transport by this group of mitochondrial carriers. 
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 Discussion 
Mitochondrial carrier transport substrate identification has previously been supported by 
genetic and biochemical methods (Gutiérrez-Aguilar & Baines 2013), as well as bioinformatic 
analysis looking at protein sequences (Robinson et al. 2008). However, there are still several 
members of the human mitochondrial carrier family which have not been functionally 
characterised. Phylogenetic profiling provides another analytical technique to help support 
mitochondrial carrier functional annotation, by linking metabolic pathways to carriers through 
their presence and absence in a set of related species (Loganantharaj & Atwi 2007). This is 
dependent on finding a good group to analyse, with enough sequenced divergent species and 
informative phylogenetic information related to the transporters of interest (Jothi et al. 2007) 
and producing a well-defined set of gene orthologues (Snitkin et al. 2006).  
Therefore, I identified two Metazoan phyla (Nematoda and Platyhelmintha) which include a 
variety of parasitic species, with variable loss of metabolic pathways within each taxon. 
Metazoans were chosen in an attempt to reduce the amount of alternative metabolic pathways 
present compared to human metabolism, which may otherwise confuse a phylogenetic 
analysis which is based primarily on human genes and pathways (Jothi et al. 2007). Where 
possible, I included several related species to counter annotation-based limitations, as it has 
previously been shown that there is reduced predictive performance in large-scale 
phylogenetic profiling in less well-annotated species (Jothi et al. 2007). The chosen phyla 
maintain a large proportion of the mitochondrially localised metabolism seen in humans 
(approximately 67% in each phylum) and show variation in the identification of the 
mitochondrial carriers, including some characterised and some uncharacterised members 
(Figures 4.4 and 4.5).  
Analysis of the characterised carriers which showed interesting phylogenetic profiles 
provided good test cases for phylogenetic profiling within the chosen phyla. Where there was 
an interesting phylogenetic pattern for a carrier in both the platyhelminthes and the 
nematodes, there were not consistent results in the analysis of the surrounding metabolism 
between the phyla. This is consistent with the idea of a greater numbers of alternative 
metabolic pathways within the eukaryotes (Jothi et al. 2007), which may differ between the 
nematodes and platyhelminthes. For SLC25A21 (the oxoadipate carrier), there was a strong 
link between the phylogenetic profile of the carrier and the genes encoding the surrounding 
lysine/tryptophan catabolism in the platyhelminthes (Figure 4.9), but not in the nematodes. 
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This was the only characterised carrier with such a strong link and suggests that phylogenetic 
profiling may be useful where there is well-characterised metabolism around the transport 
substrate. It also indicates that, at least in the Metazoa, it may be best to consider taxa 
separately when using phylogenetic profiling for transport substrate identification. 
Other characterised transporters that were investigated did not provide such well-defined 
results. In some cases, there were potential links between the patterns of single genes with the 
function of the transporter (e.g. SLC25A38 in the platyhelminthes). These cases would be 
much harder to identify for uncharacterised transporters without pre-knowledge of what 
pathways to look at. However, this suggested that it was worth considering each individual 
metabolic gene which fits the phylogenetic pattern. In other cases, there was no obvious 
phylogenetic link between the transport substrate and surrounding metabolism, supporting the 
idea that a variety of different techniques will be necessary to characterise all the remaining 
mitochondrial transporters. These lessons were then taken forward to the investigation of the 
uncharacterised transporters. 
Four groups of uncharacterised transporters were identified with interesting phylogenetic 
profiles in the platyhelminthes, the nematodes or both (Figures 4.4 – 4.5). Analysis of genes 
with close phylogenetic profiles produced sensible candidate transport substrates for two of 
these carrier groups, both using the phylogenetic patterns observed in the platyhelminthes. 
The lack of sensible candidate substrates for the remaining two uncharacterised carrier groups 
points to the limitations of this technique. For SLC25A43, the success of the analysis may be 
limited by the localisation of the transporter. If the protein encoded by this gene is localised to 
the nuclear membrane, as is suggested by subcellular localisation analysis in the Human 
Protein Atlas (Thul et al. 2017), mitochondrial metabolism would not be expected to link to 
any transport substrate. 
For the mitochondrial carrier group consisting of two uncoupling protein related genes 
(SLC25A14 and SLC25A30), phylogenetic profiling provided several candidate transport 
substrates (Table 4.8). Using supporting information from the literature, I prioritised these 
candidates, with the ketone body acetoacetate being the best-supported prediction. 
Acetoacetate fits the predicted substrate type of a small keto acid, produced from analysis of 
carrier sequence symmetry (Robinson et al. 2008). This prediction is also supported by the 
links between the carriers SLC25A14/30 and ketone body metabolism in several different 
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parts of the scientific literature surrounding these carriers and in the tissue expression patterns 
(Sánchez-Blanco et al. 2006; Kashiwaya et al. 2010; Ramsden et al. 2012). 
The second uncharacterised carrier with a good candidate substrate from phylogenetic 
profiling is SLC25A44, for which the molybdenum coenzyme precursor cPMP was identified 
as a possible transport substrate (Figure 4.25). SLC25A44 does not group closely with any 
other member of human mitochondrial carrier family (Figure 4.3) and contains a unique 
tyrosine in the substrate binding region of the carrier (Robinson et al. 2008). While these 
characteristics make the transporter particularly interesting, they also make identifying 
possible transport substrates to fit these characteristics more difficult, as there are no similar 
transporters to compare substrates with. Predictions are also limited by the lack of literature 
around this carrier. cPMP as a potential substrate fits well with what has been suggested about 
the transporter. The structure of cPMP is not similar to any transport substrate of the 
characterised transporters, and the flat rings in cPMP (Figure 4.27) would be predicted to 
interact with the aromatic ring in the tyrosine structure. 
These results show the potential utility of phylogenetic profiling within the eukaryotes to 
support the characterisation of transporters, but also the limitations. Profiling techniques are 
dependent on finding well-characterised species with variation in the genes of interest, and on 
the consistency of metabolic pathways between the species being compared. Sequencing of 
additional species from other metazoan groups containing parasitic or highly derived species 
(such as parasitic jellyfish and other parasitic species within the Cnidaria) may provide 
additional sources of interesting phylogenetic patterns for the characterisation of human 
proteins. Knowledge of the loss of pathways within certain types of species may also provide 
support for a targeted phylogenetic analysis, looking for the transporter of a specific substrate. 
For example, vitamin B12 metabolism appears to have been lost in true insects, but not in 
other members of the Pancrustacea. Therefore, these species may be a good source of data to 
further characterise this metabolic pathway. This technique could also be used to prioritise 
transport substrates for other groups of transporters beyond the mitochondrial carriers, 
particularly where their localisation in the cell is known (e.g. mitochondrial membrane, 
nuclear membrane). 
Phylogenetic profiling will not prove informative in all cases. Even in those cases where the 
technique does produce sensible predictions, further work is still necessary to prove or 
disprove the predictions. Literature evidence and additional bioinformatic studies, such as 
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those looking at the structure of the transporters in this case, can help further prioritise 
candidates. Eventually, however, the predictions must be tested using either genetic or 
biochemical techniques, such as transport assays (Gutiérrez-Aguilar & Baines 2013) and this 
will be the true test of the quality of the predictions. Early work has been started for testing 
the ability of the SLC25A14/30 carriers to transport ketone bodies.  
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 Conclusions 
In this chapter, I identified two Metazoan phyla (Nematoda and Platyhelmintha) to target for 
the purpose of predicting possible transport substrates of uncharacterised members in the 
mitochondrial carrier family. These phyla contain species with variation in the presence of 
metabolic pathways and mitochondrial carriers. I created curated datasets of orthologues of 
mitochondrial genes for sequenced members of these two phyla, to create a phylogenetic 
profile of presence and absence for each gene.  
From test cases using characterised members of the mitochondrial carrier family, I observed a 
link between the phylogenetic pattern of a carrier and the surrounding metabolism in one case 
(SLC25A21 in platyhelminthes), possible phylogenetic links between single genes and carriers 
in other cases, and no links in others. This supported the use of phylogenetic profiling to 
identify transporter function, but suggested results should not be expected for all 
uncharacterised transporters. Differences in metabolism were often not conserved between the 
two studied phyla, leading further analyses in the two phyla to be considered separately. 
I then moved on to testing four groups of uncharacterised carriers. Of these four carrier 
groups, there were strong candidate transport substrates identified for two: SLC25A14/30 as 
potential transporters of ketone bodies, which is also well-supported by the surrounding 
observational literature and SLC25A44 as a potential transporter of the molybdenum 
coenzyme precursor cPMP. These cases provide justification for testing of transport activity 









Exploring the history and function of 











Disruption of normal mitochondrial function is associated with a wide assortment of diseases. 
These range from common, multifactorial diseases often associated with age, such as 
Alzheimer’s disease (Onyango et al. 2017), cancer (Ahn & Metallo 2015) and heart disease 
(Huss & Kelly 2005); to rare, monogenetic diseases often seen in paediatric patients, such as 
respiratory chain deficiencies (DiMauro & Schon 2003). In this chapter I use ‘mitochondrial 
disease’ to refer to the less common, monogenetic forms of disease, associated with mutations 
in genes encoding the mitochondrial proteome.  
Mitochondrial diseases can be caused by mutations in mitochondrial DNA (mtDNA), but 
human mtDNA only encodes 37 genes, including 13 protein-encoding genes. Other disease-
causing mutations occur in the nuclear DNA, which encode genes necessary for 
mitochondrial function, particularly the approximately 1,500 genes which encode the 
mitochondrial proteome (Meisinger et al. 2008). Although individually most mitochondrial 
diseases are rare, together they are predicted to affect up to 9 in every 100,000 children (Darin 
et al. 2001; Skladal et al. 2003) and 1 in 4,300 adults (Gorman et al. 2015). This number can 
be higher in certain populations, depending on the frequency of disease-associated alleles 
(Skladal et al. 2003). 
Exome sequencing is an important tool in the genetic diagnosis of mitochondrial disease 
patients. However, the average success rate in larger scale studies is only around 50% (Calvo 
et al. 2012; Taylor et al. 2014). One bottleneck that may limit the success of exome 
sequencing is the prioritisation of candidate genes with rare variants for further study. 
Functional analysis of genes in cell lines or model organisms is time-consuming and resource-
intensive. Therefore, where there is no obvious candidate, bioinformatic analysis is an 
important tool to identify and prioritise the most interesting genes to take forward into 
laboratory work (Moreau & Tranchevent 2012). 
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Features of disease genes 
Understanding the features of known disease genes can inform prioritisation of candidate 
disease genes. Potentially informative features of disease genes have been identified by 
investigating phylogeny, orthology and evolution.   
Mendelian disease genes: 
• are under stronger purifying selection than those not associated with disease 
(Blekhman et al. 2008) and have a wider phylogenetic spread (i.e. orthologues are 
found in a wider range of taxa) (López-Bigas & Ouzounis 2004).  
• are more likely to be of ancient origin (Domazet-Lošo & Tautz 2008; Maxwell et al. 
2014), though genes associated with different types of diseases show variation in 
origin (Maxwell et al. 2014). For example, genes involved in diseases of nervous 
system development are more likely to originate post-split of the Metazoa from other 
eukaryotes (Maxwell et al. 2014).  
• can be traced back to historical duplications, with genes without identified duplicates 
in humans more likely to be associated with disease (Dickerson & Robertson 2012). 
Genes with highly conserved human paralogues are less likely to be associated with 
disease (López-Bigas & Ouzounis 2004). 
The evolutionary history of genes can be used to distinguish genes associated with different 
types of disease inheritance – recessive disease genes (where two faulty copies are necessary 
for a disease phenotype) and dominant disease genes (where only one faulty copy can lead to 
a disease phenotype). Dominant disease genes have, on average, a greater number of 
paralogues than recessive disease genes (Kondrashov & Koonin 2004; Furney et al. 2006); 
and are also more conserved between human and mouse, under stronger purifying selection 
(Furney et al. 2006; Blekhman et al. 2008; Cai et al. 2009). Cai et al. (2009) suggest that 
dominant disease genes are younger than recessive disease genes on average, though this was 
not statistically tested and the authors only looked as far back as the Metazoa, plus 
Saccharomyces cerevisiae.  
I hypothesised that mitochondrial disease genes might show a distinct origin and phylogenetic 
pattern compared to other human disease genes, as the mitochondria have a unique 
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evolutionary history compared to the rest of the cell and are the site of a variety of essential 
and unique functions, such as the electron transport chain.  
 
Chapter summary 
In this chapter, I investigate the phylogenetic spread and origin of disease genes in IMPI 
compared to those not associated with disease. I use the same types of analyses to compare 
mitochondrial disease genes where the diseases are inherited recessively and dominantly; and 
look for any function associated with identified differences. Finally, I investigate the potential 
utility of studying naturally occurring human loss-of-function homozygotes and knockout 
lines of three model organisms (Mus musculus, S. cerevisiae and Escherichia coli), relative to 
prioritising candidate mitochondrial disease genes.  
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 Methods 
Defining a list of diseases of the mitochondrion 
The list of human genes which form IMPI 2017 was used as the definition of the 
mitochondrial proteome, with use of the IMPI positive training set (a manually curated set of 
mitochondrial genes) as a more stringent dataset. This included 1,550 genes in IMPI 2017 and 
1,130 genes in the IMPI positive training set.  
The majority of gene-disease associations were retrieved from OMIM (Online database of 
Mendelian Inheritance in Man) (Amberger et al. 2015). The mode of disease inheritance was 
identified from OMIM, and assigned per gene as either recessive, dominant, both recessive 
and dominant, X-linked or mitochondrial. Additional monogenetic disease associations were 
retrieved from the literature, using the search pattern ‘“{gene name}” disease’ in Google 
Scholar. This method retrieved diseases associated with an additional 28 genes of the 
mitochondrial proteome (Table 5.1).  
 
Definitions of taxa 
Some analysis involves dividing the studied species into several taxa. These are defined 
below, and the assigned taxon of each studied species is listed in Appendix I – Table 1.  
• Holozoa – animals and the closely related single-celled ichthyosporea and 
choanoflagellates 
• Holomycota – fungi and Fonticula 
• Amoebozoa – amoeboid protists 
• Archaeplastida – red algae, green algae, land plants and glaucophytes 
• SAR group – stramenopiles, alveolates and rhizaria 
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Table 5.1 IMPI 2017 genes associated with monogenetic diseases which were absent from OMIM and 
identified from a literature search. 
 
Ensembl ID Gene Name Reference 
ENSG00000138138 ATAD1 (Ahrens-Nicklas et al. 2017) 
ENSG00000183978 COA3 (Ostergaard et al. 2015)  
ENSG00000162377 COA7 (Lyons et al. 2016) 
ENSG00000132591 ERAL1 (Chatzispyrou et al. 2017) 
ENSG00000267673 FDX1L (Spiegel et al. 2013)  
ENSG00000164347 GFM2 (Fukumura et al. 2015) 
ENSG00000115541 HSPE1 (Bie et al. 2016) 
ENSG00000262814 MRPL12 (Serre et al. 2013) 
ENSG00000125445 MRPS7 (Menezes et al. 2015) 
ENSG00000133026 MYH10 (Tuzovic et al. 2013) 
ENSG00000186010 NDUFA13 (Angebault et al. 2015) 
ENSG00000189043 NDUFA4 (Pitceathly et al. 2013) 
ENSG00000244005 NFS1 (Farhan et al. 2014) 
ENSG00000178694 NSUN3 (Van Haute et al. 2016) 
ENSG00000162396 PARS2 (Sofou et al. 2015) 
ENSG00000232838 PET117 (Renkema et al. 2017)  
ENSG00000147403 RPL10 (Brooks et al. 2014) 
ENSG00000134419 RPS15A (Ikeda et al. 2017) 
ENSG00000181035 SLC25A42 (Shamseldin et al. 2016) 
ENSG00000014824 SLC30A9 (Perez et al. 2017) 
ENSG00000146350 TBC1D32 (Adly et al. 2014) 
ENSG00000113272 THG1L (Edvardson et al. 2016) 
ENSG00000164983 TMEM65 (Nazli et al. 2017) 
ENSG00000126602 TRAP1 (Saisawat et al. 2014) 
ENSG00000170855 TRIAP1 (Poole et al. 2016) 
ENSG00000043514 TRIT1 (Kernohan et al. 2017) 
ENSG00000184470 TXNRD2 (Sibbing et al. 2011) 




Phylostratigraphic analysis was carried out as in Domazet-Lošo & Tautz 2008, except that 
some phylostrata were combined together in comparison to the original paper. 
Euarchontoglires, Boreoeutheria and Eutheria were combined, as were Osteichthyes with 
Vertebrata, Olfactores with Deuterostomia, and Eumetazoa with Metazoa. Genes were 
assigned to a phylostratum based on the first of the defined phylostrata to contain a predicted 
orthologue of the gene, from the previously described orthologue dataset (Chapter 2).  
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Log odds ratio (OR) was calculated, using natural logarithms, as: 
log(𝑂𝑅) =  log (
𝑛𝑜. 𝑜𝑓 𝑜𝑢𝑡𝑐𝑜𝑚𝑒 1 𝑖𝑛 𝑝ℎ𝑦𝑙𝑜𝑠𝑡𝑟𝑎𝑡𝑎 𝑛𝑜. 𝑜𝑓 𝑜𝑢𝑡𝑐𝑜𝑚𝑒 2 𝑖𝑛 𝑝ℎ𝑦𝑙𝑜𝑠𝑡𝑟𝑎𝑡𝑎⁄
𝑛𝑜. 𝑜𝑓 𝑜𝑢𝑡𝑐𝑜𝑚𝑒 1 𝑛𝑜𝑡 𝑖𝑛 𝑝ℎ𝑦𝑙𝑜𝑠𝑡𝑟𝑎𝑡𝑎 𝑛𝑜. 𝑜𝑓 𝑜𝑢𝑡𝑐𝑜𝑚𝑒 2 𝑛𝑜𝑡 𝑖𝑛 𝑝ℎ𝑦𝑙𝑜𝑠𝑡𝑟𝑎𝑡𝑎⁄
) 
where for comparing disease and non-disease, ‘outcome 1’ is disease and ‘outcome 2’ is no 
disease; and for comparing recessive and dominant inheritance, ‘outcome 1’ is dominant 
inheritance and ‘outcome 2’ is recessive inheritance.  
 
Gene annotation and enrichment 
GO Biological Process/KEGG pathway annotation and enrichment was carried out using the 
DAVID functional annotation tool (Huang et al. 2009a). Enriched clusters were identified 
using DAVID functional annotation clustering with medium classification stringency. 
GO annotation (GO:0003824 ‘catalytic activity’ and GO:0008152 ‘metabolic process’) was 
assigned to genes using QuickGO (Binns et al. 2009). Genes of central mitochondrial 
metabolism were taken from the MitoCore model (Smith et al. 2017). 
 
Essential genes in model organisms 
Mouse (Mus musculus) genes annotated with the mammalian phenotype terms “complete 
prenatal lethality” (MP:0011091) and “complete perinatal lethality” (MP:0011089) were 
retrieved from MouseMine, as were mouse orthologues of human IMPI genes with no 
assigned mouse phenotype (Motenko et al. 2015). Human IMPI 2017 genes were mapped to 
corresponding mouse genes by name where possible and by manually assessing homology 
using data from the MitoMiner database (Smith & Robinson 2016) and BLASTp searches 
(Altschul et al. 1990, 1997) where not. 
Yeast (Saccharomyces cerevisiae) essential genes were downloaded from the Saccharomyces 
Genome Deletion Project (Giaever et al. 2002) 
(http://www-sequence.stanford.edu/group/yeast_deletion_project/Essential_ORFs.txt). The 
yeast strains used in this project were based on a derivative of the S. cerevisiae S288c strain, 
which was also used in the orthology dataset predictions, allowing mapping of gene names 
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between the two. Essential yeast genes were mapped to the corresponding human gene by 
comparing the predicted yeast orthologues of each human IMPI 2017 gene to the list of yeast 
essential genes. 
Escherichia coli essential genes were downloaded from the EcoGene resource (Zhou et al. 
2013) (http://www.ecogene.org/old/topic.php?topic_id=5).  Essential E. coli genes were 
mapped to the corresponding human genes by comparing the identified E. coli orthologues of 
each IMPI 2017 gene to the list of E. coli essential genes. 
 
Human loss-of-function homozygotes 
Four loss-of-function (LoF) datasets were used to identify LoF genes in healthy humans: 
• A dataset of sequenced and imputed LoF homozygotes and compound heterozygotes 
from a healthy Icelandic population (Sulem et al. 2015). This identified 105 IMPI 
genes with at least one imputed LoF homozygote or compound heterozygote and with 
minor allele frequency below 1%. 
• A dataset of LoF homozygotes from 3,222 healthy British Pakistani adults, with high 
levels of consanguinity, including only variants with minor allele frequency below 1% 
(Narasimhan et al. 2016). Only mutations affecting 100% of transcripts were taken 
forward to the analysis, to avoid mutations affecting only minor splicing variants. This 
identified 36 IMPI genes with at least one LoF homozygote. 
• A dataset of LoF homozygotes from 10,503 Pakistani adults, including only variants 
with minor allele frequency below 1% (Saleheen et al. 2017) . Only those marked as 
‘confident pLoF’ (predicted loss-of-function) were taken forward. This identified 73 
IMPI 217 genes with at least one LoF homozygote. 
• Data from the ExAC (Exome Aggregation Consortium) resource (Lek et al. 2016). 
LoF homozygotes/hemizygotes were identified with below 1% minor allele frequency 
and no annotation/confidence flags, which were predicted to affect at least the 
canonical transcript. This identified 122 IMPI genes with at least one LoF 
homozygote. 
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Isoforms were identified from Ensembl transcripts associated with each gene (Yates et al. 
2016), with proteins retrieved from the corresponding UniProt ID (The UniProt Consortium 
2017). Only protein-encoding transcripts not labelled as fragments were included.  
 
Statistics 
Statistical analyses were carried out in R. Statistical tests utilised and any correction for 
multiple testing are indicated in the text.  
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 Results 
Phylogenetic spread of monogenetic disease genes of the mitochondrion 
Genes associated with monogenetic disease in humans have a broader phylogenetic profile  
(López-Bigas & Ouzounis 2004; Kondrashov & Koonin 2004) and are more likely to 
originate in the early Metazoa (Domazet-Lošo & Tautz 2008), than those not associated with 
monogenetic disease. I first asked whether the phylogenetic differences between disease and 
non-disease genes observed in analyses of the total human genome are replicated in the subset 
of the genes encoding the mitochondrial proteome, using the previously described dataset of 
IMPI 2017 orthologues (Chapter 2). 
Initially, I compared the distributions of the number of orthologues predicted for genes with 
associated monogenetic disease to those without any association with disease (Figure 5.1). 
Neither distribution was normally distributed (Shapiro-Wilk test; non-disease, p < 2.2  10-16; 
disease, p = 7.3  10-10), so I used nonparametric tests to test differences between the 
distributions. The distributions of numbers of predicted orthologues of non-disease and 
disease genes were significantly different (Mann-Whitney U test; p < 2.2  10-16). Genes not 
associated with disease had a lower number of predicted orthologues, on average – a mean of 
109 orthologues compared to a mean of 153 orthologues for known disease genes. This 
difference held when looking at genes in the IMPI positive training set (Mann-Whitney U 
test; p = 8.56  10-12), looking at only the number of eukaryotic orthologues (Mann-Whitney 
U test; p < 2.2  10-16) and looking at only the number of orthologues from holozoans (Mann-
Whitney U test; p < 2.2  10-16). 
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Figure 5.1 IMPI genes not associated with disease have fewer predicted orthologues. (a) Distribution 
of IMPI genes not associated with monogenetic disease. (b) Distribution of IMPI genes associated with 
monogenetic disease. Distributions are significantly different (Mann-Whitney U test, p < 2.2  10-16). 
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The distributions of orthologues will be influenced by the number of species of different types 
included in the analysis – for example, if a large number of fungi are included compared to 
the number of amoeba, the orthologue counts will be influenced more by whether there are 
fungal orthologues than amoebal orthologues. Therefore, I then looked at the spread of 
orthologues across eight defined taxa: Holozoa, Holomycota, Amoebozoa, Archaeplastida, 
SAR group, Excavata, Archaea and Bacteria (Figure 5.2). There was a significant difference 
between the number of taxa with predicted orthologues for IMPI disease and non-disease 
genes (χ2 test; p < 2.2  10-16). Nearly half (47%) of the genes not associated with 
monogenetic disease were predicted in only one taxon, whereas only 25% of disease genes 
showed the same result. Thus, IMPI disease genes are more likely to have a wider spread 
throughout the eight studied taxa than IMPI genes not associated with disease. 
 
Figure 5.2 Differences between the number of taxa with predicted orthologues for disease and non-
disease genes (χ2 test, p < 2.2  10-16). Horizontal scale is the number of taxa for which orthologues of 
each gene are identified, from: Holozoa, Holomycota, Amoebozoa, Archaeplastida, SAR group, 
Excavata, Archaea and Bacteria.  
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Phylogenetic origin of monogenetic disease genes of the mitochondrion 
Another way to look at the data is to consider the group in which orthologues are first 
identified. In general, the oldest genes are present in prokaryotes, whereas the newest genes 
will be present only in holozoan eukaryotes. I assigned each gene to one of the groups 
Holozoa, non-holozoan eukaryota or Prokaryota, based on the first appearance of a predicted 
orthologue (Table 2.2). There was a significant difference in the phylogenetic origin of IMPI 
genes associated with disease and IMPI genes with no associated disease (χ2 test; p < 2.2  
10-16), replicated within the IMPI positive training genes (χ2 test; p = 1.1  10-14). Though 
disease genes did originate in all three of the designated groups, 45% of genes with earliest 
orthologues predicted in prokaryotes were associated with monogenetic disease, compared to 
only 19% of genes with orthologues predicted only in holozoans. 
 
Table 5.2 Earliest taxa with predicted orthologues of IMPI genes, separated by known monogenetic 
disease-causing status. 
 





No disease 513 (81%) 344 (67%) 222 (54%) 
Disease 119 (19%) 167 (33%) 185 (45%) 
 
 
Phylostratigraphic analysis is a more detailed way of investigating the origin of genes 
(Domazet-Lošo & Tautz 2008). Genes are assigned to a phylostratum – a key taxonomic 
division in evolutionary history, such as the evolution of the vertebrates – based on the most 
phylogenetically distant prediction of an orthologue. The phylostrata are linearly separated, 
based around the species under investigation (in this case, humans).  This can be used to 
identify a phylostratum from which different human genes originate. In this case, I separated 
the origin of genes into fourteen phylostrata – key divisions in the evolutionary history of 
humans (Figure 5.3). 
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IMPI genes showed three main peaks of phylostratic origin (Figure 5.4). The earliest was at 
the two phylostrata ‘Cellular organisms’ (1) and ‘Eukaryota’ (2) – genes which trace back to 
the origin of life with cellular organisms and the origin of eukaryotes. A slightly larger 
proportion of IMPI genes were assigned to the phylostratum ‘Eukaryota’ (2), compared to the 
total human genome, where a larger proportion were assigned to the phylostratum ‘Cellular 
organisms’ (1) (Domazet-Lošo & Tautz 2008). This may reflect gene innovations supporting 
the function of the new mitochondrion in eukaryotes. For example, twenty-two IMPI genes 
assigned to ‘Eukaryota’ (2) were designated the GO Biological Process term ‘transport’ 
(GO:0006810), but none of the genes assigned to ‘Cellular organisms’ (1) were designated 
this term. This can be explained as transport across a mitochondrial membrane is unnecessary 
in single-compartment organisms. 
 
Figure 5.4 Phylostratigraphic analysis of all IMPI genes (black; N = 1,550), IMPI 2017 genes not 
associated with disease (grey; N = 1,079), and IMPI 2017 genes associated with monogenetic disease 
(purple; N = 471). Phylostrata are numbered as described in Figure 5.3. 
There was a second smaller peak at the phylostrata ‘Holozoa’ (4) and ‘Metazoa’ (5), which 
includes the origin of animals and their closest unicellular relatives, before the Cambrian 
explosion. The third and clearer peak was at the phylostratum for the origin of the vertebrates 
(9), also noted in the analysis of the full human genome where the peak is associated with 
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immunity-related genes (Domazet-Lošo & Tautz 2008). No GO Biological Process term was 
overrepresented in IMPI genes originating in vertebrates compared to the rest of IMPI 2017. 
However, the largest number of genes were assigned terms ‘apoptotic process’ (GO:0006915; 
19 genes) and ‘signal transduction’ (GO:0007165; 17 genes).  
Figure 5.4 suggests there are small differences between the phylostratic origins of IMPI 
disease and non-disease genes, particularly around the phylostratic divisions at ‘Cellular 
organisms’ (1) and ‘Eukaryota’ (2). To assess this difference, I plotted the log odds ratio 
between disease and non-disease genes for each investigated phylostratum (Figure 5.5). 
 
Figure 5.5 Comparing the representation of disease and non-disease IMPI genes in different 
phylostrata.  Natural log odds ratio is plotted for each phylostratum. Significance tested for each 
phylostratum using Fisher’s exact test with Bonferroni correction for multiple testing (* p = 5.36  10-5; 
** p = 7.19  10-13). Phylostrata are numbered as described in Figure 5.3. 
Two phylostrata showed significant differences for the log odds ratio between disease and 
non-disease genes. IMPI genes with a phylostratic origin in the cellular organisms (1), before 
the evolution of eukaryotes, were significantly more likely to be associated with disease, with 
a non-logged odds ratio of 2.5 (Fisher’s exact test; p = 7.2  10-13). Disease genes originating 
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in cellular organisms were enriched for basic metabolic processes, represented by one cluster 
of GO Biological Process terms with an enrichment score of 1.44 (Table 5.3), though no 
terms were statistically enriched individually. 
 
Table 5.3 Enriched cluster of GO Biological Process terms for disease-causing genes originating in 
cellular organisms, in comparison to all IMPI genes. Enrichment score = 1.44. 




Tricarboxylic acid cycle 11 7.9  10-4 0.18 
Pyruvate metabolic process 6 0.01 0.60 
Acetyl-CoA biosynthetic process from 
pyruvate 
4 0.02 0.69 
Mitochondrial acetyl-CoA biosynthetic 
process from pyruvate 
3 0.17 0.99 
Regulation of acetyl-CoA biosynthetic 
process from pyruvate 
4 0.19 0.99 
Glucose metabolic process 4 0.41 1 
 
However, IMPI genes with a phylostratic origin in the vertebrates were significantly less 
likely to be associated with disease, with a non-logged odds ratio of 0.46 (Fisher’s exact test; 
p = 5.4  10-5). No individual GO Biological Process term was enriched for the non-disease 
genes originating in vertebrates, with the largest cluster related to apoptosis with an 
enrichment score of 1.11 (Table 5.4). 
 
Table 5.4 Enriched cluster of GO Biological Process terms for non-disease genes originating in 
vertebrates, in comparison to all IMPI genes. Enrichment score = 1.11. 




Positive regulation of protein insertion into 
mitochondrial membrane involved in 
apoptotic signalling pathway 
4 0.04 0.99 
Cellular response to hypoxia 6 0.06 0.99 
Regulation of mitochondrial membrane 
permeability 
4 0.08 1 
Positive regulation of intrinsic apoptotic 
signalling pathway 
4 0.11 1 
Release of cytochrome c from mitochondria 4 0.14 1 
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Inheritance patterns of IMPI genes associated with monogenetic mitochondrial disease 
Monogenetic diseases can show different patterns of inheritance. Previous work had identified 
some differences between human genes associated with dominant disease (only one faulty 
allele causes disease) and genes associated with recessive disease (two faulty alleles necessary 
to cause disease) (Kondrashov & Koonin 2004; Cai et al. 2009), but no-one had explored 
their phylogeny beyond the yeast S. cerevisiae, or investigated genes of the mitochondrial 
proteome in particular. I explored disease genes in IMPI split by mode of inheritance, with the 
hypothesis that there is a difference in phylogenetic spread and origin between dominant and 
recessive IMPI disease genes.  
First, I compared the distributions of numbers of orthologues of dominant disease genes and 
recessive disease genes from the previously described orthologue dataset (Chapter 2). I 
removed from the analysis any gene associated with diseases of both recessive and dominant 
inheritance or genes from the sex chromosomes, as these will be under different types of 
selective pressure. Neither distribution was normally distributed (Shapiro-Wilk test; recessive 
disease genes, p = 4.5  10-7; dominant disease genes, p = 9.1  10-6), so nonparametric 
statistics were used. There was a significant difference between the distribution of orthologue 
numbers between dominant disease genes and recessive disease genes in IMPI (Figure 5.6; 
Mann-Whitney U test; p = 0.0009). On average, dominant disease genes had fewer 
orthologues than recessive disease genes (median of 122 orthologues compared to 168 
orthologues). This difference was significant when comparing only IMPI positive training set 
genes (Mann-Whitney U test; p = 2.8  10-5), only comparing numbers of eukaryotic 
orthologues (Mann-Whitney U test; p = 0.01), and even comparing numbers of holozoan 
orthologues (Mann-Whitney U test; p = 0.004) despite the low numbers of dominant disease 
genes in the dataset (only 55 in total). 
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Figure 5.6 IMPI genes associated with dominant diseases have fewer orthologues on average.  
(a) Distribution of IMPI genes associated with recessive disease. (b) Distribution of IMPI 2017 genes 
associated with dominant disease. Distributions are significantly different (Mann-Whitney U test, 
p = 0.0009). 
Next, I explored the spread of the disease gene orthologues through the eight previously defined 
taxa: Holozoa, Holomycota, Amoebozoa, Archaeplastida, SAR Group, Excavata, Archaea and 
Bacteria (Figure 5.7). There was a significant difference between the spread of predicted 
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orthologues of recessive and dominant IMPI disease genes throughout these taxa (χ2 test; 
p = 2.2  10-5). The majority (54%) of dominant disease genes only had predicted orthologues 
in one taxon, whereas nearly half (49%) of recessive disease genes had predicted orthologues 
in between six and eight taxa. Overall, the spread of recessive disease genes over different taxa 
was wider than the spread of dominant disease genes. 
 
Figure 5.7 Differences between the number of taxa with predicted orthologues of recessive and 
dominant IMPI disease genes (χ2 test, p = 1.3  10-5). Horizontal axis shows the number of taxa with 
orthologues of each gene in: Holozoa, Holomycota, Amoebozoa, Archaeplastida, SAR group, Excavata, 
Archaea and Bacteria. 
I then investigated the origin of these mitochondrial disease genes, by dividing the dominant 
and recessive disease genes into three groups dependent on where the first orthologue was 
predicted: Holozoa, non-holozoan eukaryota and Prokaryota (Table 5.5). There was a 
significant difference in the origin of dominant and recessive IMPI disease genes (χ2 test; 
p = 1.5  10-7), which was consistent within the IMPI positive training set (χ2 test; p = 5.2  
10-9). Over half of all the dominant disease genes in IMPI were novel to the Holozoa 
(30/55 = 54%), whereas 80% of recessive disease genes had an older origin.  
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Table 5.5 Earliest taxa with predicted orthologues of IMPI disease-associated genes, separated by 
known inheritance type. 
 





Dominant 30 (30%) 11 (7%) 14 (9%) 
Recessive 70 (70%) 136 (93%) 149 (91%) 
 
As before, I used phylostratigraphic analysis to investigate the origin of recessive and 
dominant disease genes in more detail (Figure 5.8). Mitochondrial disease genes showed the 
same general pattern as total IMPI genes, with the two largest peaks of innovation at the 
phylostrata defining the separation of cellular life/eukaryotes (1/2); and at the phylostratic 
origin of vertebrates (9). This was clear even when looking at only the dominant disease 
genes in the analysis, although there were comparatively few of them – only 55 compared to 
355 recessive disease genes. 76% of recessive disease genes had early phylostratic origins, 
before the separation of the opisthokonts (between 904 and 1,579 million years ago (Eme et 
al. 2014)), compared to only 45% of dominant disease genes. 
 
Figure 5.8 Phylostratigraphic analysis of IMPI disease genes, separated into recessive (blue; N = 355); 
and dominant (red; N = 55). Phylostrata are numbered as described in Figure 5.3. 
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However, the differences between recessive and dominant disease genes in these early 
phylostrata were not significant (Figure 5.9) – the p-value for genes assigned to the 
phylostratum ‘Cellular organisms’ (1) was 0.36 and for ‘Eukaryota’ was 0.44, using Fisher’s 
exact test. 
 
Figure 5.9 Comparing representation of dominant and recessive IMPI disease-associated genes in 
different phylostrata. Natural log odds ratio is plotted for each phylostratum. Significance tested for 
each phylostratum using Fisher’s exact test with Bonferroni correction for multiple testing 
(* p = 0.0003). Phylostrata are numbered as described in Figure 3. 
The only phylostratum with a significant difference between the proportions of dominant 
disease genes and recessive disease genes was the ‘vertebrata’ (9) (Figure 5.9). Disease genes 
with described dominant inheritance were significantly overrepresented in the disease genes 
originating within the vertebrates, compared to those with recessive inheritance, (Fisher’s 
exact test; p = 0.0003) with a non-logged odds ratio of 5.7. No GO Biological process term 
was individually significantly overrepresented in dominant disease genes assigned to the 
vertebrate phylostratum. However, two functional clusters were significant (Table 5.6). These 
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clusters both contained genes important in apoptosis and signalling, as well as control of cell 
proliferation, with strong overlap between the genes in the two clusters.  
Table 5.6 Enriched clusters of GO Biological Process terms for dominant disease-causing genes 
originating in vertebrates, compared to the genes forming the total IMPI set.  




Cluster 1 (Enrichment score: 2.69)    
Negative regulation of cysteine-type endopeptidase 
activity involved in apoptotic process 
4 1.4  10-4 0.053 
Signal transduction 5 4.3  10-4 0.082 
Negative regulation of apoptotic process 5 9.8  10-4 0.12 
Positive regulation of transcription from RNA 
polymerase II promoter 
4 1.7  10-3 0.15 
Cell proliferation 4 1.8  10-3 0.12 
Positive regulation of peptidyl-serine phosphorylation 3 2.2  10-3 0.12 
Platelet activation 3 5.1  10-3 0.23 
Intracellular signal transduction 3 0.038 0.73 
Cluster 2 (Enrichment score: 2.39)    
Negative regulation of apoptotic process 5 9.8  10-4 0.12 
Negative regulation of neuron death 3 1.7  10-3 0.13 
Aging 3 0.041 0.72 
 
 
Functional analysis  
Another way to investigate the characteristics of disease genes is to look at the functions of 
the proteins encoded by these genes. Previous work showed genes with enzyme activity 
(GO:0003824 ‘catalytic activity’) were more likely associated with recessive disease than 
dominant disease (Kondrashov & Koonin 2004). However, there was no significant difference 
between dominant and recessive IMPI disease genes, when looking at association with the 
this GO term (Figure 5.10a; χ2 test; p = 0.13). The percentage of dominant disease genes with 
the annotation was slightly lower than recessive disease genes (62% compared to 73%). There 
was also no significant difference between the association with metabolism (GO:0008152 
‘metabolic process’) between dominant and recessive IMPI disease genes (Figure 5.10b; 
χ2 test; p = 0.16), though again dominant disease genes were slightly less likely to be 
annotated with this term than recessive disease genes (75% compared to 83%). 
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Figure 5.10 Comparing the percentage of IMPI dominant and recessive mitochondrial disease genes 
with certain GO annotations. (a) Annotation ‘catalytic activity’ (GO:0003824). No significant 
difference (χ2 test, p = 0.13). (b) Annotation ‘metabolic process’ (GO:0008152). No significant 
difference (χ2 test, p = 0.16).  
These GO terms are both very broad. 866 (56%) IMPI genes were annotated with the GO 
term ‘catalytic activity’ and 1,111 (72%) IMPI genes were annotated with the GO term 
‘metabolic process’. I, therefore, tried a more restrictive and specific comparison, comparing 
genes catalysing reactions in central mitochondrial metabolism with those that were not, as 
defined by inclusion in the MitoCore model of central metabolism (Smith et al. 2017) (Figure 
5.11). There was a significant difference between the proportions of dominant and recessive 
IMPI disease genes involved in central mitochondrial metabolism (χ2 test; p = 0.0016). IMPI 
genes associated with recessive disease were more likely involved in central mitochondrial 
metabolism than those associated with dominant disease.  
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Figure 5.11 Percentage of IMPI dominant and recessive disease genes in the MitoCore mitochondrial 
model of central metabolism.  There is a significant difference between the annotation status of the two 
types of disease inheritance (χ2 test, p = 0.0016). 
There was also a significant difference between the evolutionary origin of IMPI genes and 
their involvement in central mitochondrial metabolism (Figure 5.12; χ2 test; p = 8.4  10-6). 
Genes which originated more recently were less likely to be involved in central mitochondrial 
metabolism than more ancient genes – 37% of genes originating in prokaryotes compared to 
21% of genes originating in non-holozoan eukaryotes and 12% of genes originating in 
holozoan eukaryotes. This may suggest a possible link between function, origin of the disease 
and gene inheritance. 
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Figure 5.12 Percentage of IMPI genes of different origin in the MitoCore model of central metabolism.  
There is a significant difference between the annotation status of the genes originating in the different 
groups (χ2 test, p = 8.4  10-6). 
 
Human loss-of-function (LoF) homozygotes  
Though I have classified genes as ‘disease’ or ‘non-disease’, the ‘non-disease’ genes will 
include genes that cause currently unassigned genetic diseases, as well as genes that, when 
mutated, potentially cause problems so large that the foetus is inviable. I decided to create a 
cleaner set of genes negatively associated with monogenetic disease for further analysis, using 
datasets of human loss-of-function (LoF) homozygotes – people with two copies of mutations 
predicted to destroy all gene function, but who had no symptomatic phenotype. These genes 
may also be useful in prioritisation of candidate disease genes, as genes with healthy human 
LoF homozygotes have been shown to have non-deleterious effects, and so may be moved 
down in terms of prioritisation of disease gene candidates. 
In total, 236 IMPI genes were identified with loss-of-function mutations affecting both alleles 
of at least one study participant, from three published studies on consanguineous populations 
(Sulem et al. 2015; Narasimhan et al. 2016; Saleheen et al. 2017) and the ExAC dataset, 
which contains information on 60,706 unrelated individuals from a variety of ethnic 
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backgrounds (Lek et al. 2016). Despite the strict criteria used for identification of LoF 
homozygotes across the data sources, 35 (15%) of these genes are associated with human 
monogenetic disease. Most of these have reasonable explanations for the observation of at 
least one seemingly healthy LoF human homozygote (Table 5.7). These genes were removed 
from the LoF set. 
Table 5.7 Possible explanations for human LoF homozygotes in IMPI genes with associated 
monogenetic disease(s). Genes can be assigned to multiple groups. 
Possible Explanation Genes 
Unaffected isoforms ATP7B, CARS2, COQ2, ELAC2, FANCG, FBXO7, GDAP1, 
NDUFS1, OPA3, WARS2, TPP1, YME1L1 
Mild/variable described 
phenotype 
ABCB6, DMGDH, IVD, PHKA1, PRIMPOL, PRODH, SLC25A13 
Late onset/undiagnosed FANCG, GDAP1, PHKA1, SPG7 
Change in function NOL3 
Unknown PDHA1, TAZ 
 
For twelve of the genes, the LoF mutation does not affect all isoforms and the unaffected 
isoforms may provide enough function to protect from disease. For example, the OPA3 gene 
encodes two nearly identical proteins produced by alternative splicing (Figure 5.13) – the 
179 aa isoform skips exon 3, whilst the 180 aa isoform skips exon 2. All currently described 
disease-causing mutations affect either both the 179 aa and 180 aa isoforms or just the 
canonical 179 aa isoform, whilst the LoF homozygote affects only the 180 aa isoform. This 
suggests the function of the 180 aa isoform is not essential for human health. A third shorter 
isoform is not described in the literature. 
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Figure 5.13 OPA3 gene and protein isoform structures, annotated with known disease-causing 
mutations. Red = LoF homozygote, green = heterozygous disease mutation, blue = compound 
heterozygous disease mutation, black = homozygous disease mutation. The LoF mutation is only located 
on the slightly longer 180 aa isoform. (MTS = predicted mitochondrial targeting sequence; TM = 
transmembrane domain; NRIKE = internal mitochondrial sorting signal). 
Other genes are associated with late onset disease so, though the study participant may seem 
healthy, they may be affected later in life. Four of the genes possibly fit this criterion (Table 
5.7). For example, the homozygous p.Leu78Ter LoF mutation in SPG7 identified in a single 
subject from a Pakistani cohort (Saleheen et al. 2017) has been described in spastic paraplegia 
patients in homozygosity (Arnoldi et al. 2008).  
Equally, seven of the disease genes have described diseases with very mild effects or have 
patients with very variable phenotypes, suggesting variable effects or incorrect assignment of 
pathogenicity (Table 5.7). For example, a heterozygous mutation in PRIMPOL has been 
described as causative of severe myopia in a Chinese family (Zhao et al. 2013) and functional 
studies showed decreased primase and polymerase activity (Keen et al. 2014). However, a 
literature search showed further work has identified the mutation in controls at a similar 
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frequency to patients (insignificant χ2 test) (Li & Zhang 2015). The identification of this LoF 
homozygote gives further evidence to the idea that decreased function of PRIMPOL does not 
cause severe myopia. 
This analysis showed that while healthy human LoF homozygotes may be a useful tool in 
prioritising candidate disease genes, it is important to look in depth at the results of the 
mutation (e.g. looking at isoforms) and to consider the type of disease (e.g. LoF homozygotes 
may not be useful in studies of late-onset disease).  
I carried out gene enrichment analysis to investigate whether any KEGG pathways or GO 
Biological Function terms were over-represented in the mitochondrial gene LoF 
homozygotes. No pathway or biological function was over-represented (no p-value < 0.05). 
One cluster of functional terms had an enrichment score above one (Table 5.8), representing 
processes involving fatty acids. 
Table 5.8 Enriched cluster of GO Biological Process and KEGG pathway terms for human LoF 
homozygotes within IMPI. Enrichment score = 1.55. 




GO Biological Process Fatty acid biosynthetic process 9 0.0046 0.97 
GO Biological Process Acetyl-CoA metabolic process 7 0.02 0.99 
KEGG Pathway Butanoate metabolism 5 0.23 0.88 
 
Phylostratigraphic analysis showed there was no significant difference in the phylostratic 
origin of IMPI genes with healthy human LoF homozygotes and other IMPI genes without 
associated disease (Figure 5.14). There was a significant negative correlation between the 
numbers of the phylostrata and log odds ratio, assuming each phylostratum is equally 
separated from the next (Pearson’s product-moment correlation; r = -0.77, p = 0.001). This 
suggested that older non-disease genes were less likely to have identified healthy LoF 
homozygotes. 
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Figure 5.14 Comparing the origin of IMPI genes with LoF homozygotes and non-disease IMPI genes 
in different phylostrata. Natural log odds ratio is plotted for each phylostratum. Significance tested for 
each phylostratum using Fisher’s exact test with Bonferroni correction for multiple testing (no 
significant phylostrata). Phylostrata are numbered as in Figure 5.3. 
 
Essential genes  
Studies of human genes and their association with disease often rely on orthologous genes in 
model organisms. Three of the most popular model organisms are mice (Mus musculus), 
baker’s yeast (Saccharomyces cerevisiae) and the -proteobacterium Escherichia coli. These 
organisms have either full or partial gene knockout collections with attached phenotype data. 
Although previous work suggested genes essential to mouse did not strongly reflect 
‘essential’ genes in humans (Liao & Zhang 2008), I investigated whether the essentiality of 
genes in several model organisms could be used to prioritise candidate genes for different 
types of human mitochondrial disease. 
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Although knockout strains of nearly all yeast and E. coli genes have been created, this is not 
true for mice. Therefore, analysis of mouse orthologues of human IMPI genes was restricted 
to the 800 genes with a descriptive mouse knockout phenotype. Yeast and E. coli analyses 
included all genes with a predicted IMPI orthologue. Where at least one non-symptomatic 
human LoF homozygote and a disease were both associated with the same gene, the gene was 
grouped with the disease genes.  
There was a significant difference between the known human disease status of essential and 
non-essential genes in mouse, yeast and E. coli (Table 5.9; χ2 test; p = 0.007, p = 0.03 and p = 
0.008, respectively). Disease genes in human were more likely to be essential in mouse and 
yeast (6% and 20% of disease genes were essential, respectively) than genes not currently 
associated with disease and genes with human LoF homozygotes (3% and 17% of genes not 
currently associated with disease, respectively); but less likely to be essential in E. coli (20% 
of disease genes were essential compared to 37% of non-disease genes). These differences, 
while significant overall, were small. Human IMPI genes with non-symptomatic human LoF 
homozygotes were very unlikely to be essential in mouse (0%) and yeast (0%), but slightly 
more likely to be essential in E. coli (22.2%). 
Table 5.9 IMPI genes with knockout models in three model organisms (mouse, S. cerevisiae and E. coli) 
separated by essentiality in the model organism and disease status in humans. Genes which are both 
associated with a disease and a predicted human LoF homozygote were grouped with the disease genes. 
 Disease No disease Human LoF 
Mouse    
Essential 19 15 0 
Non-essential 279 409 123 
S. cerevisiae    
Essential 39 47 0 
Non-essential 155 200 28 
E. coli    
Essential 22 45 4 
Non-essential 86 71 14 
 
Very few of the essential genes in any of three model organisms had described LoF 
homozygotes in humans, as would be expected with a basic level of functional conservation. 
Two exceptions in the eukaryotic model organisms come from genes which had both a 
monogenetic disease association and a predicted human LoF homozygote – these genes were 
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grouped in with the disease-associated genes in Table 5.9. PDHA1 (pyruvate dehydrogenase 
E1 alpha subunit) is an essential gene in mouse which is also associated with a homozygous 
LoF human variant. A single hemizygous male is recorded in ExAC, with a C → G mutation 
causing a p.Tyr49Ter truncation of the canonical transcript. PDHA1 changes are recorded as 
the cause of an X-linked dominant disease in humans – pyruvate dehydrogenase E1-alpha 
deficiency (OMIM:300502), including a patient with a premature termination at amino acid 
313 (Matthews et al. 1994), a later point than recorded in this male. There are a variety of 
phenotypes associated with PDHA1 deficiency, but all are early-onset. Analysis of splicing 
variants also did not provide an obvious explanation for this male. 
There was also one essential gene in yeast with an identified human LoF homozygote: TRZ1 – 
the orthologue of human ELAC2 (ElaC ribonuclease Z 2). A single human LoF homozygote 
has been described in a person from an African population, sampled in ExAC, with a splice 
acceptor variant (rs149733287). Though the mouse orthologue is marked non-essential, the 
phenotype of the mouse knockout is ‘preweaning lethality, complete penetrance’. It seems 
unlikely, therefore, that the predicted human LoF mutation causes complete loss-of-function. 
There are several alternatively spliced transcripts marked as protein coding in Ensembl, which 
may compensate for the splice site change.  
Knockout models reflect only one specific cause of a phenotype change – that caused by a 
complete loss of gene function. This is most likely to model the cause of a recessive disease 
correctly, where function of both alleles has been sufficiently changed or lost to cause a 
phenotype. However, dominant diseases are caused by a loss or gain in function of only one 
allele, and so are not well represented by complete knockouts. I investigated whether essential 
genes were more likely to be causative of dominant diseases in the three studied model 
organisms (Table 5.10). There was a significant difference between the mode of human 
disease inheritance and the essentiality of a mouse or yeast knockout for IMPI disease genes 
(Fisher’s exact test; p = 1.0  10-8 and p = 0.02, respectively), but not for essentiality of E. 
coli knockouts (Fisher’s exact test; p = 0.27). Essential genes in mouse were more likely to be 
associated with dominant disease (87%), but those in yeast (23%) and E. coli (9%) were not. 
This may relate to the (at least partial) haploid lifestyles of E. coli and yeast. 
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Table 5.10 Human IMPI genes with knockout mouse models and associated human monogenetic 
disease, divided by essentiality in mouse and the mode of disease inheritance in humans. 
 Recessive Dominant 
Mouse   
Essential 2 13 
Non-essential 187 33 
S. cerevisiae   
Essential 23 7 
Non-essential 126 11 
E. coli   
Essential 17 2 
Non-essential 70 3 
 
 
The two essential mouse genes associated solely with recessive disease are SLC25A26 (a 
mitochondrial transporter for S-adenosylmethionine) and SUCLA2 (a subunit of succinyl-CoA 
synthetase). Patients with SLC25A26 mutations have varied residual activity of the 
transporter, with the severity of the symptoms correlating with the residual transport activity 
(Kishita et al. 2015). Not all function has been lost as in the mouse knockout model, so it may 
be that complete loss-of-function is lethal in humans as in mouse. Though a variety of 
SUCLA2 deficient patients have been described, I could not find direct measurements of 
succinyl-CoA synthetase activity in these patients. 
The association of mouse essential genes with dominant disease in humans may help 
prioritise candidates for dominantly inherited disease in genetically uncharacterised human 
patients. To support this idea, I looked at a measurement associated with both dominant 
disease and haploinsufficiency (inability of one functional copy of a gene to sustain sufficient 
function) in humans – the pLI (probability of being loss-of-function intolerant) score (Lek et 
al. 2016).  
As in the total human genome (Lek et al. 2016), IMPI dominant disease genes had a 
significantly higher average pLI score (Figure 5.15) than recessive disease genes (Welch’s 
t-test; p = 2.8  10-11) and non-disease genes (Welch’s t-test; p = 4.3  10-8 ). I also compared 
the pLI scores of genes with non-symptomatic human LoF homozygotes to the other three 
groups, finding a significant difference with non-disease genes and with dominant disease 
genes (Welch’s t-test; p = 3.1  10-15 and p = 7.4  10-13 respectively). This is consistent with 
using the pLI score as an indicator of possible disease genes, particularly for dominant 
Chapter 5  Monogenetic Mitochondrial Diseases 
 171 
diseases. The boxplot for ‘non-disease’ genes shows the likely heterogeneous nature of this 
group – 11% of these genes had a pLI score above 0.8 compared to 2% of genes with LoF 
human heterozygotes. These high scoring pLI genes are good candidates for possible 
dominant disease genes in humans, though they may also reflect genes so essential to human 
function that any change is lethal. This second category may never be observed in human 
disease patients, and study of the essentiality of these genes will rely on model organisms. 
 
Figure 5.15 Boxplot of pLI Scores for IMPI genes. Comparing genes with human LoF homozygotes 
(N = 200), recessive disease genes (N = 353), dominant disease genes (N = 55) and ‘no disease’ genes 
(N = 855). p-values from Welch’s t-tests, with Bonferroni correction for multiple testing (*** p < 0.001; 
ns = not significant). 
As a step towards identifying these essential genes, I then looked at only the genes essential to 
mouse which are currently not associated with disease. There was a significant difference 
between the pLI scores of these genes and the pLI scores of non-essential mouse genes not 
currently associated with disease (Figure 5.16; Welch’s t-test; p = 0.03). Essential genes in 
mouse not currently associated with disease had a higher mean pLI score (0.51) than non-
essential genes (0.23).  
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Figure 5.16 Boxplot of pLI scores of human IMPI genes not currently associated with disease or a LoF 
homozygote, separated by essentiality of the orthologue in mice. Comparing genes which are essential 
(N = 15) in mouse to those which are non-essential (N = 522). p-value from Welch’s t-test. 
Six genes had a pLI score over 0.9 (Table 5.11), which may be the best candidates for genes 
essential in both humans and mice, or dominant disease genes in humans. 
Table 5.11 IMPI genes not currently associated with a monogenetic disease in humans, which are 







ENSG00000147162 OGT O-Linked N-acetylglucosamine Transferase 1.00 
ENSG00000149428 HYOU1 Hypoxia Up-regulated 1 1.00 
ENSG00000067225 PKM Pyruvate Kinase, Muscle 0.99 
ENSG00000100030 MAPK1 Mitogen-Activated Protein Kinase 1 0.98 
ENSG00000108953 YWHAE Tyrosine 3-Monooxygenase/Tryptophan 
5-Monooxygenase Activation Protein 
Epsilon 
0.96 
ENSG00000167004 PDIA3 Protein Disulphide Isomerase Family A 
Member 3 
0.96 
Chapter 5  Monogenetic Mitochondrial Diseases 
 173 
 Discussion 
Previous work had investigated some phylogenetic and evolutionary features of human 
disease genes. Mitochondria have a unique evolutionary history, as descendants of an 
endosymbiotic α-proteobacterium (Sagan 1967; Müller & Martin 1999) . Therefore, I used a 
dataset of orthologues of members of the mitochondrial proteome (as defined by IMPI) to 
explore the phylogenetic and evolutionary features of mitochondrial disease genes. 
Known monogenetic disease genes in IMPI have, on average, a wider spread of orthologues 
throughout the tree of life, and originate earlier than, IMPI genes without associated disease 
(Figures 5.1 – 5.5, Table 5.2). This is consistent with previous analyses which had looked at 
genome-wide analyses of human monogenetic disease genes (López-Bigas & Ouzounis 2004; 
Domazet-Lošo & Tautz 2008; Maxwell et al. 2014), despite the unique history of the 
mitochondria. There are two large peaks of mitochondrial gene innovation: one in the cellular 
organisms and early eukaryotes – these are enriched with disease-causing genes; and the 
second at the origin of the vertebrates – these are enriched with genes not associated with 
disease. The genes originating in the vertebrates include a large number which are associated 
with apoptosis and signalling, which is consistent with a rise in complexity of the immune 
system in vertebrates (Aravind et al. 2001) and an increase in the complexity of development 
controlled by additional signalling (Pires-da Silva & Sommer 2003). This is different than 
when looking at the same comparison genome-wide, where a greater majority of genes are of 
newer origin and other phylostrata show significant differences (e.g. genes originating in 
eukaryotes are depleted in disease-causing genes, whereas there is no significant difference in 
the mitochondrial analysis) (Domazet-Lošo & Tautz 2008). However, that study looked more 
at gene families than individual genes, as the authors do not try and separate the origin of 
paralogues within the same family. The analysis in this chapter may be more useful in 
specifically prioritising candidate genes for mitochondrial disease patients. 
In my reading of the literature I could not find any previous work which had looked in depth 
at the phylogenetic spread and origin of disease genes showing different types of inheritance 
patterns – namely recessive and dominant. IMPI genes associated with dominant disease 
have, on average, a narrower phylogenetic spread and are of more recent origin than IMPI 
genes associated with recessive disease (Figures 5.6 – 5.9, Table 5.5). A previous study found 
a similar but qualitative difference in the origin of recessive and dominant disease genes 
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across the complete human genome, but only looked at orthologues in the Metazoa and 
S. cerevisiae, and recorded no significance testing (Cai et al. 2009).  
The difference in origin of dominant and recessive IMPI disease genes can be, at least 
partially linked to function. Recessive disease genes are more likely associated with central 
metabolism in mitochondria (Figure 5.11), as are older genes (Figure 5.12). Dominant genes 
are more likely to originate in vertebrates (Figure 5.9) and are enriched in processes such as 
cell proliferation and apoptosis (Table 5.6). This is consistent with a previous hypothesis 
which suggested that increased complexity in Metazoa necessitated expansion of a variety of 
protein types, including those involved in transcription, signalling and cellular structures 
(Jimenez-Sanchez et al. 2001).  
However, there was no significant link between enzyme function as defined by the GO term 
‘catalytic activity’ (GO:0003824) and inheritance type of the disease gene (Figure 5.10), as 
seen previously (Kondrashov & Koonin 2004). This may be due to the increase in annotation 
assigning catalytic activity to a wider range of genes since the original analysis, or a real 
difference between a genome-wide analysis and an investigation of only mitochondrial genes. 
Though the previously mentioned work was based on splitting IMPI into disease-causing 
genes and non-disease-causing genes, the non-disease group is likely a heterogeneous mix, 
containing genes which really are non-essential to human function, disease-causing genes 
which have yet to be identified, and genes which are so essential to function we may never 
identify human patients with functional mutations. I explored known human LoF 
homozygotes of IMPI genes, identified from a variety of sources, as a set of genes which are 
likely to be truly non-essential and which should perhaps be deprioritised as candidate disease 
genes. These genes showed no significant difference in phylostratic origin compared to other 
IMPI genes not associated with disease (Figure 5.14). However, examples of human LoF 
homozygote genes that are associated with disease highlight several considerations to using 
LoF homozygotes to rule genes out for further analysis in patients (Table 5.10) – for example, 
does the LoF mutation affect all splice variants and was the patient’s disease late-onset? 
The closest we may get to identifying essential genes is by studying model organisms. 
However, previous work had suggested there was not a strong correlation between essentiality 
in mouse and in human (Liao & Zhang 2008). Essential genes in mouse and yeast were 
slightly but significantly more likely to be associated with disease (Table 5.10), indicating 
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that human patients are born and diagnosed with mutations in genes which are essential in the 
model organisms. However, most of the diseases in human associated with essential genes 
from mouse were dominantly inherited (Table 5.11). These genes also had a significantly 
higher pLI score (Figure 5.16), suggesting essential genes in mouse are most likely associated 
with either dominant disease or haploinsufficiency in humans. This suggests knockout model 
organisms, particularly mouse, could be used in prioritising gene candidates for dominant 
disease or for identifying the most essential genes in humans. 
Even with better prioritisation of candidate genes and an increase in success rate, exome 
sequencing will not provide sufficient data to identify the cause for all genetic mitochondrial 
disease. Other causes may be identified, for example, by investigating copy number variants 
(CNVs) – larger scale deletions and/or duplications – which are difficult to identify from 
exome data (Krumm et al. 2012). Whole genome sequencing allows better detection of 
structural changes, as well as analysis of non-exonic sequences. A recent study showed that 
whole genome sequencing improved diagnostic rates in paediatric patients with suspected 
genetic disease (Lionel et al. 2018). Mitochondrial disease has also been associated with 
digenic gene inheritance (Van Goethem et al. 2003) – the contribution of mutations in two 
separate, though related, genes to a single phenotype, which may be considered in cases 
which are proving intractable to solve. 
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 Conclusions 
In this chapter, I have investigated the origin and phylogenetic spread of mitochondrial 
proteome-encoding genes associated with monogenetic disease. Disease associated genes are 
more likely to have a wider spread of orthologues throughout the tree of life than those not 
associated with disease, though genes associated with dominant disease have a narrower 
spread and more recent origin than genes associated with recessive disease. Disease genes are 
also more likely to have originated earlier in human evolutionary history than genes not 
associated with disease. Genes associated with dominant disease, however, are more likely to 
have originated in the Holozoa than recessive disease genes, and this may be linked to the 
overrepresentation of ancient genes of central metabolism in the recessive disease gene group. 
This information could be used to prioritise candidate genes from exome sequencing of 
mitochondrial disease patients. Study of model organisms with gene knockouts and healthy 
human LoF homozygotes may inform candidate gene prioritisation for patients with different 
















Viruses and the mitochondria 
Mitochondria are involved in a variety of cellular processes which could be of value to a 
virus, in terms of survival and replication in a eukaryotic cell. These include:  
• energy metabolism, including the production of ATP via the electron transport chain, 
which may be manipulated to favour viral replication, 
• apoptosis (controlled cell death), which may be important in cellular immune 
responses against viruses, and in the escape of replicated viruses from a host cell 
(Galluzzi et al. 2008), 
• nucleotide and amino acid metabolism, which could provide source materials for viral 
replication, 
• DNA replication, as the host mitochondrial machinery could be hijacked by the virus, 
• and protein translation, for the same reason (mitochondria contain their own ribosome 
and associated machinery). 
There are many examples where viruses have been shown to manipulate some of these 
mitochondrial processes (Ohta & Nishiyama 2011). For example, human cytomegalovirus 
infection is associated with changes in several mitochondrial associated processes. Energy 
metabolism is manipulated to increase flux through glycolysis for energy (Munger et al. 
2006) and to increase flux through the tricarboxylic acid cycle via glutamine metabolism 
(Chambers et al. 2010). Fatty acid synthesis is also increased to support production of the 
viral envelope (Munger et al. 2008). Infection with this virus also induces mitochondrial 
biogenesis, with an associated increase in mitochondrial transcription and translation  
(Karniely et al. 2016). These are just a few examples, from a single virus, of the many ways 
mitochondria can be manipulated. 
Specific virally-encoded proteins have been linked to changes in mitochondrial function on 
infection with some viruses. For example, the UL12 gene in herpes simplex virus type 1 
encodes an exonuclease that causes the degradation of mitochondrial DNA (Corcoran et al. 
2009), which has been linked to mitochondrial damage as an important part of early viral 
infection (Wnęk et al. 2016).
Chapter 6  Viruses and Mitochondria 
 180
Viral orthologues of mitochondrial proteins 
Viral genomes can encode proteins which are orthologous with mitochondrial proteins from 
eukaryotes. Some of these orthologous proteins are mitochondrially localised in humans or 
other eukaryotes, though the virally encoded proteins may also localise to other subcellular 
compartments  (Ohta & Nishiyama 2011). For example, there are several identified viral 
orthologues of the Bcl-2 family of proteins across different viral families (Cuconati & White 
2002), which function in the control of the mitochondrial pathway of apoptosis in humans 
(Gross et al. 1999). The first identified viral member of the Bcl-2 family was the E1B-19K 
protein encoded in the genome of an adenovirus (White et al. 1991) – a group of viruses 
known to cause illness in a range of vertebrates. E1B-19K is an anti-apoptotic member of the 
family, preventing the breakdown of DNA (White et al. 1991). A more recent study of 
E1B-19K has shown that the modification of the host cell death process produced by this 
protein reduces the response of the host innate immune system, which may increase the 
success of viral replication (Radke et al. 2014). There are both pro-apoptotic and anti-
apoptotic members of this family across the viral proteome, as there are in humans. One 
example of a pro-apoptotic viral Bcl-2 family protein is protein 7A encoded by the RNA 
virus, ‘severe acute respiratory syndrome corona virus’. This protein is associated with an 
increase in the efficiency of apoptosis but is not necessary for viral replication (Schaecher et 
al. 2007).  
Whilst viral orthologues of several mitochondrial proteins have been identified, there has not 
been a large-scale study of this phenomenon or the general types of proteins involved. The 
development of a new set of genes predicted to encode the human mitochondrial proteome 
(IMPI 2017) provides the opportunity to make this assessment, facilitating insight into the 
importance of controlling or manipulating the host cell mitochondria across knowns viruses. 
 
Chapter summary 
In this chapter, I explore the viral proteome for viral protein orthologues of the human 
mitochondrial proteome. I investigate the types of viruses with and without predicted 
orthologues; the numbers of orthologues identified within different viruses; and the families 
of genes with predicted viral orthologues. I explore one example of possible horizontal 
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transfer of a gene encoding a mitochondrial protein to a virus from its host cell. I then 
investigate the predicted viral orthologues of the mitochondrial carrier family.  
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 Methods 
Identifying viral orthologues of human mitochondrial genes 
A database of viral protein sequences was created by downloading all viral sequences (NCBI 
taxid: 10239) from the NCBI protein database (www.ncbi.nlm.nih.gov/protein). For all genes 
in IMPI 2017 (www.mrc-mbu.cam.ac.uk/impi) and MitoCarta 2.0 (Calvo et al. 2015) (two 
different definitions of the human mitochondrial proteome), the canonical protein sequence in 
humans was identified. This was used in a reciprocal best hit analysis to identify possible viral 
orthologues (Figure 6.1), using an E-value threshold of 10 for each BLASTp search. The 
human sequence was first used as the bait for a BLASTp search against the database of all 
viral sequences. For each viral strain with a hit, the top scoring hit was used in a BLASTp 
search back against a database of human protein sequences. If the top hit from this search 
matched a protein encoded by the original human gene used to search the viral sequence 
database, a viral orthologue was predicted. 
 
Figure 6.1 Summary of the reciprocal best hit process for identifying possible viral orthologues of 
human IMPI genes encoding the mitochondrial proteome.  
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For genes with identified reciprocal best hits in at least one virus, the predicted protein 
domain structure of the viral predicted orthologues protein was compared to the structure of 
the human protein using NCBI CDD (Conserved Domain Database) searches (Marchler-
Bauer et al. 2017). Proteins with functionally equivalent domains were kept as predicted 
orthologues. 
 
Information on viruses 
A list of viral strains with fully sequenced genomes was retrieved from the NCBI genome 
website (www.ncbi.nlm.nih.gov/genome), using the taxid 10239 for ‘Viruses’. Baltimore 
classification for each virus with a full genome was identified by retrieving the genome type 
from the NCBI taxonomy database (www.ncbi.nlm.nih.gov/taxonomy) and matching this to 
the Baltimore classification system (Baltimore 1971). The viral families for each viral strain 
were also retrieved, where available, from the NCBI taxonomy database. 
The host phyla for each virus with at least one predicted orthologue of a human IMPI protein 
was identified from the NCBI taxonomy database, with additional hosts retrieved from the 
Virus-Host database where possible (Mihara et al. 2016). 
 
Functional enrichment 
Pathway annotation and enrichment was completed using the DAVID functional annotation 
tool (Huang et al. 2009a), using the IMPI gene list as a background, investigating annotation 
from KEGG, Reactome and GO Biological Process. 
 
Phageness 
‘Phageness’ (Kristensen et al. 2011) was calculated for each IMPI 2017 gene with at least one 
predicted viral orthologue, as follows: 
𝑃ℎ𝑎𝑔𝑒𝑛𝑒𝑠𝑠 𝑞𝑢𝑜𝑡𝑖𝑒𝑛𝑡 =  log (
𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝑜𝑓 𝑔𝑒𝑛𝑒 𝑖𝑛 𝑠𝑒𝑞𝑢𝑒𝑛𝑐𝑒𝑑 𝑣𝑖𝑟𝑢𝑠𝑒𝑠
𝐹𝑟𝑒𝑞𝑢𝑒𝑛𝑐𝑦 𝑜𝑓 𝑔𝑒𝑛𝑒 𝑖𝑛 𝑠𝑡𝑢𝑑𝑖𝑒𝑑 𝑐𝑒𝑙𝑙𝑢𝑙𝑎𝑟 𝑜𝑟𝑔𝑎𝑛𝑖𝑠𝑚𝑠
) 
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Where the frequency of genes in sequenced viruses is the fraction of viruses with fully 
sequenced genomes with a predicted orthologue of the gene; and the frequency of genes in 
studied cellular organisms is the fraction of the 359 species included in the orthologue 
database (Chapter 2) with a predicted orthologue of the gene. 
 
Matrix clustering 
R was used to cluster genes by their phylogenetic patterns. A binary matrix of the presence 
and absence of predicted orthologues of IMPI 2017 genes with at least one predicted viral 
orthologue was created. A distance matrix was calculated from this binary matrix using the 
function dist(), with the method ‘euclidean’. Clustering of the genes was achieved using the 
function hclust(), with the method ‘ward.D2’. 
 
Localisation 
Localisation of protein products in humans was taken from the COMPARTMENTS 
subcellular localisation database (Binder et al. 2014). If a compartment outside of the 
mitochondria had a score of 3 or over, the protein was assigned dual localisation.  
 
Gene families 
Gene families for each IMPI 2017 gene with a predicted viral orthologue were retrieved from 
the HGNC (HUGO Gene Nomenclature Committee) gene family dataset (Gray et al. 2016). 
 
MTFP1 phylogenetic tree 
Orthologues of MTFP1 in cellular organisms were retrieved from the orthology dataset 
described in Chapter 2. Sequences of a cross-section of these species and all identified viral 
sequences were aligned using MUSCLE with default settings (Edgar 2004a, 2004b) and 
alignments were manually improved in Jalview (Waterhouse et al. 2009). A phylogenetic tree 
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was calculated using PhyML 3.0 using the best method (highest maximum likelihood score) 
from the two topology search methods (SPR – Subtree Pruning and Regrafting; and NNI – 
Nearest Neighbour Interchange) and 100 bootstrap replicates. The tree was visualised in 
Interactive Tree Of Life (Letunic & Bork 2016). 
 
Viral mitochondrial carrier analysis 
To create the tree of predicted viral mitochondrial carrier proteins, I aligned the viral protein 
sequences and the cow (Bos taurus) AAC1 sequence (accession: P02722.3) using MUSCLE 
with default settings  (Edgar 2004a, 2004b) and manually assessed alignments in Jalview 
(Waterhouse et al. 2009). An unrooted phylogenetic tree was calculated using PhyML 3.0, 
using the best method (maximum likelihood score) from the two topology search methods 
(SPR – Subtree Pruning and Regrafting; and NNI – Nearest Neighbour Interchange) and 100 
bootstrap replicates. The tree was visualised in Interactive Tree Of Life (Letunic & Bork 
2016). 
Matrix and cytoplasmic network motifs, as well as predicted contact points, were identified in 
each of the three repeats of the viral carriers from alignment with the cow (Bos taurus) AAC1 
protein (accession: P02722.3) (Robinson et al. 2008). The consensus sequence for these 
motifs predicts the formation of six salt bridges from six pairs of residues – three forming a 
network on the side of the carrier closest to the cytoplasm and three forming a network on the 
mitochondrial matrix side of the carrier (Figure 6.2).  
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Figure 6.2 Scoring method for the strength of cytoplasmic and matrix salt bridge networks in 
mitochondrial carrier family proteins, using the consensus motifs for each network. Red = negative 
residue, blue = positive residue, dotted line = interaction. Numbers for each pair indicate the assigned 
strength of the interaction, whilst the central number indicates the total strength of the network. 
Residues at these positions in the viral carriers were used to predict scores for the strength of 
the two networks, by summing the scores given for each of the three predicted pairs in each 
network.  
Scores were assigned as follows (as in Robinson et al. 2008): 
• A score of 1 was given for a residue pair predicted to form an ionic salt bridge, 
• A score of 0.5 was given for a residue pair predicted to form a cation-π interaction or a 
hydrogen bond, 
• A score of 0 was given for any other residue pairs.  
 
Statistics 
Statistical analyses were carried out in R. Statistical tests used, along with any correction for 
multiple testing, are indicated in the text.   
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 Results 
Identifying orthologues of human mitochondrial genes in viruses 
Though there have been studies of individual genes shared between viruses and cellular 
organisms, there has not been a wide-scale look at genes shared between the human 
mitochondria and viruses. To investigate this, I first identified orthologues of human 
mitochondrial genes (as defined by both IMPI 2017 and MitoCarta 2.0) in viral sequences, 
using reciprocal best hit analysis. I used a liberal E-value of 10 as the cut-off for calling the 
orthologues, to minimise rates of false negatives for viral proteins that may be evolutionarily 
distant from the human sequence. This identified 8,263 viral orthologues of 649 IMPI 2017 
genes across 3,559 viral strains, and 6,257 viral orthologues of 492 MitoCarta 2.0 genes 
across 3,047 viral strains. I then removed some predicted orthologues which did not show the 
same protein domain structure as the human protein. E-values of retained and removed hits 
overlapped substantially (Figure 6.3), with some retained hits having E-values as large as 2.5.  
 
Figure 6.3 Comparative histograms of log10 (reciprocal BLASTp E-values) for retained (purple) and 
removed (grey) predicted viral orthologues of human IMPI mitochondrial proteins. 
After domain assessment, there were 5,204 predicted viral orthologues of 156 IMPI 2017 
genes (10.1% of all genes), across 2,540 viral strains, and 4,274 predicted viral orthologues of 
125 MitoCarta 2.0 genes (10.8% of all genes), across 2,263 viral strains. 
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There is a large overlap of genes between IMPI 2017 and MitoCarta 2.0, and this is reflected 
in the strong correlation between the number of orthologues found per virus in each data set, 
only including those with full genomes recorded by the NCBI (Figure 6.4, correlation 
coefficient = 0.936, p < 2.2  10-16). The number of orthologues predicted per virus tends to 
be slightly higher using the IMPI 2017 dataset, probably reflective of the larger size of the 
gene set compared to MitoCarta 2.0. Therefore, from this point on, all analyses use the IMPI 
2017 dataset to define the genes of the human mitochondrial proteome.  
 
Figure 6.4 Comparison of the number of predicted mitochondrial gene orthologues per viral strain, 
between those defined by IMPI 2017 and those defined by MitoCarta 2.0. Darker shades represent a 
larger number of viruses. 
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Viruses with predicted mitochondrial gene orthologues 
I then investigated the composition of this dataset of viral orthologues of human 
mitochondrial genes. To investigate the type of viruses most likely to have a predicted 
orthologue of a mitochondrial protein, I classified all viral strains with full genomes in NCBI 
using the Baltimore classification system, which separates viruses by the type of genome and 
method of genome replication (Baltimore 1971). I then identified the number of viral strains 
within each group which had at least one predicted mitochondrial orthologue (Table 6.1).  
Table 6.1 Predicted mitochondrial protein orthologues in viral strains with fully sequenced genomes, 
separated by Baltimore classification (ds = double-stranded, ss = single-stranded, RT = reverse-
transcribing). 




of viruses  
% of viruses with 
mitochondrial 
orthologue(s) Group Genome 
I dsDNA 1285 2736 47.0 
II ssDNA 0 1003 0.0 
III dsRNA 0 300 0.0 
IV (+)ssRNA 37 1313 2.8 
V (-)ssRNA 0 442 0.0 
VI ssRNA-RT 4 66 6.1 
VII dsDNA-RT 6 86 7.0 
 
There are predicted viral orthologues of IMPI 2017 genes in viruses with both DNA and RNA 
genomes, as well as both double-stranded (ds) and single-stranded (ss) genomes. Viral strains 
with dsDNA genomes have by far the highest number of strains with at least one predicted 
mitochondrial orthologue, as well as the highest percentage of all sequenced strains with at 
least one predicted mitochondrial orthologue – nearly half of all sequenced dsDNA viruses. 
Few members of the other Baltimore groups have predicted orthologues of mitochondrial 
genes, with less than 10% of the total fully sequenced viral strains having at least one 
predicted orthologue. 
The viral strains with predicted orthologues of mitochondrial genes infect a wide range of 
host species, including bacteria, archaea and eukaryotes (Figure 6.5). This is perhaps 
reflective of the wide spread of IMPI 2017 orthologues across all types of cellular organisms 
(Chapter 2). Viral host phyla which include popular model organisms (e.g. Escherichia coli in 
Proteobacteria) or other well-studied species (such as humans) have higher numbers of 
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viruses with predicted mitochondrial orthologues. This suggests that the viral proteome 
analysed is skewed towards certain types of viruses. Very few of the viral strains with an 
identified mitochondrial orthologue infect archaeal species.  
 
Figure 6.5 Host phyla (or closest available taxonomic rank) for viral strains with at least one predicted 
orthologue of IMPI mitochondrial proteins. Colours indicate prokaryotic (red), eukaryotic (blue) or 
unknown (grey) hosts.  
Viruses with a fully sequenced genome and at least one predicted orthologue of an IMPI 2017 
gene belong to twenty-two different viral families (Figure 6.6), with an additional 74 of these 
viruses unclassified. This is around 20% of all viral families with at least one fully sequenced 
member strain. The percentage of viral strains within each family with a predicted 
mitochondrial orthologue ranges from 6.1% (Retroviridae) to 100% (several different 
families, with between 1 and 24 fully sequenced viral members). The largest number of 
mitochondrial protein orthologues are predicted in ‘Acanthamoeba polyphaga mimivirus’ 
(NCBI taxid: 212035), a member of the Mimiviridae – one of several families of so-called 
‘giant viruses’.  
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Figure 6.6 (overleaf) Number of mitochondrial orthologues in viruses with full genomes separated by 
viral family. Numbers under each plot indicate the total number of viruses in that family with at least 
one mitochondrial orthologue. Width of each bar indicates the number of viruses with the indicated 
number of orthologues (note the different scales between the plots, to account for the variation between 
the number of viral strains in different viral families). 
In summary, a wide range of viruses contain orthologues of human mitochondrial genes. They 
are not limited by genome type, host cell or the viral family, though there are examples of 
each which currently have no predicted viral orthologues of mitochondrial genes.  
 
Function of viral orthologues of mitochondrial proteins 
I then explored the types of mitochondrial proteins which viruses share with humans. 256 
different IMPI 2017 genes have a predicted viral orthologue (Appendix III – Table 1). After 
grouping the genes into related HGNC protein families, there were 61 different protein 
families identified, as well as an additional 62 genes with no associated family. Thus, the viral 
proteome includes orthologues of the products of genes producing a wide-ranging set of 
mitochondrial proteins.  
I assessed the enrichment of functional terms in the mitochondrial genes with viral 
orthologues, compared to IMPI 2017. Four terms were enriched with p < 0.05 after correction 
for multiple testing (Table 6.2). These categories are important for correct transcription and/or 
translation in humans, which suggests viruses share genes with humans encoding 
mitochondrial proteins to assist with their replication, perhaps through hijacking of the 
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Table 6.2 Functional annotation enrichment for mitochondrial genes with at least one viral orthologue. 
Terms from KEGG, GO Biological Process (GO BP) and Reactome with p < 0.05 after multiple testing 
correction. 




KEGG Pyrimidine metabolism 12 7.7 8.8  10-7 1.5  10-4 
GO BP tRNA aminoacylation for 
protein translation 
10 6.5 4.5  10-5 2.7  10-2 
GO BP DNA repair 11 7.1 2.6  10-5 3.1  10-2 
GO BP DNA replication 8 5.2 1.2  10-4 4.8  10-2 
 
Clustering genes by their pattern of orthologues from viruses with full genomes, the nine most 
frequently identified genes cluster together (Figure 6.7).  
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These nine genes are each identified in over 150 viral strains (Table 6.3). However, of the 
2,112 viral strains with a predicted orthologue of at least one of these genes, no virus was 
identified that encodes more than five of these genes, and 65.4% of viral strains only encode 
one of these genes. This suggests that the clustering of these genes is due mainly to the larger 
number of viral strains with identified orthologues, rather than a true relationship between the 
presence of any of these genes in a viral genome. 
Table 6.3 IMPI genes with predicted orthologues in over 150 viral strains.  
Ensembl ID Gene Localisation Function 
ENSG00000167136 DUT Dual Production of dUMP in thymidine 
nucleotide anabolism and maintenance 
of low dUTP/dTTP ratio 
ENSG00000176890 TYMS Dual Thymidine nucleotide anabolism 
ENSG00000106028 SSBP1 Dual Binds single-stranded DNA during 
replication 
ENSG00000125656 CLPP Mitochondria ATP-Mg2+ dependent peptidase 
ENSG00000099821 POLRMT Mitochondria Mitochondrial transcription 
ENSG00000171865 RNASEH1 Dual Degradation of RNA-DNA hybrids 
during transcription 
ENSG00000076248 UNG Dual Removal of uracil from DNA 
ENSG00000142168 SOD1 Dual Free radical metabolism 
ENSG00000107815 C10orf2 Mitochondria DNA helicase involved in replication 
 
Three of the top identified genes are involved in thymidine nucleotide metabolism, 
particularly related to uracil (Table 6.3). Controlling uracil metabolism may be important to 
maintaining the integrity of the viral genome, as DNA polymerases cannot necessarily 
distinguish between thymine and uracil during replication (Brynolf et al. 1978; Tye et al. 
1978). However, DUT has also been shown to play additional roles in the lifecycle of several 
viruses. For example, the Epstein-Barr virus orthologue of DUT helps control the immune 
response by modulating host-cell inflammatory cytokines (Ariza et al. 2009). 
The proteins encoded by most of these top predicted genes are thought to be dual localised in 
humans, suggesting a potential weaker link to controlling the function of the mitochondria. 
Two of the three genes with proteins mainly localised to the mitochondria are involved in 
DNA replication and transcription of DNA producing RNA. These two genes – mitochondrial  
RNA polymerase (POLRMT) and mitochondrial DNA helicase (C10orf2) – are thought to be 
of phage origin (Masters et al. 1987; Cermakian et al. 1996; Spelbrink et al. 2001). 
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Overall, the viral proteome contains potential orthologues of a wide range of mitochondrial 
genes. The functions of these genes, including those which are most frequently predicted as 
orthologues, tend to be linked to nucleotide metabolism, transcription and translation.  
 
Spread of viral orthologues of mitochondrial proteins 
Another way to look at these results is to look at the spread of orthologues in the studied 
viruses. The phageness quotient of a gene is a log-odds ratio measure of the frequency of a 
gene in viruses compared to the frequency of a gene in another set of organisms (Kristensen et 
al. 2011) – in this case, the cellular organisms used to create an orthologue database in 
Chapter 2. A gene which is more frequently identified in viruses than cellular organisms 
would have a score above zero, whilst a gene which is more frequently identified in cellular 
organisms than viruses would have a score below zero. For the 994 IMPI 2017 (86.4%) genes 
with no predicted viral orthologues, the phageness quotient would be -.  All the genes with 
at least one viral orthologue are more frequently identified in the studied cellular species than 
the sequenced viruses – i.e. they all have scores below zero (Figure 6.8).  
 
Figure 6.8 Density plot of the phageness quotient of each of the IMPI 2017 genes with at least one 
predicted viral orthologue. Gene phageness quotient is a log-odds ratio measure of the frequency of 
gene orthologue detection in all fully sequenced viruses compared to the frequency of gene orthologue 
detection in the cellular organisms included in the orthology dataset from Chapter 2. 
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There is a peak at a phageness quotient of approximately -2.5, which is equivalent to a gene 
that is approximately 300 times more frequent in the studied cellular organisms than viruses. 
This suggests that though there a wide variety of mitochondrial proteins with predicted 
orthologues in viruses, each gene is relatively rare compared to their spread in cellular 
organisms.  
One explanation for this could be that viral orthologues of mitochondrial genes are not spread 
widely across families of viruses but instead tend to be unique to certain viral families. This is 
supported by looking at the number of viral families with an identified orthologue of each 
protein, with most proteins having predicted orthologues in very few families (Figure 6.9). 
The two most widespread IMPI 2017 genes across viral families are DUT (deoxyuridine 
triphosphatase, identified in 19 families) and TYMS (thymidylate synthetase, identified in 13 
viral families). However, over half (56.2%) of all the genes with at least one predicted viral 
orthologue are only identified in one viral family. A possible explanation for this would be the 
unique transfer of genes between a host and a virus, with spread throughout a family as the 
viral family expands, although this idea would need to be supported by further data. 
  
 
Figure 6.9 Histogram of the number of viral families with a predicted orthologue, for each IMPI 2017 
gene with at least one viral orthologue and one virus with an assigned family. 
Chapter 6  Viruses and Mitochondria 
 198
Transfer of genes between virus and host genomes 
Proteins which are shared between viruses and the hosts may indicate gene transfer between 
these two entities. There is already evidence for this type of transfer with, for example, the 
mitochondrial RNA polymerase (POLRMT) (Cermakian et al. 1996). I decided to use 
phylogenetic trees to investigate the possible origin of some mitochondrial genes encoded by 
viruses. Clustering of viral sequences close to their hosts, rather than separately from cellular 
organisms, would provide evidence that there was possible transfer of the gene from the host 
to the virus or vice versa. 
One gene I investigated was MTFP1 (Mitochondrial Fission Process 1), which encodes a 
protein regulating the fission of mitochondria (Tondera et al. 2004, 2005). This gene was a 
good candidate for analysis, as it was only identified in eukaryotic species in the IMPI 2017 
orthologue database (Chapter 2) and contains a functional domain (pfam10558) unique to this 
gene in humans. This could reduce confusion due to potential gene transfer between 
prokaryotic species and/or presence of paralogues. Viral orthologues of these gene were 
predicted for seventeen viral strains, from two different families –  the Mimiviridae (fourteen 
sequences) and the Phycodnaviridae (three sequences).  
I used PhyML to calculate a phylogenetic tree of a selection of eukaryotic and all viral 
orthologues of human MTFP1 (Figure 6.10). The tree suggests that there may be two separate 
origins of this gene in viruses. The Phycodnaviridae sequences cluster with the green algae, 
particularly Ostreococcus and Micromonas species – these are the hosts of the detected 
viruses encoding these sequences. This provides some evidence that the genes in the 
Phycodnaviridae may originate from horizontal transfer from their host cells. (Whilst it is 
possible that the gene moved the opposite way – from virus to host cell –  it is unlikely 
considering the spread of the gene throughout the eukaryotes).  
However, the sequences from the Mimiviridae cluster separately and seem distantly related to 
all other sequences. This phylogenetic tree, therefore, does not provide evidence about a 
possible origin of these genes in the Mimiviridae. There are several possibilities for the lack 
of strong relationship between these sequences and the rest of the phylogenetic tree, including 
that Mimiviridae sequences have become highly diverged from the original sequence or that 
there are no sequences included from species close to the Mimiviridae true hosts, as these are 
not always clear (Claverie et al. 2009). 
Chapter 6  Viruses and Mitochondria 
 199 
Though I also investigated several other genes (including BCS1L, THG1L, PRODH, and 
GFER) no other phylogenetic tree produced such a clear result of possible host/viral gene 
transfer as that seen for MTFP1. This could be due to some of the limitations I tried to avoid 
when choosing MTFP1 for analysis, such as having prokaryotic orthologues or being part of a 
larger gene family, which are harder to distinguish from each other. It could also be a 
limitation of the technique, which is dependent on the sequences included and the rate of 
divergence of the sequences. 
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Mitochondrial carriers in viruses 
The mitochondrial carrier family is a group of proteins with a similar tri-repeat structure 
(Gutiérrez-Aguilar & Baines 2013). Most of the characterised members of this family move 
substrates across the inner mitochondrial membrane, though there are exceptions to this rule. 
A single viral orthologue of a mitochondrial carrier from a member of the Mimivirus group 
has been expressed and characterised as a dATP and dTTP carrier (Monné et al. 2007). I used 
my viral mitochondrial protein orthologue dataset to identify additional viral strains with 
predicted orthologues of mitochondrial carriers.  
There are 27 viral mitochondrial carrier orthologues in the orthology dataset across 26 viral 
strains. One viral strain (Hokovirus HKV1) encoded two predicted mitochondrial carrier 
proteins. These viral strains belonged to the families Mimiviridae, Nudiviridae and 
Hytrosaviridae, as well as some unclassified viruses. Mimiviridae have been proposed as a 
member of a new order of viruses known as the Megavirales (Colson et al. 2013), whereas the 
other families have not been classified into a viral order. They are all double-stranded DNA 
viruses, with some of the largest known viral genomes (http://www.giantvirus.org/top.html). 
The host species of the Nudiviridae and Hytrosaviridae are insects and crustaceans, whereas 
most Mimiviruses have been cultivated in amoeboid species, but their true hosts are not 
characterised (Claverie et al. 2009).  
I used the sequences of these predicted viral carriers to produce an unrooted phylogenetic tree 
(Figure 6.11).  
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The sequences from the three members of the Nudiviridae and Hytrosaviridae cluster together 
(bootstrap 100/100), with the remaining sequences grouping into two additional clusters, each 
one containing one of the sequences from Hokovirus HKV-1. It is therefore possible that these 
mitochondrial carriers are functioning differently from the carriers encoded by Megavirales 
members.  
This is possibly supported by looking at the sequences of the viruses from the different 
families. The three viruses from the Nudiviridae and Hytrosaviridae encode different residues 
at the substrate contact points II and III – which define the likely substrate specificity of the 
carriers – compared with the other viral mitochondrial carriers (Figure 6.12). This may 
suggest that they transport a different substrate from other viral mitochondrial carriers (dATP 
for the characterised transporter from Mimivirus (Monné et al. 2007)), or that the substrate 
binds differently. 
Mitochondrial carriers function by the formation and breakage of salt bridge networks – one 
at the mitochondrial matrix face of the protein, and the second at the intermembrane space or 
cytoplasmic face of the protein (King et al. 2016). With the increased number of viral 
mitochondrial carrier sequences available, it becomes possible to assess the average predicted 
strength of the mitochondrial and cytoplasmic salt networks (Robinson et al. 2008). On 
average, the mitochondrial carriers from the Nudiviridae and Hytrosaviridae have both a 
reasonably strong mitochondrial (1.8/3) and cytoplasmic (1.7/3) salt bridge network, 
suggesting these transporters function as exchangers. The other viral mitochondrial carriers 
have a strong mitochondrial salt bridge network (2.8/3) and a weaker cytoplasmic salt bridge 
network (1.2/3) (Figure 6.12). Though this suggests these carriers may be uniporters, 
characterisation of the Mimivirus carrier showed only exchange activity (Monné et al. 2007). 
In summary, this analysis predicts there may be at least two groups of viral mitochondrial 
carriers in different viral families, with potentially different substrate binding and exchange 
activities. 
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 Discussion 
The scientific literature is full of examples of viral proteins which have been shown to 
influence the function of a host cell mitochondria and/or seem to be orthologous with 
mitochondrial protein sequences (Ohta & Nishiyama 2011). However, I could not find 
evidence of a wide-scale screen for potential mitochondrial protein orthologues in viruses, 
which could help our understanding of the influence of mitochondria in viral infections. 
Therefore, I used reciprocal best hit analysis to identify possible orthologues of human 
mitochondrial proteins across the sequenced viral proteome.  
This analysis showed that viruses share a wide range of human mitochondrial proteins, with 
around 10% of IMPI 2017 genes having at least one predicted orthologue. These genes are 
enriched for functions which can be linked to the success of viral replication (Table 6.2), 
including nucleotide metabolism, DNA replication/repair, and translation. Viruses have been 
increasingly linked to mitochondrial metabolism in general, including key aspects such as the 
tricarboxylic acid cycle (Claus & Liebert 2014). There has also been a described case of an 
entire metabolic pathway transferring from an algal host to a virus (Monier et al. 2009). 
Despite this, very few human mitochondrial metabolic enzymes, outside of those involved in 
nucleotide metabolism, had predicted orthologues within the studied viral proteome.  
The predicted orthologues are widely spread throughout the viruses, with approximately 22% 
of fully sequenced viruses encoding orthologues of at least one gene linked to the 
mitochondria in humans. Viruses with double-stranded DNA genomes were the most likely to 
encode an orthologue of a mitochondrial protein (~ 45% of sequenced viruses). Orthologues 
of individual genes are often unique to certain families of viruses (Figure 6.9), which perhaps 
supports the idea of individual cases of gene transfer between different types of viruses and 
host cells.  
The viruses with the largest numbers of predicted mitochondrial orthologues were the 
so-called ‘giant viruses’ – those known to have much larger than average genomes – with, for 
example, 32 orthologues predicted in the unclassified Klosneuvirus KNV1. This would 
perhaps be expected, as the traditional idea is that giant viruses grew due to the acquisition of 
a variety of genes from their hosts (Koonin 2005b). However, more recent work has predicted 
that this type of genetic transfer is not as common as had been expected (Monier et al. 2007). 
It is therefore interesting that so many mitochondrial proteins seem to be shared between giant 
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viruses and cellular organisms. Mitochondria may be key to the replication of some giant 
viruses, with mitochondria surrounding the cytoplasmic virus factories necessary for 
replication (Suzan-Monti et al. 2007; Campos et al. 2014). It may be that these orthologues of 
mitochondrial proteins help recruit or co-opt some function of these mitochondria.  
Genes shared between viruses and cellular organisms are often assumed to be the result of 
horizontal gene transfer – either from virus to host cell or vice versa. This phenomenon has 
been observed in a wide variety of viruses and genes (Liu et al. 2010, 2011; Gilbert et al. 
2016). MTFP1 orthologues in members of the Phycodnaviridae (more specifically, 
Prasinoviruses) are a good example of possible horizontal gene transfer from the host cell (in 
this case, marine green alga) to the virus. Prasinoviruses are not known to specifically utilise 
the mitochondria during their lifecycle (Weynberg et al. 2017). MTFP1, however, has been 
linked to cell survival and apoptosis in eukaryotic cell lines  (Morita et al. 2017) and during 
the treatment of cancer (Aung et al. 2017a, 2017b). It would therefore be interesting to 
explore the expression of the MTFP1 orthologues from the Prasinoviruses, particularly in 
relation to how they may control apoptosis of the host cell during the viral life cycle.  
Exploration of the mitochondrial carrier orthologues encoded by viruses has identified at least 
three different clusters of related sequences. One cluster contains the mitochondrial carrier 
encoded by the Mimivirus, which has previously been shown to transport dATP. Another 
cluster contains sequences from the Hytrosaviridae and Nudiviridae – viruses which infect 
insects. Sequences of carriers from these clusters differ, both in the strength of their 
cytoplasmic/matrix salt networks and in their substrate binding sites. The mitochondrial 
carrier in Musca domestica salivary gland hypertrophy virus (a member of the Hytrosaviridae) 
is one of the top fifteen most-expressed transcripts during viral infection (Kariithi et al. 2017). 
Understanding the function and activity of this carrier in the Hytrosaviridae and Nudiviridae 
may improve understanding of the viral infective processes. 
The variety of mitochondrial proteins with possible orthologues detected across the viral 
proteome suggests that viruses have developed myriad ways to control and co-opt the 
mitochondria and its processes, beyond those which have currently been studied. 
Investigating the expression and importance of these viral genes could contribute to the 
understanding of the importance of mitochondria in viral infections and may illuminate new 
methods of controlling these processes.   
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 Conclusions 
The currently sequenced viral proteome contains predicted orthologues of a wide range of 
mitochondrial proteins. Viruses from a variety of different families and with different types of 
genomes encode predicted mitochondrial protein orthologues. Those genes with predicted 
viral orthologues are often related to nucleotide metabolism, DNA replication, transcription 
and translation – all functions which can be linked to the success of viral replication. Most 
genes are restricted to only one or a few viral families. There is some evidence for potential 
host cell to virus gene transfer for one of these genes (MTFP1); as well as for at least one 
more group of mitochondrial carrier orthologues, beyond those which have been functionally 
characterised, which could be of interest to study.









Conservation of non-enzymatic 








Proteins can be adorned with a variety of modifications. One type of protein modification is 
lysine N-acetylation (addition of an acetyl group). Acetyl groups can be enzymatically 
transferred from acetyl-CoA to the lysine ε-amino group by acetyltransferases and removed 
by deacetylases (Choudhary et al. 2014). 
Sirtuin 3 (SIRT3) is an NAD+-dependent, mitochondrial deacetylase (Lombard et al. 2007), 
but there is no definitive mitochondrial acetyltransferase. The mitochondrial matrix is a 
unique environment, with high levels of acetyl-CoA (Hansford & Johnson 1975) and a high 
pH, due to H+ ion movement out of the matrix which is necessary to generate the proton 
motive force (Llopis et al. 1998; Abad et al. 2004). Non-enzymatic acetylation of proteins has 
been demonstrated in these conditions (Wagner & Payne 2013).  
Recently, work from the Murphy group showed that, at least in vitro, lysine residues can be 
non-enzymatically N-acetylated by acetyl-CoA. This occurs via a reversible process 
involving, first, nucleophilic attack of a cysteine residue on the acetyl-CoA forming an 
S-acetylated cysteine (James et al. 2017). In some cases, this acetyl group is transferred to a 
nearby lysine residue (S  N acetyl-transfer; Figure 7.1), forming an acetylated lysine. 
 
Figure 7.1 Non-enzymatic S  N acetylation of surface lysine residues. Acetyl groups (red) are 
transferred from acetyl-CoA; first to an exposed cysteine residue on the protein surface, then onto a 
lysine residue which is structurally close. 
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Studies have estimated that ~35% of mitochondrial proteins have potential acetylation sites 
(Anderson & Hirschey 2012), but few have characterised changes in function due to 
acetylation (Baeza et al. 2016). Most of the studied changes are in key metabolic enzymes, 
where the acetylation causes inhibition and levels can be controlled by the NAD+-dependent 
SIRT3 deacetylase (Baeza et al. 2016). This organised acetylation, therefore, may link 
metabolism to indicators of energy levels within the cell (acetyl-CoA and NAD+). 
However, when lysine acetylation in the mitochondria is quantified by mass spectrometry, 
most acetylated residues have very low stoichiometry (< 1%) (Weinert et al. 2014, 2015). 
This brings up the question of how functional a sizeable proportion of the detected acetylation 
is.  
One proposal is that some non-enzymatic acetylation acts as a ‘carbon stress’ on the cell, with 
higher concentrations of acetyl-CoA increasing non-specific acetylation (Wagner & Hirschey 
2014). Acetylation may disrupt protein function through altering interactions with other 
proteins, substrates or cofactors, and/or increasing protein aggregation, which over time may 
damage the cell (Kuczyńska-Wiśnik et al. 2016). This could contribute to the link between 
acetylation and a variety of disease states, including heart failure (Lee & Tian 2015) and 
neurodegenerative disorders, such as Huntingdon’s disease, Alzheimer’s disease and 
Parkinson’s disease (Min et al. 2015).  
 
Animal longevity 
Animal lifespan correlates with size – larger animals live, on average, longer than smaller 
animals (Blueweiss et al. 1978). However, there is variation between different groups of 
animals and extraordinary exceptions within groups. For example, bats live longer, on 
average, than rodents and other non-flying eutherians of a similar size (Austad & Fischer 
1991). However, Heterocephalus glaber (the naked mole-rat) is an exception within the order 
Rodentia, and has been known to live up to nine times as long as the average similarly-sized 
mouse (Buffenstein 2008). 
Studies on several sirtuin deacetylases have suggested a link between acetylation and 
longevity within a variety of species. The first study to identify this link was in yeast, where 
cells mutant for the sirtuin SIR2 did not show the normal increase in longevity seen with 
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caloric restriction (Lin et al. 2000). Looking at the sirtuins in mice, brain-specific 
overexpression of Sirt1 increases lifespan (Satoh et al. 2013) and Sirt6 overexpression has 
been shown to increase lifespan of male mice (Kanfi et al. 2012). Caloric restriction also 
alters acetylation in mouse liver mitochondria (Schwer et al. 2009). It is therefore interesting 




In this chapter, I describe the creation of a dataset of cysteine-lysine (Cys-Lys) and serine-
lysine (Ser-Lys) pair conservation across a variety of vertebrate species. I analyse the 
conservation of pairs in different compartments (cytosol and mitochondrial matrix) and the 
driving cause where pairs are not conserved. I then investigate association of Cys-Lys pair 
conservation with lifespan. 
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 Methods 
Identifying close, surface pairs 
Creation of 3D protein models and distance/surface calculations were carried out by Dr 
Anthony Smith of the Bioinformatics group, Medical Research Council Mitochondrial 
Biology Unit, University of Cambridge, CB2 0XY, UK. UniProt sequences of acetylated 
mouse proteins from Weinert et al. (2015) were aligned with a non-redundant PDB sequence 
database clustered at 95%, using MODELLER (Webb & Sali 2017). For proteins with a best 
match with over 50% sequence identity, the sequence was aligned with the structural template 
and five structures were predicted by using MODELLER. The structure with the lowest 
DOPE (discrete optimised protein energy) score was used for further calculations. Distance 
between atoms in the structure were calculated using trigonometric calculations and the 
solvent accessible area calculated using the program areaimol (Winn et al. 2011). 
 
Identifying orthologues of acetylated mouse proteins 
For mouse proteins with a calculated structural model, one-to-one human orthologues were 
identified where possible from Ensembl Compara (Herrero et al. 2016). Proteins without one-
to-one human orthologues were removed from the analysis, to remove complication from 
paralogues. Orthologues of the human sequence in 70 vertebrate species (Appendix IV – Table 
1) for each remaining protein were identified using the reciprocal best hit method (Figure 
7.2). For each sequence, a BLASTp search (Altschul et al. 1990, 1997) was run against a 
local BLASTp database including non-identical protein sequences from the 70 different 
vertebrate species (E-value cut-off 1  10-10).  A second (reciprocal) BLASTp search was run 
against a BLASTp database of human proteins (E-value cut-off 1  10-10), using the top hit 
from the original search for each species as the query sequence. The sequence was identified 
as an orthologue if the reciprocal BLASTp search returned a protein equivalent to the original 
human protein as the top hit.  
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Figure 7.2 Summary of the reciprocal best hit method for identifying orthologues of proteins which 
contain detected acetylated residues in a mouse dataset from Weinert et al. (2015).  
Proteins with fewer than sixty identified orthologues were removed from further analysis 
(Figure 7.3(a)). Five species with outlying numbers of orthologues were also removed from 
further analysis (Figure 7.3(b)). 
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Figure 7.3 Quality control of the analysed proteins and species. (a) Density plot of the number of 
predicted orthologues for each targeted human protein. Dashed line is the cut-off for taking proteins 
forward for further analysis. (b) Boxplot of the number of detected orthologues for each included 
species. Labelled outliers (over 1.5 × IQR + Q3) were removed from further analysis. 
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Estimating relative conservation of residues and pairs 
Sequences of predicted orthologues of each protein and the original mouse protein sequence 
were aligned using MUSCLE with default settings (Edgar 2004a, 2004b). Proximal, surface 
Cys-Lys and Ser-Lys pairs were identified in the predicted mouse structure, as those with ≤ 
11.5 Å between the residues and both residues with ≥ 5 Å2 solvent exposure. Corresponding 
residues were identified for each species with an identified orthologue from the alignments 
with the mouse protein (Figure 7.4).  
Pairs were assigned as either: 
• Conserved – both residues match to the mouse pair, 
• Not conserved – either one or both residues do not match to the mouse pair, 
• Not present – either one or both positions has no assigned residue. This could be from 
inaccuracies in a predicted protein; a match to a different isoform or protein; or a real 
lack of residues at these positions.
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Defining cytosolic and mitochondrial matrix proteins 
Definitions of cytosolic and mitochondrial proteins were decided in collaboration with Dr 
Anthony Smith of the Bioinformatics group and Dr Andrew James of the Mitochondrial 
Dysfunction group, Medical Research Council Mitochondrial Biology Unit, University of 
Cambridge, CB2 0XY, UK. Proteins were designated as cytosolic if they were annotated in 
human or mouse Gene Ontology as cytosolic, or they were assigned as cytosolic with an 
evidence level of validated/supported in the Human Protein Atlas (Thul et al. 2017). Proteins 
were designated as mitochondrial matrix if they were annotated in human or mouse Gene 
Ontology as mitochondrial matrix, or identified as mitochondrial in an ascorbate peroxidase 
(APEX)-tagging study (Rhee et al. 2013), or assigned to the matrix in MitoCore – a model of 
mitochondrial metabolism (Smith et al. 2017). Proteins designated as both cytosolic and 
mitochondrial matrix were removed, to remove inaccuracies from differing levels of exposure 
to the two different chemical environments. 
 
Estimating lifespan of sequenced vertebrates 
Analysis of lifespan was limited to vertebrates, with particular effort to include a wide range 
of rodents, bats and birds. Included species had to have: 
• a full sequenced genome in the NCBI nr database with protein annotation, 
• a maximum lifespan listed in the AnAge Database (De Magalhães & Costa 2009; 
Tacutu et al. 2013), 
• and an estimated adult bodyweight in grams, either from the AnAge Database or 
another recorded source.  
Avian species included were either Sanger sequenced or noted as high-coverage genomes in 
G. Zhang et al. 2014.  
To account for the relationship between body weight and lifespan, the maximum longevity 
(tmax) residual was calculated as described in the AnAge Database (Tacutu et al. 2013): 
𝑡𝑚𝑎𝑥 𝑟𝑒𝑠𝑖𝑑𝑢𝑎𝑙 =  
𝑚𝑎𝑥𝑖𝑚𝑢𝑚 𝑜𝑏𝑠𝑒𝑟𝑣𝑒𝑑 𝑙𝑖𝑓𝑒𝑠𝑝𝑎𝑛 (𝑦𝑒𝑎𝑟𝑠)
4.88 ×  𝑎𝑣𝑒𝑟𝑎𝑔𝑒 𝑎𝑑𝑢𝑙𝑡 𝑤𝑒𝑖𝑔ℎ𝑡 (𝑔) 0.153
 ×  100 
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Statistics 
Statistical analyses were carried out in R. Statistical differences between residue groups was 
estimated using paired ANOVA and paired t-tests with Bonferroni correction. Differences in 
lifespan of mammal groups were tested using one-way ANOVA and post-hoc Tukey honest 
significant difference tests. Correlation was estimated as the Pearson product correlation 
coefficient (r) with an associated p-value.   
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 Results 
Creating a dataset of cysteine-lysine pair conservation 
The degree to which acetylation is an enzymatically controlled regulatory process or a 
potentially damaging non-enzymatic reaction is still under discussion (Wagner & Hirschey 
2014), particularly with the discovery that close cysteine-lysine pairs increase non-enzymatic 
S  N lysine acetylation (James et al. 2017). One way to investigate functionality of residues 
is to look at the conservation across species – residues with important functional roles are 
more likely to be conserved across species.  
Previous work has studied acetylation motifs in primary sequences (Rardin et al. 2013; 
Svinkina et al. 2015), but this analysis lacks information about the residues which are close in 
real protein structures due to tertiary structure. To address this, 3D structures were created of 
619 mouse proteins with quantified acetylation (Weinert et al. 2015) and a strong homologous 
known structure (over 50% sequence identity). Calculations measuring the distance between 
the amino nitrogen of lysine residues and the thiol sulphur of cysteine residues allowed 
identification of close cysteine-lysine (Cys-Lys) pairs; and only solvent accessible (> 5Å2) 
pairs were taken forward, as non-enzymatic S  N acetylation requires exposure of the 
residues to the environment. This produced a dataset of 52,321 distances between surface 
cysteines and lysines.  
To investigate conservation, I used the reciprocal best hit method to identify orthologues of 
modelled proteins, across 72 vertebrate species. After quality control of species and proteins, I 
retained 29,173 orthologues of 442 proteins across 67 species (including mouse) for further 
analysis. Within these proteins, there are 890 surface Cys-Lys pairs and 6,353 surface Ser-Lys 
pairs located ≤ 11.5Å apart in the predicted mouse protein structures. By aligning the 
identified orthologues, I identified the presence or absence of these pairs in the other studied 
species, creating a large dataset of pair conservation in comparison to mouse. 
If the bulk of non-enzymatic S  N acetylation is harmful, it may be expected that Cys-Lys 
pairs which are close enough to support non-enzymatic acetylation would be less conserved 
across species than non-acetylated Cys-Lys pairs. This was demonstrated in this dataset 
(Figure 7.5(a)) – across the tested species, Cys-Lys pairs which had observed N-acetylated 
lysines in mouse are less conserved than those located in the same proteins without observed 
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N-acetylation in mouse, (mean fraction conserved  standard deviation (s.d.); 0.63  0.11 
compared to 0.76  0.09). Additionally, Cys-Lys pairs in the mitochondrial matrix (where 
conditions favour non-enzymatic acetylation) are significantly less conserved, on average, 
than Cys-Lys pairs in the cytosol (Figure 7.5(b); mean fraction conserved  s.d.; 0.72  0.09 
compared to 0.76  0.09). This is evidence that non-enzymatic S  N acetylation may have 
some harmful effects, which are selected against. 
 
Figure 7.5 Fraction of conserved Cys-Lys pairs across the studied vertebrate species. (a) Separated by 
acetylation status of the lysine in mouse. (b) Separated by localisation of the protein. p-values from 
paired t-tests (paired by species). 
 
Close acetylated Cys-Lys pairs are less conserved in the cytosol 
The mitochondrial matrix contains high levels of acetyl-CoA and is more alkaline than the 
cytosol – a particularly good environment for non-enzymatic acetylation (Wagner & Payne 
2013). One prediction from this is that there would be differences in the conservation of Cys-
Lys pairs which are acetylated in mouse between the matrix and the cytosol, with the 
chemical environment providing different selective pressures. 
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Conservation would be expected to differ in species depending on evolutionary distance from 
mouse, as it is based on changes from observations in mouse. To correct for that bias, ratios of 
conservation of acetylated residue pairs to non-acetylated residue pairs were calculated for 
each species (where acetylation is based on the observed status in mouse). This gives a 
measure of relative conservation, independent of distance from mouse. Completely equal 
conservation would produce a ratio of 1, with higher ratios suggesting pairs acetylated in 
mouse were more conserved, and lower ratios that pairs acetylated in mouse were less 
conserved. Close, surface serine-lysine (Ser-Lys) pairs were used as a control, as serine is 
very close structurally to cysteine, but without the active sulphur necessary for non-enzymatic 
acetylation. 
Conservation of both Cys-Lys and Ser-Lys pairs in the mitochondrial matrix are centred 
around one (equal conservation of putative acetylated and putative non-acetylated pairs) 
(Figure 7.6(a)). There is also no significant difference between the ratios for Cys-Lys pairs 
and Ser-Lys pairs in this cellular compartment. However, there is a significant difference 
between the ratios for Cys-Lys pairs and Ser-Lys pairs in the cytosol (Figure 7.6(a); p < 2.2  
10-16, paired t-test). Though the conservation ratios for both pair groups are centred lower than 
one, the Cys-Lys pair ratio is significantly lower than the Ser-Lys pair ratio – meaning 
putative acetylated pairs are less conserved than putative non-acetylated pairs. Putative 
acetylated Cys-Lys pairs in the cytosol are also less conserved than putative acetylated Ser-
Lys pairs (p = 2.8  10-16, paired t-test), despite cysteines being the most highly conserved 
amino acid (Marino & Gladyshev 2010). 
This analysis was repeated with only mammalian species, which are warm-blooded and 
maintain constant body temperature, as non-enzymatic S  N acetylation is temperature 
dependent (James et al. 2017). Results were consistent within mammals (Figure 7.6(b)) – 
putative acetylated Cys-Lys pairs in the cytosol were less conserved than putative acetylated 
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Figure 7.6 Proximal cytosolic Cys-Lys pairs that are known to be acetylated in mouse are less 
conserved. (a) All analysed species. (b) Only mammalian species. p-values reported from paired t-tests 
with Bonferroni multiple testing correction. 
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The lack of conservation of residue pairs could be driven by lack of conservation of either 
residue singly or both together. To analyse this, I looked at the conservation of single residues 
from cytosolic pairs known to be acetylated in mouse, compared to cytosolic residues not in 
acetylated pairs in mouse (Figure 7.7). The mean conservation ratios for lysine in Cys-Lys 
pairs (0.965), serine in Ser-Lys pairs (0.955) and lysine in Ser-Lys pairs (0.953) are all close 
to 1 and the means are not significantly different. However, the mean conservation ratio for 
cysteine in Cys-Lys pairs is lower at 0.836 and is significantly different from the other residue 
groups tested. The range of conservation is also higher for cysteines in Cys-Lys pairs – i.e. 
there is a greater spread in conservation ratios, which drives the spread in conservation of 
cytosolic Cys-Lys pairs. 
 
Figure 7.7 Changes in cysteine conservation drive changes in Cys-Lys pair conservation in the cytosol. 
p-values reported from paired t-tests with Bonferroni correction. 
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Conservation of cytosolic Cys-Lys pairs correlates with a measure of mammalian 
lifespan 
Studies observing the effect of sirtuin deacetylases on lifespan in a variety of species, from 
yeast (Lin et al. 2000) to mice (Kanfi et al. 2012), provide a possible link between lifespan 
and acetylation. One way to investigate a possible effect of S  N acetylation is to look at the 
conservation of Cys-Lys pairs which are acetylated in mouse across species – if S  N 
acetylation has a detrimental effect on lifespan, putative acetylated Cys-Lys pairs may be less 
conserved in longer-lived species. 
As the number of species included was relatively small compared to previous studies of 
lifespan, I first checked to see if the strong correlation previously found between higher adult 
weight and higher adult lifespan held (Figure 7.8). While individually only the birds and 
‘other mammals’ groupings have significant correlation, the combined correlation for all 
included species is significant, (p = 1.69  10-9), with increasing size correlated with 
increasing lifespan (r = 0.638). This confirms that the known longevity trend is maintained 
even in this relatively small sample of species. 
The bats included in this analysis show the opposite pattern to that expected (although the 
correlation is not statistically significant) – smaller bats are actually the longest lived. This 
appears to be mainly driven by the two smallest bats included (Myotis lucifigus and Myotis 
brandtii), which are two of the longest lived bat species known (Wilkinson & South 2002; 
Podlutsky et al. 2005). 
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Figure 7.8 Lifespan correlates with adult body weight in vertebrates. Pearson correlation coefficient 
(r) and p-value reported for each grouping of species.  
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Another important previous observation was that bats tend to live longer than non-flying 
mammals of a similar weight (Austad & Fischer 1991). With only a small sample of bats to 
work from, it was important to check that this finding held in this sample analysis. To do this, 
I used a longevity measure (maximum longevity (tmax) residual) which compares the 
maximum observed lifespan to a predicted lifespan based on weight (Tacutu et al. 2013). A 
tmax residual higher than 100% reflects a species with a higher observed lifespan than 
predicted based on adult size; whilst if a species has a tmax residual below 100% it has a lower 
observed lifespan than predicted based on adult size. Only mammals were included as this 
measure is based on the mammalian allometric equation. The mammals were split into four 
groupings: primates, rodents, bats and other mammals. 
ANOVA analysis identified a significant difference between the groups (p < 2.2  10-16). Bats 
are significantly longer-lived than rodents (p = 0.001) and other mammals (p = 0.003), despite 
the small sample size of only six bats (Figure 7.9). Two labelled outliers are humans (Homo 
sapiens) in the primates and the naked mole-rat (Heterocephalus glaber) in the rodents. The 
naked mole-rat is known for being an exceptionally long-lived rodent (Sherman & Jarvis 
2002), whilst humans are the best observed species with many methods of extending lifespan 
(through medicine etc.).
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Figure 7.9 Bats live significantly longer for their weight than rodents and the group ‘other mammals’. 
Maximum longevity residual is a measure of percent of predicted lifespan for maximum observed 
lifespan, corrected for adult body weight. p-values from Tukey honest significant difference post-hoc 
analysis. 
I then plotted mammalian lifespan, as measured by the tmax residual, against conservation of 
cytosolic Cys-Lys pairs which are acetylated in mouse for these species. tmax residual is 
significantly and highly correlated with the conservation of cytosolic putative acetylated Cys-
Lys pairs (r = -0.750, p = 1.36  10-7), but not cytosolic putative acetylated Ser-Lys pairs (r = 
-0.285, p = 0.092) (Figure 7.10(a)). Maximum lifespan, not corrected for bodyweight, is also 
correlated with conservation of cytosolic putative acetylated Cys-Lys pairs, but slightly less 
strongly (r = -0.531, p = 0.0008). The same pattern is not seen for mitochondrial matrix 
putative acetylated Cys-Lys pairs (r = -0.129, p = 0.356), though there is a weak but 
significant correlation with mitochondrial matrix acetylated Ser-Lys pairs (r = 0.380, p = 
0.022) (Figure 7.10(b)).  
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Figure 7.10 Correlation of the conservation of putative acetylated Cys-Lys (KC) and Ser-Lys (KS) pairs 
with a measure of mammalian lifespan – the maximum longevity residual. (a) Cytosolic proteins. For 
KC pairs: r = -0.750, p = 1.36  10-7. For KS pairs: r = -0.285, p = 0.092.  
(b) Proteins localised to the mitochondrial matrix. For KC pairs: r = -0.129, p = 0.356. For KS pairs: 
r = -0.380, p = 0.022.  
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 Discussion 
Previous work had shown that non-enzymatic S  N lysine acetylation with transfer of an 
acetyl group from acetyl-CoA via a cysteine residue occurs, at least in vitro (James et al. 
2017). This had not been demonstrated in vivo and the role of the majority of acetylation is 
still under discussion. As conservation can be used to investigate function, I identified 
vertebrate orthologues of modelled mouse proteins known to have acetylated lysine residues 
(Weinert et al. 2015) and used these to estimate conservation of 890 surface Cys-Lys pairs 
less than 11.5Å apart.  
In this dataset, Cys-Lys pairs which are acetylated in mouse are significantly less conserved 
than non-acetylated Cys-Lys pairs (Figure 7.5), suggesting non-enzymatic S  N acetylation 
may be damaging and, thus, selected against. This is despite acetylated lysines being more 
conserved than non-acetylated lysines overall (Henriksen et al. 2012), with acetylation being 
well conserved across species (Weinert et al. 2011; Rardin et al. 2013). Additional analyses 
supporting the possible in vivo damaging effect of non-enzymatic S  N acetylation using the 
modelled protein dataset were carried out by Dr Andrew James of the Mitochondrial 
Dysfunction group, Medical Research Council Mitochondrial Biology Unit, University of 
Cambridge, CB2 0XY, UK. He found that close surface Cys-Lys pairs are significantly less 
frequent in the acetylating environment of the mitochondrial matrix than the cytosol; that 
cysteine residues are significantly less exposed to the protein surface in the matrix than in the 
cytosol; and that Cys-Lys pairs are significantly further apart than corresponding Ser-Lys 
pairs in both the mitochondrial matrix (0.47Å difference) and the cytosol (0.29Å difference). 
Damaging effects of having close surface Cys-Lys pairs due to non-enzymatic S  N 
acetylation may contribute to the lower conservation observed for cysteines on the surface of 
proteins compared to internal cysteines (Marino & Gladyshev 2010). 
Though the frequency of surface Cys-Lys pairs in the mitochondrial matrix is lower than in 
the cytosol, Cys-Lys pairs which are acetylated in mouse are not significantly less conserved 
than Ser-Lys pairs which are acetylated in mouse, in this compartment (Figure 7.6). However, 
there is a significant difference in conservation between putative acetylated Cys-Lys pairs and 
putative acetylated Ser-Lys pairs in the less favourable acetylating environment of the cytosol 
(Figure 7.6), driven by decreased conservation of cysteine residues close to putative 
acetylated lysines (Figure 7.7). One possibility is that there has already been strong selection 
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against the close Cys-Lys pairs in the mitochondria, earlier in the eukaryotic phylogenetic tree 
than the branching of the studied vertebrates, which has maximised non-functional pair loss in 
this environment. This could be investigated by looking at conservation of Cys-Lys pairs in 
mitochondrial matrix proteins beyond vertebrates, though increasingly differing lifestyles and 
environmental conditions may also influence changes in amino acid frequency or acetylation 
profiles. The less favourable environment in the cytoplasm (lower pH and lower 
concentration of acetyl-CoA) may have decreased selective pressure for the loss of Cys-Lys 
pairs. 
Conservation of cytosolic putative acetylated Cys-Lys pairs, but not Ser-Lys pairs or matrix 
Cys-Lys pairs, correlates strongly with maximum lifespan and tmax residual, which corrects 
for differences in body weight (Figure 7.10). This contributes to the idea that non-enzymatic 
S  N acetylation may be damaging, as species that live longer have less of these putative 
acetylated pairs. It was unexpected that this link was identified in cytosolic proteins rather 
than matrix proteins, because of the respective chemical environments of the two 
compartments. However, though the matrix is the highly acetylating environment, a non-
mitochondrial sirtuin deacetylase was actually first associated with changes in lifespan (Lin et 
al. 2000) and other non-mitochondrial sirtuin deacetylases have since also been associated 
with changes in lifespan (Kanfi et al. 2012; Satoh et al. 2013).  
Though the link between non-enzymatic S  N acetylation and possible cell damage is 
consistent with the very low stoichiometry of most quantified acetylation (Weinert et al. 
2015), only a minority (5.7%) of N-acetylated lysine residues in this study have a surface 
cysteine residue within 11.5Å, so other mechanisms of acetylation are clearly important. This 
could be enzymatic acetylation or other forms of non-enzymatic acetylation. This analysis 
was based on N-acetylation identified in mouse liver tissue, but conditions in different tissues 
(including concentrations of deacetylases or other molecules that interfere with S  N acetyl 
transfer, such as glutathione) may change the magnitude of contribution from non-enzymatic 
S  N acetylation (James et al. 2017). 
The cellular changes caused by uncontrolled, non-enzymatic S  N acetylation and, 
therefore, the possible effects on fitness which allow selection against close Cys-Lys pairs are 
unclear. N-acetylation of lysine residues removes the positive charge and sterically blocks the 
lysine residue from further reactivity (Choudhary et al. 2014). It may affect protein 
interaction with other proteins, cofactors or substrates, and/or increase protein aggregation 
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(Kuczyńska-Wiśnik et al. 2016). Differences between how these problems are dealt with in 
the mitochondria and the cytoplasm may also contribute to the magnitude of the problem 
caused by S  N acetylation in these compartments. 
Possible damaging effects of non-enzymatic S  N acetylation may also help explain the link 
between changes in acetylation and some disease states. For example, SIRT1 deacetylase 
overexpression has been shown to provide some protection against neuronal death in a mouse 
model of Alzheimer’s disease (Kim et al. 2007) and increased acetylation caused by 
decreased Sirt3 activity (due to a reduced NAD+/NADH ratio from dysfunction of complex I) 
has been linked to heart failure (Lee & Tian 2015).   
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 Conclusions 
By studying the conservation of structurally close Cys-Lys pairs on the surface of proteins, I 
provide evidence that non-enzymatic S  N acetylation is likely to be damaging to cells. 
Though the mitochondrial matrix is the more acetylating environment, only cytosolic putative 
acetylated Cys-Lys pairs show changes in conservation in comparison to non-acetylated pairs. 
This decrease in conservation is driven by changes in cysteine residues. Conservation of 
cytosolic putative acetylated Cys-Lys pairs is correlated with mammalian lifespan corrected 
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Thesis summary 
The general aim of this thesis was to use the new definition of the human mitochondrial 
proteome, provided by IMPI 2017, as a basis to explore the phylogenetic history of the human 
mitochondrial proteome, through the identification of orthologues. This orthology dataset was 
then used in the discovery of new knowledge about mitochondrial disease and the function of 
the mitochondrial proteome. 
The first step was to create the mitochondrial proteome orthology dataset, by identifying 
orthologues of IMPI 2017 genes across a range of species (both eukaryotic and prokaryotic), 
as described in Chapter 2. Reciprocal best hit analysis, followed by a manual curation 
process, was used to produce a large dataset of 190,097 predicted orthologous sequences of 
1,550 genes across 359 species. Nearly three quarters of the genes had predicted orthologues 
only in eukaryotic species and nearly half only had predicted orthologues in metazoan 
species. This reflects a huge increase in mitochondrial complexity since the mitochondrion’s 
roots in the α-proteobacteria, just as other parts of the eukaryotic cell have gained in 
complexity. 
The orthology dataset provided a solid starting point for investigations into the function of the 
uncharacterised parts of the mitochondrial proteome. Phylogenetic profiling relies on the 
identification of a pattern of presence and absence of genes across a range of species to 
predict the potential functions of an uncharacterised gene, under the assumption that genes 
involved in similar structures or pathways will have similar profiles. I carried out 
phylogenetic profiling analyses of the respiratory complexes, electron transfer flavoprotein 
and ATP synthase, by using the orthology dataset to create phylogenetic profiles of all the 
IMPI 2017 genes (Chapter 3). There were no new predictions for genes associated with 
complexes I-IV or ATP synthase, though C8orf82 is a good candidate for a gene associated 
with the function of the electron transfer flavoprotein.  
By considering the results of phylogenetic profiling analyses, I derived a set of guidelines to 
increase the probability of success for future phylogenetic analysis in eukaryotes. To increase 
the chance of success, complexes and pathways studied by phylogenetic profiling should 
show good variation in their presence and absence across the studied species. When looking 
for the function of human proteins, it is useful to have variation in species which share a 
common ancestor with humans as recently as possible. This allows the inclusion in the 
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analysis of a higher number of recent gene innovations, as well as gene loss events in parasitic 
species. Having a set of closely related species within a single taxon, with variation in the 
phylogenetic profile of the studied complex/pathway, is also useful, as exemplified by the 
differences in complex I presence in closely related yeasts. 
Using these guidelines, I designed a further phylogenetic profiling analysis to identify 
potential transport substrates for uncharacterised members of the mitochondrial carrier family, 
as described in Chapter 4. Variation in the presence and absence of several mitochondrial 
carriers was observed in two metazoan phyla (the nematodes and the platyhelminthes). A 
dataset of predicted orthologues of genes encoding the mitochondrial proteome in a range of 
sequenced species from each taxon was, therefore, created to facilitate profiling analysis. This 
was first used to study the characterised mitochondrial carriers, as a proof that this approach 
could produce sensible results. Phylogenetic profiling produced a good prediction for the 
transport substrate of one carrier (SLC25A21) in the platyhelminthes and provided less 
obvious links to the transport substrates of a few other carriers. However, these predictions 
were not consistent when comparing the results from the two phyla, so in further analysis the 
results from the two phyla were considered separately. 
The knowledge gained from investigation of the characterised carriers was used to structure 
the study of four groups of uncharacterised carriers which had different patterns of presence 
and absence within the two studied phyla. Potential transport substrates were predicted for 
two of the four groups, based on the phylogenetic profile and literature evidence. These were 
ketone bodies for the SLC25A14/30 carriers and cyclic pyanopterin monophosphate (a 
precursor for molybdenum cofactor) for the SLC25A44 carrier. This evidence provides a good 
case for wet laboratory work to test the function of these two carrier groups and testing for the 
transport of ketone bodies by SLC25A14/30 has been started. This work shows the potential 
of phylogenetic profiling to identify eukaryotic gene functions when the target genes and 
species studied are chosen with care. 
A second use of the original orthology dataset described in Chapter 2 was to investigate 
phylogenetic features of mitochondrial genes associated with monogenetic disease 
(Chapter 5). Disease genes had older predicted orthologues, as well as a wider spread of 
orthologues in different taxa, than genes that are not currently associated with disease. 
However, the opposite was true of genes associated with dominantly inherited diseases which 
were younger, with less phylogenetic spread, than genes associated with recessive disease. 
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These features have been included in a machine learning approach to predict mitochondrial 
disease genes, which will be used as part of a pipeline to prioritise candidate disease genes in 
the sequenced exome/genome of patients with mitochondrial disease. 
After exploring the orthology of genes encoding the mitochondrial proteome in cellular 
organisms, I was inspired to investigate the same in the other possible domain of life – the 
viruses (Chapter 6). A wide range of viruses had predicted orthologues of at least one gene 
associated with the mitochondrial proteome, and these genes were often associated with 
processes that could be linked to viral replication (e.g. DNA replication, translation). Despite 
this wide range, most genes were only identified in a single or few viral families.  
The final analysis dealt with in this thesis investigated the conservation of sites of potential 
non-enzymatic S  N acetylation, across vertebrate species (Chapter 7), to explore the 
hypothesis that these pairs are potentially damaging. Acetylated and close cysteine-lysine 
pairs on the surface of proteins were less conserved than non-acetylated pairs, but only in 
cytosolic proteins (not proteins in the mitochondrial matrix). The level of conservation of 
these pairs correlates with mammalian lifespan – species with less conservation of these pairs 
have longer lifespan adjusted for bodyweight. This supports the hypothesis that non-
enzymatic S  N acetylation may be potentially damaging, at least in the cytosol; enough so 
that these pairs are less conserved in longer lived species. 
 
Further work 
The creation of an extensive orthology dataset of human mitochondrial proteins provides a 
starting point for many potential additional analyses. The difficulty in assigning some 
orthologues from related groups of genes and the lack of literature for many of these groups 
suggests that there is still much work to be done in the clarification of the history of 
paralogous gene groups. Additionally, most of the work described in this thesis has been on a 
gene level – looking at the predicted presence and absence of genes. However, the orthology 
dataset consists of the actual sequences identified as predicted orthologues, facilitating 
sequence level comparisons across species.  
One example of a potential sequence level analysis could be the examination of the 
performance of different mitochondrial targeting sequence (MTS) prediction programs across 
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different taxa. There are a variety of available MTS prediction programs which use different 
methodologies to attempt to predict N-terminal MTSs from a protein sequence (Sun & 
Habermann 2017). The sequences from the orthology dataset could be used to compare the 
performance of these programs in different taxa, as it may be the case that certain approaches 
work better in some species. Preliminary work in generating IMPI 2017 has shown the 
recognition of human mitochondrially-targeted proteins by machine learning is improved by 
considering whether predicted MTSs are conserved among orthologues from mouse, rat and 
zebrafish. 
Considering future phylogenetic profiling efforts, several additional taxa may be of particular 
interest, particularly as genomes become available for more obscure metazoan species. For 
example, in this analysis, the parasitic cnidarian Thelohanellus kitauei showed great variance 
in predicted mitochondrial metabolism compared to other cnidaria, as would be predicted by 
the huge metabolic losses previously described (Yang et al. 2014). Sequencing and analysis 
of other myxozoans will therefore be of interest. There has also been a controversial 
identification of metazoan species (members of the Loricifera) living in an anoxic 
environment (Danovaro et al. 2010), though this has been challenged (Mentel et al. 2016). 
Loriciferans may be a useful taxon for phylogenetic profiling once genomes from these 
species start to be sequenced.  
My investigations of metabolism have also identified pathways which may be particularly 
amenable to phylogenetic profiling analysis, due to the identified variation in their presence 
and absence across species. One example is the metabolism of the cofactors derived from 
vitamin B12: methylcobalamin (synthesised in the cytoplasm in mammals) and 
adenosylcobalamin (synthesis in the mitochondria in mammals) (Zhang et al. 2009). 
Differences in the synthesis and utilisation of adenosylcobalamin were identified in the 
nematodes, platyhelminthes and members of the Pancrustacea studied. Phylogenetic study of 
potential transporters in these taxa could be of interest, as the import mechanism of vitamin 
B12 derivatives into the mitochondria is unresolved (Froese & Gravel 2010).  
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Final words 
In summary, in this thesis I have used studies of the orthology and phylogeny of genes of the 
human mitochondrial proteome to explore several aspects of mitochondrial function, disease 
and ageing. Part of this thesis has informed the start of targeted functional testing for some 
uncharacterised mitochondrial carriers. Information on the phylogenetic spread and history of 
genes is being included in a machine learning approach to identify candidate genes from 
sequence data of mitochondria disease patients. The mitochondrial proteome orthology 
dataset produced by this work provides opportunities for many further analyses of 
mitochondrial function and history. 
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 Appendix I: Orthology dataset summary 
 
Table 1. Species included in the orthology dataset with number of predicted IMPI 2017 orthologues. 
Species Group No. orthologues 
Homo sapiens Holozoa 1,550 
Pan troglodytes Holozoa 1,531 
Gorilla gorilla Holozoa 1,486 
Pongo abelii Holozoa 1,488 
Nomascus leucogenys Holozoa 1,489 
Macaca fascicularis Holozoa 1,534 
Callithrix jacchus Holozoa 1,514 
Saimiri boliviensis Holozoa 1,501 
Carlito syrichta Holozoa 1,459 
Otolemur garnettii Holozoa 1,461 
Mus musculus Holozoa 1,504 
Rattus norvegicus Holozoa 1,504 
Cricetulus griseus Holozoa 1,498 
Cavia porcellus Holozoa 1,485 
Heterocephalus glaber Holozoa 1,508 
Oryctolagus cuniculus Holozoa 1,429 
Bos taurus Holozoa 1,510 
Equus caballus Holozoa 1,472 
Canis familiaris Holozoa 1,444 
Odobenus rosmarus Holozoa 1,497 
Orcinus orca Holozoa 1,489 
Myotis lucifugus Holozoa 1,402 
Loxodonta africana Holozoa 1,400 
Dasypus novemcinctus Holozoa 1,457 
Sarcophilus harrisii Holozoa 1,347 
Monodelphis domestica Holozoa 1,429 
Ornithorhynchus anatinus Holozoa 1,233 
Melopsittacus undulatus Holozoa 1,190 
Gallus gallus Holozoa 1,286 
Alligator mississippiensis Holozoa 1,371 
Python bivittatus Holozoa 1,361 
Anolis carolinensis Holozoa 1,355 
Chrysemys picta Holozoa 1,439 
Chelonia mydas Holozoa 1,377 
Nanorana parkeri Holozoa 1,330 
Xenopus tropicalis Holozoa 1,365 
Latimeria chalumnae Holozoa 1,352 
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Oryzias latipes Holozoa 1,317 
Oreochromis niloticus Holozoa 1,350 
Esox lucius Holozoa 1,366 
Danio rerio Holozoa 1,357 
Scleropages formosus Holozoa 1,362 
Lepisosteus oculatus Holozoa 1,287 
Callorhinchus milii Holozoa 1,343 
Oikopleura dioica Holozoa 718 
Ciona intestinalis Holozoa 909 
Branchiostoma floridae Holozoa 1,024 
Strongylocentrotus purpuratus Holozoa 1,088 
Saccoglossus kowalevskii Holozoa 1,056 
Acyrthosiphon pisum Holozoa 916 
Pediculus humanus corporis Holozoa 922 
Danaus plexippus Holozoa 903 
Bombyx mori Holozoa 927 
Aedes aegypti Holozoa 946 
Anopheles gambiae Holozoa 945 
Drosophila melanogaster Holozoa 946 
Camponotus floridanus Holozoa 906 
Apis mellifera Holozoa 930 
Tribolium castaneum Holozoa 983 
Orchesella cincta Holozoa 864 
Daphnia pulex Holozoa 964 
Hyalella azteca Holozoa 953 
Limulus polyphemus Holozoa 1,014 
Ixodes scapularis Holozoa 895 
Priapulus caudatus Holozoa 990 
Caenorhabditis elegans Holozoa 846 
Caenorhabditis briggsae Holozoa 830 
Strongyloides ratti Holozoa 725 
Ascaris suum Holozoa 675 
Brugia malayi Holozoa 749 
Loa loa Holozoa 732 
Trichinella spiralis Holozoa 614 
Trichuris suis Holozoa 640 
Schmidtea mediterranea Holozoa 733 
Clonorchis sinensis Holozoa 724 
Opisthorchis viverrini Holozoa 720 
Schistosoma mansoni Holozoa 709 
Schistosoma haematobium Holozoa 663 
Hymenolepis microstoma Holozoa 659 
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Echinococcus granulosus Holozoa 715 
Echinococcus multilocularis Holozoa 704 
Aplysia californica Holozoa 1,042 
Lottia gigantea Holozoa 1,010 
Crassostrea gigas Holozoa 858 
Helobdella robusta Holozoa 918 
Capitella teleta Holozoa 1,046 
Mnemiopsis leidyi Holozoa 675 
Nematostella vectensis Holozoa 961 
Acropora digitifera Holozoa 908 
Hydra vulgaris Holozoa 825 
Thelohanellus kitauei Holozoa 228 
Amphimedon queenslandica Holozoa 855 
Trichoplax adhaerens Holozoa 885 
Monosiga brevicollis MX1 Holozoa 604 
Salpingoeca rosetta Holozoa 713 
Sphaeroforma arctica Holozoa 639 
Capsaspora owczarzaki ATCC 30864 Holozoa 760 
Leptosphaeria maculans JN3 Holomycota 574 
Aspergillus nidulans FGSC A4 Holomycota 584 
Neurospora crassa OR74A Holomycota 596 
Botrytis cinerea T4 Holomycota 572 
Xylona heveae TC161 Holomycota 584 
Tuber melanosporum Mel28 Holomycota 555 
Dactylellina haptotyla CBS 200.50 Holomycota 566 
Debaryomyces hansenii CBS767 Holomycota 535 
Scheffersomyces stipitis CBS 6054 Holomycota 509 
Saccharomyces cerevisiae S288c Holomycota 478 
Candida glabrata CBS 138 Holomycota 479 
Candida albicans SC5314 Holomycota 493 
Yarrowia lipolytica CLIB122 Holomycota 559 
Schizosaccharomyces pombe 972h- Holomycota 500 
Pneumocystis jirovecii RU7 Holomycota 432 
Coprinopsis cinerea Holomycota 589 
Serpula lacrymans var. lacrymans S7.9 Holomycota 548 
Calocera cornea HHB12733 Holomycota 568 
Trichosporon asahii var. asahii CBS 2479 Holomycota 502 
Cryptococcus gattii WM276 Holomycota 542 
Wallemia mellicola CBS 633.66 Holomycota 529 
Tilletiaria anomala UBC 951 Holomycota 536 
Ustilago maydis 521 Holomycota 550 
Melampsora larici-populina 98AG31 Holomycota 541 
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Puccinia graminis f. sp. tritici CRL 75-36-700-3 Holomycota 519 
Rhodotorula graminis WP1 Holomycota 560 
Mixia osmundae IAM 14324 Holomycota 554 
Rhizophagus irregularis DAOM 181602 Holomycota 647 
Mucor circinelloides f. circinelloides 1006PhL Holomycota 675 
Rhizopus delemar RA 99-880 Holomycota 612 
Mortierella verticillata NRRL 6337 Holomycota 677 
Allomyces macrogynus ATCC 38327 Holomycota 621 
Spizellomyces punctatus DAOM BR117 Holomycota 645 
Batrachochytrium dendrobatidis JAM81 Holomycota 589 
Gonapodya prolifera JEL478 Holomycota 612 
Nematocida parisii ERTm3 Holomycota 104 
Edhazardia aedis USNM 41457 Holomycota 114 
Vavraia culicis Holomycota 118 
Trachipleistophora hominis Holomycota 119 
Spraguea lophii 42_110 Holomycota 104 
Encephalitozoon intestinalis ATCC 50506 Holomycota 111 
Encephalitozoon cuniculi GB-M1 Holomycota 111 
Enterocytozoon bieneusi H348 Holomycota 73 
Rozella allomycis CSF55 Holomycota 424 
Fonticula alba Holomycota 511 
Polysphondylium pallidum PN500 Amoebozoa 556 
Dictyostelium purpureum Amoebozoa 553 
Dictyostelium discoideum AX4 Amoebozoa 567 
Dictyostelium fasciculatum Amoebozoa 569 
Acytostelium subglobosum LB1 Amoebozoa 577 
Acanthamoeba castellanii str. Neff Amoebozoa 560 
Entamoeba dispar SAW760 Amoebozoa 126 
Entamoeba histolytica HM-1:IMSS Amoebozoa 137 
Nicotiana tabacum Archaeplastida 600 
Solanum lycopersicum Archaeplastida 589 
Beta vulgaris subsp. vulgaris Archaeplastida 589 
Cucumis sativus Archaeplastida 591 
Fragaria vesca subsp. vesca Archaeplastida 595 
Arabidopsis lyrata subsp. lyrata Archaeplastida 571 
Arabidopsis thaliana Archaeplastida 592 
Vitis vinifera Archaeplastida 599 
Nelumbo nucifera Archaeplastida 596 
Musa acuminata subsp. malaccensis Archaeplastida 592 
Sorghum bicolor Archaeplastida 561 
Brachypodium distachyon Archaeplastida 582 
Oryza sativa Japonica Group Archaeplastida 596 
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Zea mays Archaeplastida 596 
Elaeis guineensis Archaeplastida 582 
Zostera marina Archaeplastida 571 
Amborella trichopoda Archaeplastida 594 
Selaginella moellendorffii Archaeplastida 573 
Physcomitrella patens Archaeplastida 598 
Marchantia polymorpha subsp. polymorpha Archaeplastida 545 
Chlorella variabilis Archaeplastida 542 
Coccomyxa subellipsoidea C-169 Archaeplastida 552 
Chlamydomonas reinhardtii Archaeplastida 526 
Volvox carteri f. nagariensis Archaeplastida 513 
Gonium pectorale Archaeplastida 505 
Ostreococcus tauri Archaeplastida 501 
Ostreococcus lucimarinus CCE9901 Archaeplastida 481 
Micromonas pusilla CCMP1545 Archaeplastida 508 
Klebsormidium nitens Archaeplastida 607 
Galdieria sulphuraria Archaeplastida 518 
Chondrus crispus Archaeplastida 435 
Cyanidioschyzon merolae strain 10D Archaeplastida 490 
Cyanophora paradoxa Archaeplastida 440 
Vitrella brassicaformis CCMP3155 SAR Group 521 
Oxytricha trifallax SAR Group 455 
Stylonychia lemnae SAR Group 428 
Paramecium tetraurelia strain d4-2 SAR Group 422 
Tetrahymena thermophila SB210 SAR Group 454 
Ichthyophthirius multifiliis SAR Group 363 
Symbiodinium minutum Clade B1 SAR Group 413 
Perkinsus marinus ATCC 50983 SAR Group 410 
Reticulomyxa filosa SAR Group 397 
Ectocarpus siliculosus SAR Group 586 
Aureococcus anophagefferens SAR Group 461 
Nannochloropsis gaditana SAR Group 566 
Blastocystis hominis SAR Group 339 
Thalassiosira oceanica SAR Group 465 
Thalassiosira pseudonana CCMP1335 SAR Group 497 
Phaeodactylum tricornutum SAR Group 534 
Aphanomyces invadans SAR Group 635 
Saprolegnia diclina VS20 SAR Group 621 
Albugo laibachii Nc14 SAR Group 513 
Albugo candida SAR Group 511 
Phytophthora infestans T30-4 SAR Group 593 
Phytophthora sojae SAR Group 609 
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Babesia bovis T2Bo SAR Group 280 
Eimeria tenella SAR Group 309 
Eimeria maxima SAR Group 206 
Eimeria acervulina SAR Group 246 
Cryptosporidium hominis TU502 SAR Group 164 
Cryptosporidium muris RN66 SAR Group 205 
Cryptosporidium parvum Iowa II SAR Group 179 
Theileria annulata strain Ankara SAR Group 273 
Theileria parva SAR Group 270 
Theileria orientalis strain Shintoku SAR Group 275 
Toxoplasma gondii GT1 SAR Group 400 
Neospora caninum Liverpool SAR Group 383 
Plasmodium chabaudi chabaudi SAR Group 341 
Plasmodium falciparum 3D7 SAR Group 336 
Emiliania huxleyi CCMP1516 Excavata Plus 529 
Guillardia theta CCMP2712 Excavata Plus 549 
Trichomonas vaginalis G3 Excavata Plus 175 
Tritrichomonas foetus Excavata Plus 175 
Giardia lamblia ATCC 50803 Excavata Plus 116 
Naegleria gruberi strain NEG-M Excavata Plus 495 
Angomonas deanei Excavata Plus 398 
Trypanosoma cruzi strain CL Brener Excavata Plus 395 
Trypanosoma brucei brucei TREU927 Excavata Plus 375 
Leishmania major strain Friedlin Excavata Plus 402 
Leishmania infantum JPCM5 Excavata Plus 397 
Monocercomonoides Excavata Plus 114 
Archaeoglobus fulgidus DSM 4304 Archaea 93 
Ferroglobus placidus DSM 10642 Archaea 91 
Geoglobus ahangari Archaea 90 
Hadesarchaea archaeon YNP_N21 Archaea 60 
Halobacterium salinarum R1 Archaea 124 
Natronomonas pharaonis DSM 2160 Archaea 130 
Haloarcula marismortui ATCC 43049 Archaea 129 
Natrinema pellirubrum DSM 15624 Archaea 129 
Methanobrevibacter smithii ATCC 35061 Archaea 71 
Methanothermobacter thermautotrophicus str. Delta H Archaea 76 
Methanosphaera stadtmanae DSM 3091 Archaea 70 
Methanocaldococcus jannaschii DSM 2661 Archaea 64 
Methanococcus maripaludis C5 Archaea 67 
Methanosarcina acetivorans C2A Archaea 104 
Methanoregula boonei 6A8 Archaea 91 
Methanoplanus limicola DSM 2279 Archaea 87 
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Methanopyrus kandleri AV19 Archaea 61 
Pyrococcus furiosus DSM 3638 Archaea 81 
Thermococcus kodakarensis KOD1 Archaea 80 
Palaeococcus pacificus DY20341 Archaea 87 
Thermoplasma volcanium GSS1 Archaea 103 
Ferroplasma acidarmanus fer1 Archaea 110 
Picrophilus torridus DSM 9790 Archaea 109 
Aeropyrum pernix K1 Archaea 102 
Pyrobaculum aerophilum str. IM2 Archaea 97 
Sulfolobus tokodaii str. 7 Archaea 107 
Ignicoccus hospitalis Archaea 69 
Staphylothermus marinus F1 Archaea 68 
Cenarchaeum symbiosum A Archaea 93 
Nitrosopumilus maritimus SCM1 Archaea 100 
Nitrososphaera viennensis EN76 Archaea 101 
Candidatus Korarchaeum cryptofilum OPF8 Archaea 85 
Candidatus Haloredivivus sp. G17 Archaea 49 
Candidatus Nanosalinarum sp. J07AB56 Archaea 54 
Candidatus Parvarchaeum acidophilus ARMAN-5 Archaea 61 
Nanoarchaeum equitans Kin4-M Archaea 40 
Lokiarchaeum sp. GC14_75 Archaea 105 
Planctomyces maris DSM 8797 Bacteria 203 
Isosphaera pallida ATCC 43644 Bacteria 229 
Rhodopirellula baltica SH 1 Bacteria 209 
Chlamydophila pneumoniae CWL029 Bacteria 143 
Chlamydia trachomatis Bacteria 137 
Waddlia chondrophila WSU 86-1044 Bacteria 196 
Fervidobacterium nodosum Rt17-B1 Bacteria 171 
Kosmotoga olearia TBF 19.5.1 Bacteria 170 
Petrotoga mobilis SJ95 Bacteria 174 
Thermosipho africanus TCF52B Bacteria 169 
Thermotoga maritima MSB8 Bacteria 160 
Mesotoga prima MesG1.Ag.4.2 Bacteria 176 
Dictyoglomus thermophilum H-6-12 Bacteria 159 
Dictyoglomus turgidum DSM 6724 Bacteria 154 
Aquifex aeolicus VF5 Bacteria 189 
Persephonella marina EX-H1 Bacteria 191 
Thermovibrio ammonificans HB-1 Bacteria 176 
Leptospirillum rubarum Bacteria 190 
Leptospirillum ferrodiazotrophum Bacteria 194 
Thermodesulfovibrio yellowstonii DSM 11347 Bacteria 179 
Mycoplasma genitalium G37 Bacteria 104 
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Onion yellows phytoplasma OY-M Bacteria 93 
Sebaldella termitidis ATCC 33386 Bacteria 182 
Leptotrichia buccalis C-1013-b Bacteria 163 
Fusobacterium nucleatum subsp. nucleatum ATCC 25586 Bacteria 160 
Bacillus subtilis subsp. subtilis str. 168 Bacteria 223 
Staphylococcus aureus subsp. aureus Mu50 Bacteria 207 
Listeria monocytogenes EGD-e Bacteria 196 
Streptococcus agalactiae Bacteria 175 
Clostridium tetani E88 Bacteria 163 
Clostridium acetobutylicum ATCC 824 Bacteria 187 
Thermoanaerobacter tengcongensis MB4 Bacteria 193 
Mycobacterium tuberculosis CDC1551 Bacteria 227 
Corynebacterium efficiens YS-314 Bacteria 202 
Streptomyces coelicolor Bacteria 249 
Thermosynechococcus elongatus BP-1 Bacteria 209 
Gloeobacter violaceus PCC 7421 Bacteria 225 
Prochlorococcus marinus str. MIT 9313 Bacteria 193 
Roseiflexus castenholzii DSM 13941 Bacteria 239 
Chloroflexus aggregans DSM 9485 Bacteria 235 
Herpetosiphon aurantiacus DSM 785 Bacteria 241 
Anaerolinea thermophila UNI-1 Bacteria 205 
Ktedonobacter racemifer DSM 44963 Bacteria 240 
Sphaerobacter thermophilus DSM 20745 Bacteria 228 
Thermus thermophilus HB8 Bacteria 222 
Meiothermus silvanus DSM 9946 Bacteria 227 
Deinococcus radiodurans R1 Bacteria 222 
Methylacidiphilum infernorum V4 Bacteria 197 
Opitutus terrae PB90-1 Bacteria 222 
Akkermansia muciniphila ATCC BAA-835 Bacteria 180 
Porphyromonas gingivalis W83 Bacteria 163 
Bacteroides thetaiotaomicron VPI-5482 Bacteria 198 
Flavobacterium psychrophilum Bacteria 216 
Chloroherpeton thalassium ATCC 35110 Bacteria 221 
Chlorobium tepidum TLS Bacteria 194 
Prosthecochloris aestuarii DSM 271 Bacteria 203 
Treponema denticola ATCC 35405 Bacteria 151 
Borrelia burgdorferi B31 Bacteria 122 
Brachyspira murdochii DSM 12563 Bacteria 178 
Leptospira interrogans serovar Lai str. 56601 Bacteria 217 
Acidobacterium capsulatum ATCC 51196 Bacteria 221 
Candidatus Koribacter versatilis Ellin345 Bacteria 229 
Terriglobus saanensis SP1PR4 Bacteria 214 
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Gemmatimonas aurantiaca T-27 Bacteria 239 
Agrobacterium tumefaciens str. C58 Bacteria 280 
Rhizobium etli CFN 42 Bacteria 292 
Rickettsia prowazekii str. Madrid E Bacteria 198 
Nitrosospira multiformis ATCC 25196 Bacteria 232 
Nitrosomonas europaea ATCC 19718 Bacteria 233 
Burkholderia mallei ATCC 23344 Bacteria 260 
Neisseria meningitidis ATCC 13091 Bacteria 212 
Pseudomonas syringae pv. tomato str. DC3000 Bacteria 265 
Pseudomonas aeruginosa PA7 Bacteria 290 
Escherichia coli BW25113 Bacteria 251 
Vibrio cholerae O1 biovar El Tor str. N16961 Bacteria 224 
Bdellovibrio bacteriovorus HD100 Bacteria 231 
Geobacter sulfurreducens PCA Bacteria 223 
Lawsonia intracellularis N343 Bacteria 146 
Helicobacter winghamensis ATCC BAA-430 Bacteria 174 
Helicobacter pylori J99 Bacteria 162 
Wolinella succinogenes DSM 1740 Bacteria 183 
Campylobacter jejuni subsp. jejuni NCTC 11168 Bacteria 176 
Aminobacterium colombiense DSM 12261 Bacteria 181 
Anaerobaculum hydrogeniformans ATCC BAA-1850 Bacteria 178 
Dethiosulfovibrio peptidovorans DSM 11002 Bacteria 183 
Calditerrivibrio nitroreducens DSM 19672 Bacteria 201 
Deferribacter desulfuricans SSM1 Bacteria 210 
Denitrovibrio acetiphilus DSM 12809 Bacteria 214 
Thermodesulfatator indicus DSM 15286 Bacteria 172 
Thermodesulfobacterium commune DSM 2178 Bacteria 168 

























































































































































































































Appendix II: Mitochondrial genes matching mitochondrial carrier 
phylogenetic patterns in nematodes and platyhelminthes 
 
Table 1. IMPI 2017 positive training set genes matching the phylogenetic pattern of the SLC25A21 and 
SLC25A43 transporters in the studied platyhelminthes – present in the free-living Schmidtea 
mediterranea and absent in the blood flukes, liver flukes and tapeworms. 
Ensembl ID Gene Function 
ENSG00000109576 AADAT Transamination of 2-aminoadipate to 2-oxoadipate and 
kynurenine to kynurenic acid 
ENSG00000183044 ABAT Conversion of GABA to succinate semialdehyde 
ENSG00000167315 ACAA2 Acetyl-CoA acyltransferase – last step of mitochondria 
fatty acid beta-oxidation spiral 
ENSG00000167107 ACSF2 Acyl-CoA synthetase, preferring medium-chain 
substrates 
ENSG00000154930 ACSS1 Acetyl-CoA synthetase 
ENSG00000147576 ADHFE1 Oxidation of -hydroxybutyrate to succinate 
semialdehyde 
ENSG00000113492 AGXT2 Multifunctional aminotransferase 
ENSG00000164904 ALDH7A1 Production of betaine aldehyde from betaine and 
2-aminoadipate from 2-aminoadipate 6-semialdehyde 
ENSG00000174606 ANGEL2 Unknown 
ENSG00000125375 ATP5S Subunit of ATP synthase 
ENSG00000189227 C15orf61 Unknown 
ENSG00000145439 CBR4 Quinone reductase and 3-keto-acyl-acyl carrier protein 
reductase in fatty acid biosynthesis 
ENSG00000121289 CEP89 Complex IV regulation 
ENSG00000181192 DHTKD1 Production of glutaryl-CoA from 2-oxoadipate 
ENSG00000132837 DMGDH Demethylation of dimethylglycine to sarcosine 
ENSG00000132199 ENOSF1 Catabolism of L-fuconate to 
2-keto-3-deoxy-L-fuconate 
ENSG00000130299 GTPBP3 Mitochondrial tRNA modification 
ENSG00000151806 GUF1 Mitoribosome fidelity factor – catalyses movement of 
ribosome back one codon 
ENSG00000181061 HIGD1A Complex IV regulation 
ENSG00000189221 MAOA Outer mitochondrial membrane monoamine 
metabolism 
ENSG00000050393 MCUR1 Regulation of calcium uniporter 
ENSG00000103150 MLYCD Catalyses conversion of malonyl-CoA to acetyl-CoA 
ENSG00000103152 MPG DNA repair 
ENSG00000254858 MPV17L2 Regulation of mitoribosome assembly and stability 
ENSG00000108826 MRPL27 Subunit of the mitoribosome 






Ensembl ID Gene Function 
ENSG00000161653 NAGS Production of N-acetylglutamate – a cofactor for CPS1 
in the urea cycle 
ENSG00000162600 OMA1 Mitochondrial quality control 
ENSG00000036473 OTC Conversion of carbamoyl phosphate and L-ornithine to 
L-citrulline and Pi, in the urea cycle 
ENSG00000128050 PAICS Catalyses two steps in purine biosynthesis 
ENSG00000179598 PLD6 Possibly cardiolipin metabolism 
ENSG00000138035 PNPT1 RNA processing 
ENSG00000126432 PRDX5 Reactive oxygen species metabolism 
ENSG00000148334 PTGES2 Prostaglandin E2 synthase 
ENSG00000169972 PUSL1 Unknown 
ENSG00000118508 RAB32 Regulation of protein kinase A signalling and 
mitochondrial fission 
ENSG00000136444 RSAD1 Unknown 
ENSG00000123453 SARDH Production of glycine from sarcosine 
ENSG00000122912 SLC25A16 Groups with SLC25A42 – the CoA transporter 
ENSG00000183032 SLC25A21 Exchange of mitochondrial 2-oxoglutarate for 
cytoplasmic 2-oxoadipate 
ENSG00000077713 SLC25A43 Unknown 
ENSG00000070214 SLC44A1 Choline transporter 
ENSG00000106028 SSBP1 Single-stranded DNA binding protein involved in 
mitochondrial DNA replication 
ENSG00000175600 SUGCT Conversion of glutarate to glutaryl-CoA 
ENSG00000179152 TCAIM Regulation of T-cell activity 
ENSG00000164362 TERT Maintenance of telomeres 
ENSG00000185973 TMLHE Conversion of trimethyllysine to 
hydroxytrimethyllysine 
ENSG00000128311 TST Cyanide detoxification 












Table 2. IMPI 2017 positive training set genes matching the phylogenetic pattern of the SLC25A38 
transporter in the studied platyhelminthes – present in the free-living Schmidtea mediterranea, liver 
flukes and tapeworms, and absent in the blood flukes. 
Ensembl ID Gene Function 
ENSG00000115657 ABCB6 Transport of a porphyrin across the membrane in 
haem synthesis 
ENSG00000125246 CLYBL Production of malate from glyoxylate and 
acetyl-CoA; and β-methylmalate from glyoxylate and 
propionyl-CoA 
ENSG00000157184 CPT2 Production of N-acyl-CoA from imported 
N-acylcarnitine 
ENSG00000127884 ECHS1 Hydration of 2-trans-enoyl-CoAs to L-3-
hydroxyacyl-CoAs in mitochondrial fatty acid 
-oxidation 
ENSG00000168237 GLYCTK Glycerate kinase 
ENSG00000138796 HADH Oxidation of straight chain 2-hydroxacyl-CoAs in 
mitochondrial fatty acid -oxidation 
ENSG00000005156 LIG3 DNA ligase involved in repair 
ENSG00000266472 MRPS21 Subunit of the mitoribosome 
ENSG00000151413 NUBPL Complex I assembly factor 
ENSG00000142082 SIRT3 Lysine deacetylase 
ENSG00000085491 SLC25A24 ADP/ATP carrier 
ENSG00000144659 SLC25A38 Probable glycine carrier 






Table 3. IMPI 2017 positive training set genes matching the phylogenetic pattern of the SLC25A1 and 
SLC25A29 transporters in the studied nematodes – missing from the Dorylaimia. 
Ensembl ID Gene Function 
ENSG00000135776 ABCB10 Possibly related to haem transport 
ENSG00000143149 ALDH9A1 Conversion of γ-aminobutyaldehyde to 
γ-butyrobetaine 
ENSG00000256053 APOPT1 Regulation of apoptosis 
ENSG00000139637 C12orf10 Unknown 
ENSG00000016391 CHDH Production of betaine aldehyde from choline 
ENSG00000006695 COX10 Produces haem O from protohaem IX, for usage in 
Complex IV 
ENSG00000149485 FADS1 Fatty acid desaturase 
ENSG00000104687 GSR Reduction of oxidised glutathione disulphide 
ENSG00000119431 HDHD3 Unknown 
ENSG00000067829 IDH3G Regulatory subunit of isocitrate dehydrogenase 
ENSG00000184903 IMMP2L Removal of targeting sequence 
ENSG00000103642 LACTB Possibly involved in lipid metabolism or as a filament 
protein 
ENSG00000166816 LDHD Lactate dehydrogenase 
ENSG00000005156 LIG3 DNA ligase involved in repair 
ENSG00000108829 LRRC59 Regulation of mitochondrial dynamics? 
ENSG00000156928 MALSU1 Regulation of mitoribosome activity 
ENSG00000103150 MLYCD Production of acetyl-CoA from malonyl-CoA 
ENSG00000175806 MSRA Repair of damaged methionine residues in proteins 
ENSG00000134265 NAPG Trafficking between organelles 
ENSG00000158828 PINK1 Kinase involved in stress response 
ENSG00000107959 PITRM1 Degradation of cleaved targeting sequences 
ENSG00000101546 RBFA Maturation of mitoribosome 
ENSG00000126858 RHOT1 Mitochondrial trafficking 
ENSG00000196636 SDHAF3 Complex II assembly factor 
ENSG00000144040 SFXN5 Unknown 
ENSG00000110911 SLC11A2 Metal ion transporter (particularly iron) 
ENSG00000100075 SLC25A1 Citrate transporter 
ENSG00000197119 SLC25A29 Basic amino acid transporter 





Table 4. IMPI 2017 positive training set genes matching the phylogenetic pattern of the SLC25A14 and 
SLC25A30 transporters in the studied platyhelminthes – present in the free-living 
Schmidtea mediterranea and liver flukes; missing in the blood flukes and tapeworms. 
Ensembl ID Gene Function 
ENSG00000008311 AASS First two steps of lysine degradation, producing 
α-aminoadipic semialdehyde 
ENSG00000115361 ACADL Long chain acyl-CoA dehydrogenase 
ENSG00000122971 ACADS Short chain acyl-CoA dehydrogenase 
ENSG00000196177 ACADSB Short branched chain acyl-CoA dehydrogenase 
ENSG00000072778 ACADVL Very long chain acyl-CoA dehydrogenase 
ENSG00000111058 ACSS3 Acyl-CoA synthetase – required for fatty acid 
synthesis 
ENSG00000119711 ALDH6A1 Production of acetyl-CoA and propionyl-CoA from 
malonate and methylmalonate respectively 
ENSG00000148090 AUH Conversion of 3-methylglutaconyl-CoA to 
3-hydroxy-3-methylglutaryl-CoA 
ENSG00000248098 BCKDHA Branched chain amino acid dehydrogenase subunit 
ENSG00000083123 BCKDHB Branched chain amino acid dehydrogenase subunit 
ENSG00000103507 BCKDK Control of branched chain amino acid dehydrogenase 
ENSG00000213563 C8orf82 Unknown 
ENSG00000173992 CCS Chaperone for copper insertion into superoxide 
dismutase 
ENSG00000110090 CPT1A Formation of acylcarnitine 
ENSG00000137992 DBT Branched chain amino acid dehydrogenase subunit 
ENSG00000104325 DECR1 Accessory protein of mitochondrial fatty acid 
-oxidation, dealing with unsaturated fatty acids 
ENSG00000104823 ECH1 Enoyl-CoA hydratase 
ENSG00000198721 ECI2 Accessory protein of mitochondrial fatty acid 
-oxidation, dealing with unsaturated fatty acids 
ENSG00000140374 EFTA Electron transfer flavoprotein subunit 
ENSG00000105379 ETFB Electron transfer flavoprotein subunit 
ENSG00000171503 ETFDH Electron transfer flavoprotein dehydrogenase 
ENSG00000105607 GCDH Decarboxylation of glutaryl-CoA to crotonyl-CoA 
ENSG00000105607 GSTK1 Glutathione transferase 
ENSG00000100577 GSTZ1 Conversion of maleylacetoacetate to 
fumarylacetoacetate 
ENSG00000084754 HADHA Last steps of mitochondrial fatty acid -oxidation 
ENSG00000138029 HADHB Last steps of mitochondrial fatty acid -oxidation 
ENSG00000106049 HIBADH Oxidation of 3-hydroyisobutyrate to methylmalonate 
semialdehyde 
ENSG00000198130 HIBCH Hydrolysis of 3-hydroxyisobutyryl-CoA and 
3-hydroxypropanoyl-CoA 
ENSG00000117305 HMGCL Final step of leucine catabolism and start of ketone 
body synthesis 
ENSG00000119471 HSDL2 Unknown 
ENSG00000128928 IVD Conversion of isovaleryl-CoA to 
3-methylcrotonyl-CoA 
ENSG00000078070 MCCC1 Methylcrotonyl-CoA carboxylase 
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Ensembl ID Gene Function 
ENSG00000131844 MCCC2 Methylcrotonyl-CoA carboxylase 
ENSG00000151611 MMAA Vitamin B12 metabolism 
ENSG00000139428 MMAB Vitamin B12 metabolism 
ENSG00000146085 MUT Vitamin B12 dependent production of succinyl-CoA 
from methylmalonyl-CoA 
ENSG00000213965 NUDT19 Renal CoA diphosphohydrolase 
ENSG00000170917 NUDT6 Unknown – possibly control of cell proliferation 
ENSG00000083720 OXCT1 Ketone body catabolism 
ENSG00000163644 PPM1K Control of branched chain amino acid dehydrogenase 
ENSG00000187024 PTRH1 Unknown 
ENSG00000182199 SHMT2 Interconversion of glycine and serine 
ENSG00000089163 SIRT4 Removal of biotinyl and lipoyl groups 






Table 5. IMPI 2017 positive training set genes matching the phylogenetic pattern of the SLC25A43 
transporter in the studied nematodes – only in the Dorylaimia. 
Ensembl ID Gene Function 
ENSG00000178074 C2orf69 Unknown 
ENSG00000162129 CLPB Peptidase 
ENSG00000140465 CYP1A1 Wide-ranging monooxygenase 
ENSG00000172500 FIBP Regulation of mitogenesis 
ENSG00000115317 HTRA2 Protease linked to apoptosis 
ENSG00000002549 LAP3 Aminopeptidase 
ENSG00000108788 MLX Sensing cellular energy status and transcription 
regulator 
ENSG00000103152 MPG DNA glycosylase involved in repair 
ENSG00000125459 MSTO1 Regulation of mitochondrial morphology 
ENSG00000107951 MTPAP Addition of polyA tail to mitochondrial mRNA 
ENSG00000109180 OCIAD1 Unknown 
ENSG00000125741 OPA3 Unknown 
ENSG00000106246 PTCD1 Mitochondrial tRNA regulation 
ENSG00000049883 PTCD2 Mitochondrial tRNA regulation 
ENSG00000077713 SLC25A43 Unknown 





Table 6. IMPI 2017 positive training set genes matching the phylogenetic pattern of the SLC25A44 
transporter in the studied platyhelminthes – missing in the tapeworms. 
Ensembl ID Gene Function 
ENSG00000059573 ALDH18A1 Conversion of glutamate to glutamate 
5-semialdehyde 
ENSG00000143149 ALDH9A1 Conversion of γ-aminobutyaldehyde to 
γ-butyrobetaine 
ENSG00000145020 AMT Part of glycine cleavage system 
ENSG00000256053 APOPT1 Regulation of apoptosis 
ENSG00000174928 C3orf33 Unknown 
ENSG00000016391 CHDH Production of betaine aldehyde from choline 
ENSG00000167113 COQ4 Organisation of part of the coenzyme Q 
biosynthesis pathway 
ENSG00000102967 DHODH Production of orotate from dihydroorotate with 
quinone as an electron acceptor 
ENSG00000180185 FAHD1 Oxaloacetate decarboxylase 
ENSG00000091483 FH Fumarase 
ENSG00000171766 GATM Synthesis of guanidinoacetate from arginine and 
glycine 
ENSG00000178445 GLDC Part of glycine cleavage system 
ENSG00000101365 IDH3B Subunit of isocitrate dehydrogenase 
ENSG00000087299 L2HGDH Oxidisation of L-2-hydroxyglutarate to 
α-ketoglutarate 
ENSG00000135537 LACE1 Mitochondrial morphology and protein metabolism 
ENSG00000124615 MOCS1 First step of molybdenum cofactor synthesis 
ENSG00000174099 MSRB3 Reduction of methionine sulphoxide to methionine 
ENSG00000103707 MTFMT Addition of formyl group to initiator methionyl-
tRNA 
ENSG00000214114 MYCBP Control of MYC transcription factor 
ENSG00000123213 NLN Oligopeptidase hydrolysis 
ENSG00000173599 PC Pyruvate carboxylase 
ENSG00000186642 PDE2A cAMP and cGMP phosphodiesterase 
ENSG00000164306 PRIMPOL DNA primase and polymerase 
ENSG00000111737 RAB35 Regulation of trafficking 
ENSG00000171861 RNMTL1 Mitochondrial rRNA modification 
ENSG00000160785 SLC25A44 Unknown 
ENSG00000213699 SLC35F6 Mitochondrial membrane potential maintenance 
ENSG00000163071 SPATA18 Mitochondrial quality control 
ENSG00000139531 SUOX Oxidation of sulphite to sulphate 
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 Appendix III: Mitochondrial proteins in viruses 
 
Table 1. IMPI 2017 genes with at least one predicted viral orthologue, with information about the gene 
family and the families of viruses with predicted orthologues. 




Viral families with 
orthologues 























ENSG00000106028 SSBP1  339 Myoviridae, Podoviridae, 
Siphoviridae, Unclassified 




ENSG00000099821 POLRMT  297 Myoviridae, Podoviridae, 
Siphoviridae, Unclassified 














ENSG00000142168 SOD1  192 Baculoviridae, Mimiviridae, 
Phycodnaviridae, Poxviridae, 
Unclassified 
ENSG00000107815 C10orf2 DNA helicases 155 Myoviridae, Podoviridae, 
Siphoviridae, Unclassified 
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Viral families with 
orthologues 





ENSG00000023572 GLRX2 Glutaredoxin domain 
containing 
103 Mimiviridae, Myoviridae, 
Phycodnaviridae, 
Siphoviridae, Unclassified 





















ENSG00000051180 RAD51 Fanconi anemia 
complementation 
groups 
67 Myoviridae, Siphoviridae, 
Unclassified 
ENSG00000072756 TRNT1  61 Bicaudaviridae, Myoviridae, 
Podoviridae, Siphoviridae, 
Unclassified 
ENSG00000044574 HSPA5 Heat shock 70kDa 
proteins 
56 Closteroviridae, Mimiviridae, 
Unclassified 
ENSG00000063761 ADCK1  50 Pandoraviridae, 
Phycodnaviridae, 
Siphoviridae, Unclassified 
ENSG00000164978 NUDT2 Nudix hydrolase family 46 Ascoviridae, Mimiviridae, 
Myoviridae, Unclassified 
ENSG00000112031 MTRF1L  44 Myoviridae, Siphoviridae, 
Unclassified 
ENSG00000124523 SIRT5 Sirtuins 42 Myoviridae, Podoviridae, 
Siphoviridae, Unclassified 
ENSG00000143774 GUK1  38 Myoviridae, Pandoraviridae, 
Poxviridae, Siphoviridae, 
Unclassified 
ENSG00000125871 MGME1 Exonucleases 37 Myoviridae, Siphoviridae, 
Unclassified 




ENSG00000166855 CLPX AAA ATPases 32 Myoviridae, Podoviridae, 
Siphoviridae, Unclassified 
ENSG00000103642 LACTB Mitochondrial 
ribosomal proteins 
32 Myoviridae, Siphoviridae 
ENSG00000140521 POLG DNA polymerases 32 Myoviridae, Podoviridae, 
Siphoviridae, Unclassified 
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Viral families with 
orthologues 
ENSG00000116863 ADPRHL2  31 Baculoviridae, Mimiviridae, 
Myoviridae, Phycodnaviridae, 
Unclassified 
ENSG00000215021 PHB2  31 Myoviridae, Podoviridae, 
Siphoviridae, Unclassified 






ENSG00000141378 PTRH2 Cilia and flagella 
associated 
30 Myoviridae, Poxviridae, 
Siphoviridae, Unclassified 
ENSG00000113272 THG1L  30 Mimiviridae, Myoviridae, 
Siphoviridae, Unclassified 
ENSG00000076043 REXO2 Exonucleases 28 Phycodnaviridae, 
Podoviridae, Poxviridae, 
Siphoviridae, Unclassified 
ENSG00000205309 NT5M 5’-nucleotidases 27 Mimiviridae, Myoviridae, 
Siphoviridae, Unclassified 
ENSG00000039650 PNKP HAD Asp-based non-
protein phosphatases 









ENSG00000173137 ADCK5  25 Phycodnaviridae, 
Unclassified 















24 Myoviridae, Unclassified 
ENSG00000016391 CHDH  21 Mimiviridae, Unclassified 
ENSG00000135821 GLUL  20 Mimiviridae, Unclassified 
ENSG00000134905 MCL1 BCL2 family 20 Herpesviridae, Iridoviridae, 
Poxviridae 
ENSG00000128050 PAICS Purinosome 20 Myoviridae, Siphoviridae, 
Unclassified 
ENSG00000134905 CARS2 Aminoacyl tRNA 
synthetases, Class I 
19 Mimiviridae, Unclassified 
ENSG00000242114 MTFP1  19 Mimiviridae, 
Phycodnaviridae 
ENSG00000171552 BCL2L1 BCL2 family 18 Asfarviridae, Herpesviridae, 
Iridoviridae 
ENSG00000105819 PMPCB M16 metallopeptidases 18 Mimiviridae, Myoviridae 




Heat shock 70kDa 
proteins 
17 Closteroviridae, Mimiviridae, 
Phycodnaviridae, 
Unclassified 
ENSG00000197122 SRC SH2 domain containing 
Src family tyrosine 
kinases 
17 Retroviridae 
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Viral families with 
orthologues 
ENSG00000126215 XRCC3  17 Myoviridae, Unclassified 
ENSG00000087074 PPP1R15A Protein phosphatase 1 
regulatory subunits 
16 Ascoviridae, Asfarviridae, 
Baculoviridae, Herpesviridae, 
Hytrosaviridae, Poxviridae 





15 Myoviridae, Pandoraviridae, 
Siphoviridae, Unclassified 
ENSG00000103018 CYB5B  15 Mimiviridae 
ENSG00000189221 MAOA  14 Phycodnaviridae 
ENSG00000100596 SPTLC2  13 Phycodnaviridae 
ENSG00000106077 ABHD11 A hydrolase domain 
containing 
12 Siphoviridae, Unclassified 
ENSG00000244005 NFS1  12 Asfarviridae, Unclassified 
ENSG00000104763 ASAH1  11 Mimiviridae 
ENSG00000204389 HSPA1A Heat shock 70kDa 
proteins 
TIM23 complex 
11 Mimiviridae, Unclassified 
ENSG00000144381 HSPD1 Chaperonins 11 Myoviridae, Podoviridae, 
Unclassified 
ENSG00000103024 NME3 NME/NM23 family 11 Mimiviridae, Unclassified 
ENSG00000126432 PRDX5 Peroxiredoxins 11 Myoviridae 
ENSG00000100033 PRODH  11 Phycodnaviridae, 
Unclassified 
ENSG00000178952 TUFM  11 Myoviridae, Siphoviridae, 
Unclassified 
ENSG00000113013 HSPA9 Heat shock 70kDa 
proteins 
10 Closteroviridae 
ENSG00000137513 NARS2 Aminoacyl tRNA 
synthetases, Class II 
10 Mimiviridae, Unclassified 
ENSG00000139190 VAMP1 Vesicle associated 
membrane proteins 
10 Phycodnaviridae 
ENSG00000162129 CLPB AAA ATPases 
Ankyrin repeat domain 
containing 
9 Myoviridae, Unclassified 
ENSG00000008405 CRY1  9 Mimiviridae, 
Phycodnaviridae, 
Unclassified 




ENSG00000178700 DHFRL1  8 Myoviridae, Unclassified 
ENSG00000162999 DUSP19 Atypical dual 
specificity 
phosphatases 
8 Baculoviridae, Poxviridae, 
Siphoviridae 
ENSG00000133315 MACROD1  8 Hesperidia, Iridoviridae, 
Gravidae 
ENSG00000133878 DUSP26 Atypical dual 
specificity 
phosphatases 
7 Baculoviridae, Iridoviridae, 
Lipothrixviridae, 
Pandoraviridae, Unclassified 
ENSG00000183597 TANGO2  7 Poxviridae, Unclassified 
ENSG00000100823 APEX1  6 Mimiviridae, 
Phycodnaviridae, 
Unclassified 
ENSG00000138363 ATIC Purinosome 6 Myoviridae, Pandoraviridae 
ENSG00000115204 MPV17  6 Phycodnaviridae 
ENSG00000239672 NME1 NME/NM23 family 6 Mimiviridae, Unclassified 
ENSG00000184428 TOP1MT Topoisomerases 6 Mimiviridae, Unclassified 
ENSG00000167468 GPX4 Selenoproteins 5 Poxviridae 
ENSG00000115541 HSPE1 Chaperonins 5 Myoviridae 
ENSG00000119912 IDE M16 metallopeptidases 5 Mimiviridae, Unclassified 
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Viral families with 
orthologues 
ENSG00000143799 PARP1 Zinc finger PARP-type 
Poly(ADP-ribose) 
polymerases 
5 Baculoviridae, Iridoviridae, 
Unclassified 
ENSG00000150787 PTS  5 Myoviridae, Siphoviridae 
ENSG00000167136 ENDOG  4 Unclassified 
ENSG00000167085 PHB  4 Podoviridae, Siphoviridae, 
Unclassified 
ENSG00000166532 RIMKLB  4 Myoviridae 
ENSG00000087088 BAX BCL2 family 4 Herpesviridae, Iridoviridae 
ENSG00000171791 BCL2 BCL2 family 4 Asfarviridae, Herpesviridae 
ENSG00000153291 SLC25A27 Solute carriers 4 Mimiviridae, Unclassified 
ENSG00000174032 SLC25A30 Solute carriers 4 Mimiviridae 




ENSG00000188917 TRMT2B tRNA 
methyltransferases 
4 Mimiviridae, Unclassified 
ENSG00000130985 UBA1 Ubiquitin like modifier 
activating enzymes 
Cilia and flagella 
associated 
4 Mimiviridae, Unclassified 
ENSG00000142208 AKT1 Pleckstrin homology 
domain containing 
3 Retroviridae 




ENSG00000166347 CYB5A  3 Phycodnaviridae, 
Unclassified 
 
ENSG00000136628 EPRS Aminoacyl tRNA 
synthetases, Class I 
Aminoacyl tRNA 
synthetases, Class II 
3 Unclassified 
ENSG00000178445 GLDC  3 Myoviridae 
ENSG00000105135 ILVBL  3 Phycodnaviridae, 
Unclassified 
ENSG00000136003 ISCU  3 Siphoviridae 
ENSG00000065427 KARS Aminoacyl tRNA 




ENSG00000247626 MARS2 Aminoacyl tRNA 
synthetases, Class I 
3 Unclassified 
ENSG00000103202 NME4 NME/NM23 family 3 Mimiviridae 
ENSG00000138942 RNF185 Ring finger proteins 3 Iridoviridae 
ENSG00000182199 SHMT2  3 Myoviridae, Nudiviridae 
ENSG00000139131 YARS2 Aminoacyl tRNA 
synthetases, Class I 
3 Myoviridae, Unclassified 
ENSG00000118520 ARG1  2 Phycodnaviridae, 
Unclassified 
ENSG00000106105 GARS Aminoacyl tRNA 
synthetases, Class II 
2 Unclassified 
ENSG00000171766 GATM  2 Myoviridae 




ENSG00000233276 GPX1 Selenoproteins 2 Poxviridae 
ENSG00000112855 HARS2 Aminoacyl tRNA 
synthetases, Class II 
2 Unclassified 
ENSG00000135070 ISCA1  2 Phycodnaviridae 
ENSG00000133703 KRAS RAS type GTPase 
family 
2 Retroviridae, Unclassified 
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Viral families with 
orthologues 







2 Siphoviridae, Unclassified 
ENSG00000011052 NME2 NME/NM23 family 2 Alloherpesviridae, 
Unclassified 
ENSG00000102078 SLC25A14 Solute carriers 2 Mimiviridae, Unclassified 
ENSG00000164933 SLC25A32 Solute carriers 2 Nudiviridae 
ENSG00000204394 VARS Aminoacyl tRNA 
synthetases, Class I 
2 Unclassified 
ENSG00000154258 ABCA9 ATP binding cassette 
subfamily A 
1 Poxviridae 
ENSG00000135776 ABCB10 ATP binding cassette 
subfamily B 
1 Siphoviridae 
ENSG00000172955 ADH6 Alcohol 
dehydrogenases 
1 Myoviridae 
ENSG00000198610 AKR1C4 Aldo-keto reductases 1 Unclassified 
ENSG00000081181 ARG2  1 Unclassified 
ENSG00000130707 ASS1  1 Unclassified 
ENSG00000103502 CDIPT  1 Unclassified 
ENSG00000170312 CDK1 Cyclin dependent 
kinases 
1 Herpesviridae 




ENSG00000047230 CTPS2  1 Unclassified 
ENSG00000087470 DNM1L  1 Unclassified 
ENSG00000145982 FARS2 Aminoacyl tRNA 
synthetases, Class II 
1 Unclassified 
ENSG00000096384 HSP90AB1 Heat shock 90kDa 
proteins 
1 Unclassified 
ENSG00000087299 L2HGDH  1 Unclassified 
ENSG00000002549 LAP3 Aminopeptidases 1 Unclassified 
ENSG00000266472 MRPS21 Mitochondrial 
ribosomal proteins 
1 Myoviridae 
ENSG00000198804 MT-CO1 Mitochondrial complex 
IV: cytochrome c 
oxidase subunits 
1 Unclassified 
ENSG00000132781 MUTYH DNA glycosylases 1 Unclassified 





ENSG00000128694 OSGEPL1  1 Siphoviridae 




ENSG00000135002 RFK  1 Unclassified 
ENSG00000100316 RPL3 L ribosomal proteins 1 Retroviridae 
ENSG00000073169 SELO  1 Myoviridae 
ENSG00000183032 SLC25A21 Solute carriers 1 Mimiviridae 
ENSG00000114120 SLC25A36 Solute carriers 1 Hytrosaviridae 
ENSG00000162241 SLC25A45 Solute carriers 1 Unclassified 
ENSG00000112096 SOD2  1 Unclassified 
ENSG00000143374 TARS2 Aminoacyl tRNA 
synthetases, Class II 
1 Unclassified 
ENSG00000066651 TRMT11 tRNA 
methyltransferases 
1 Pandoraviridae 
ENSG00000100300 TSPO  1 Unclassified 
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Viral families with 
orthologues 
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 Appendix IV: Acetylation study species 
 
Table 1. Vertebrate species included in the orthology dataset for the acetylation study. 
Species Group Species Group 
Homo sapiens Primates Eptesicus fuscus Bats 
Pan troglodytes Primates Myotis brandtii Bats 
Gorilla gorilla Primates Myotis lucifugus Bats 
Macaca fascicularis Primates Alligator mississippiensis Reptiles 
Callithrix jacchus Primates Alligator sinensis Reptiles 
Saimiri boliviensis Primates Crocodylus porosus Reptiles 
Carlito syrichta Primates Gavialis gangeticus Reptiles 
Otolemur garnettii Primates Thamnophis sirtalis Reptiles 
Oryctolagus cuniculus Primates Ophiophagus Hannah Reptiles 
Bos taurus Other Mammals Anolis carolinensis Reptiles 
Equus caballus Other Mammals Chelonia mydas Reptiles 
Canis familiaris Other Mammals Chrysemys picta Reptiles 
Orcinus orca Other Mammals Xenopus laevis Amphibia 
Loxodonta africana Other Mammals Gallus gallus Birds 
Dasypus novemcinctus Other Mammals Melopsittacus undulates Birds 
Sarcophilus harrisii Other Mammals Meleagris gallopavo Birds 
Monodelphis domestica Other Mammals Taeniopygia guttata Birds 
Ornithorhynchus anatinus Other Mammals Haliaeetus leucocephalus Birds 
Marmota marmota Rodents Falco peregrinus Birds 
Ictidomys tridecemlineatus Rodents Corvus brachyrhynchos Birds 
Heterocephalus glaber Rodents Nipponia nippon Birds 
Cavia porcellus Rodents Egretta garzetta Birds 
Chinchilla lanigera Rodents Charadrius vociferous Birds 
Octodon degus Rodents Cuculus canorus Birds 
Castor canadensis Rodents Calypte anna Birds 
Dipodomys ordii Rodents Chaetura pelagica Birds 
Jaculus jaculus Rodents Columba livia Birds 
Microtus ochrogaster Rodents Anas platyrhynchos Birds 
Mesocricetus auratus Rodents Struthio camelus Birds 
Peromyscus maniculatus Rodents Latimeria chalumnae Fish 
Neotoma lepida Rodents Oryzias latipes Fish 
Mus musculus Rodents Oreochromis niloticus Fish 
Rattus norvegicus Rodents Esox Lucius Fish 
Pteropus alecto Bats Danio rerio Fish 
Pteropus vampyrus Bats Lepisosteus oculatus Fish 
Rousettus aegyptiacus Bats Callorhinchus milii Fish 
 
